СПОСОБ ПРОФИЛАКТИКИ ДИАБЕТА ПОСРЕДСТВОМ ФИТОМАГНИТОФОРЕЗА

Изобретение относится к медицине. Предложен способ профилактики диабета посредством фитомагнитофореза на кожу паравертебральных зон шейного отдела позвоночника и прилегающих к ним надплечий фитомази, содержащей 25% по весу настойки листьев лавра благородного на 40% этаноле. Способ позволяет снизить повышенный уровень глюкозы, а концентрации глюкозы, находящиеся в "зоне нормы", приблизить к оптимуму. 1 табл.

ДОКТОРСКИЙ БАЛЬЗАМ "ЗДОРОВЬЯ ДЛЯ"

Изобретение относиться к лечебно-профилактическим бальзамам и может быть использовано для профилактики болезней нервной системы, органов кровообращения, дыхания, пищеварения, опорно-двигательного аппарата, обмена веществ, мочевыводящей и половой систем и кожи. Докторский бальзам "Здоровья для" содержит водные и водно-спиртовые экстракты из семян, плодов, листьев и корней применяющихся для пищевых целей лекарственных растений: листья перечной мяты, семена тмина, плоды шиповника коричного, плоды рябины обыкновенной, листья черной смородины, семена калины, корни пырея, и дополнительно следующих растений: корни лопуха, корни пастернака посевного, корни дягиля, корни цикория, гвоздику, корицу, семена укропа, семена кориандра, семена расторопши, семена арбуза, цветы боярышника красного, цветы граната, плоды черноплодной рябины, чернослив, абрикос сушеный (курага), плоды боярышника красного, плоды боярышника черного, плоды шиповника собачьего, плоды барбариса, плоды каштана сладкого, арбузные ...

КОМПОЗИЦИИ ДЛЯ ПРОФИЛАКТИКИ ИЛИ ОБЛЕГЧЕНИЯ СИНДРОМОВ МНОЖЕСТВЕННЫХ ФАКТОРОВ РИСКА

Изобретение относится к фармацевтической промышленности, в частности к получению средства для профилактики или облегчения синдрома множественных факторов риска. Средство для профилактики или облегчения синдрома множественных факторов риска, которое включает по меньшей мере один компонент в определенном количестве, выбранный из группы, состоящей из гидрофобного экстракта солодки, экстракта желтого корня (куркумы), экстракта гвоздики и экстракта корицы. Вышеописанное средство способствует эффективной профилактике или облегчению синдрома множественных факторов риска. 2 н. и 7 з.п. ф-лы, 18 табл.

ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ БРОНХИТА И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Изобретение относится к фармацевтической промышленности, в частности к фармацевтической композиции для лечения бронхита. Фармацевтическая композиция для лечения бронхита содержит порошок SCUTELLARIAE RADIX; эфирное масло, полученное из смеси растений CITRI RETICULATAE PERICARPIUM и CINNAMOMI RAMULUS; сконцентрированный водный экстракт, полученный изтравяного остатка, оставшегося после получения эфирного масла, и смеси растений, состоящей из ATRACTYLODIS MACROCEPHALAE RHIZOMA, PORIA, GLYCYRRHIZAE RADIX ET RHIZOMA, FARFARAE FLOS, FORSYTHIAE FRUCTUS; сконцентрированный этанольный экстракт из PINELLIAE RHIZOMA, PERILLAE FRUCTUS, SINAPIS SEMEN, RAPHANI SEMEN, ASTERIS RADIX ET RHIZOMA, HOUTTUYNIAE HERBA, ARMENIACAE SEMEN AMARUM.Заявленная фармацевтическая композиция эффективна в устранении мокроты, облегчении кашля, ослаблении астмы, а также сопротивлении воспалению, и оказывает хороший лечебный эффект при лечении бронхита. 10 з.п. ф-лы, 15 табл., 12 пр.

НОВАЯ СТАНДАРТИЗОВАННАЯ КОМПОЗИЦИЯ, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ В РЕГРЕССИИ РНК-ВИРУСНОЙ ИНФЕКЦИИ

Настоящее изобретение относится к противовирусным препаратам, полученным из источников растительного происхождения, т.е. коричного дерева, литчи и арахиса. Согласно настоящему изобретению предложена композиция и способ получения указанной композиции, содержащей пентамерный, тримерный и тетрамерный флавоноид процианидин. Данная композиция улучшает иммунный ответ и, как обнаружено, подходит для лечения и контроля ВИЧ-инфекции и СПИДа, а также для предупреждения, лечения и контроля вируса и инфекции гриппа. 5 н. и 20 з.п. ф-лы, 5 табл., 14 пр., 5 ил.

КОМПОЗИЦИЯ ИНГРЕДИЕНТОВ ДЛЯ БИОЛОГИЧЕСКИ АКТИВНОЙ ДОБАВКИ К ПИЩЕ "УССУРОЧКА"

Изобретение относится к пищевой промышленности. Биологически активная добавка к пище дополнительно содержит растворимые пищевые волокна, схинзандрилметиловые эфиры полиоксифенолов, эфирные масла и коричный альдегид, причем соотношение пищевых органических кислот, витаминов растворимых пищевых волокон, схинзандрилметиловых эфиров полиоксифенолов, эфирных масел и коричного альдегида составляет (15-87):(0,01-0,9) (1-50):(0,003-0,5):(0,1-5,2): (0,0001-0,01). Биологически активная добавка может применяться в безалкогольных напитках, слабоалкогольных напитках, соусах, полуфабрикатах для кондитерских изделий, мармеладе и т.п. Основной задачей заявленного изобретения является получение биологически активной добавки, обладающей витаминными, антидепрессивными, тонизирующим, антиоксидантными, противовоспалительным, иммунокоррегирующими и общеукрепляющими свойствами, повышающей физическую и умственную работоспособность, оказывающую благотворное влияние на желудочно-кишечный тракт, за счет оптимального ...

СПОСОБ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, ОБЛАДАЮЩЕГО ПРОТИВОВОСПАЛИТЕЛЬНЫМ ДЕЙСТВИЕМ

Изобретение относится к фармацевтической промышленности, а именно к способу получения средства, обладающего противовоспалительным действием. Способ получения лекарственного средства, обладающего противовоспалительным действием, представляющего собой сухой экстракт, полученный путем трехкратной экстракции растительного сырья: плодов граната, коры корицы, плодов кардамона, плодов перца длинного, корня имбиря, плодов яблони, корней девясила, плодов кориандра, плодов солодки, которое измельчают до размера частиц диаметром 1 мм и экстрагируют 50% этиловым спиртом в соотношении сырье : экстрагент, равном 1:(14-16), при температуре 60°C и постоянном перемешивании, при этом 1-ю и 2-ю экстракцию проводят в течение 60 минут, 3-ю экстракцию в течение 30 минут, объединенные извлечения упаривают до 1/3 первоначального объема и очищают сепарированием, очищенный экстракт доупаривают до 1/5 первоначального объема, высушивают в вакуумной сушилке при температуре 60°C в течение 8 ч, измельчают на мельнице ...

НАРУЖНОЕ СРЕДСТВО ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ С ТЕРМОЭФФЕКТОМ (ВАРИАНТЫ)

Изобретение относится к косметической промышленности, а именно к созданию наружного средства для местного применения с термоэффектом. В качестве действующих веществ средство содержит экстракт прополиса, комплекс углекислотных экстрактов арники, березы, зеленого чая, крапивы, ромашки, комплекс углекислотных экстрактов чеснока, мелиссы, каштан конский, желчь медицинскую, камфору, мумие, диметилсульфоксид, спирт этиловый, карбомер, триэтаноламин, эуксил, эфирное масло можжевельника; кроме того, средство содержит капсин, эфирное масло мяты, ментол, экстракт перца, углекислотный экстракт пихты сибирской, комплекс углекислотных экстрактов облепихи, петрушки, солодки. Данное наружное средство оказывает комплексное воздействие в зоне нанесения, удобно и эффективно в любой ситуации, когда требуется быстрая корректировка состояния реципиента при отсутствии квалифицированной медицинской или ветеринарной помощи. 3 табл.

МАЗЬ ПРОТИВОВОСПАЛИТЕЛЬНОГО, ОБЕЗБОЛИВАЮЩЕГО И РАНОЗАЖИВЛЯЮЩЕГО ДЕЙСТВИЯ (ВАРИАНТЫ)

Изобретение относится к медицине и касается создания лечебных средств, обладающих противовоспалительным обезболивающим и ранозаживляющим действием. Мазь может быть использована для лечения седалищного нерва, инсульта, остеохондроза, ревматоидного артрита, полиартрита, радикулита, подагры, миозита, заболеваний верхних дыхательных путей, дерматита, ожогов, ушибов и угревой сыпи. Мазь 1 содержит, мас.%: пихтовое масло 17; вазелин 23; ланолин остальное. Мазь 2 содержит, мас. %: пихтовое масло 5; камфорное масло 5; багульниковое масло 5; масло корня мандрагоры 5; масло плодов можжевельника 5; мед 5, мумие 5; медвежий жир 10; ланолин остальное. Мазь 3 содержит, мас.%: пихтовое масло 5; гвоздичное масло 0,6; масло корицы 0,6; эвкалиптовое масло 0,6; мятное масло 0,6; масло донника 5; масло алое 5; масло корня мандрагоры 5; масло подорожника 5; мед 5; лосиный жир 5; медвежий жир 5; ланолин остальное. Мазь 4 содержит, мас.%: пихтовое масло 12, масло перца красного 12; мед 24, медвежий жир 4; ланолин ...

СРЕДСТВО "ЛАБУНИК" И СПОСОБ ЛЕЧЕНИЯ КОЖНЫХ ЗАБОЛЕВАНИЙ

Изобретение относится к медицине и может быть использовано для лечения псориаза, атопического дерматита, крапивницы, экземы, отека Квинке, трофических язв. Для лечения кожных заболеваний используют мазь. Мазь содержит, г: траву и цветы чистотела большого 8 - 10; листья подорожника большого, и/или среднего, и/или ланцетовидного 8 - 10; цветы ландыша майского 8 - 10; трава и цветы ромашки аптечной 8 - 10; мед цветочный майский 10 - 12; белок сырого куриного яйца 6 - 8; эвкалиптовое масло 0,3; ланолин 5 - 7; солидол медицинский 100 - 110. Способ лечения заключается в нанесении мази на очаг поражения на 3 - 4 ч. Затем мазь смывают теплой водой и обрабатывают кожу смягчающим кремом. Местное применение средства не вызывает аллергических реакций и побочных эффектов. Лечение мазью является практически безрецидивным. 2 с.п. ф-лы. c ...

БИОЛОГИЧЕСКИ-АКТИВНАЯ КОМПОЗИЦИЯ "ФИТАОН-2" И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Использование: лечебно-профилактические разделы медицины - физиотерапия, дерматология, терапия. Сущность изобретения: бальзамическое биологически активное средство содержит экстракты растений - листа мяты перечной, почек сосны обыкновенной, корня солодки, цветков календулы лекарственной, трав тысячелистника обыкновенного, зверобоя обыкновенного, чистотела, чабреца обыкновенного, сушеницы топяной, душицы, плодов черного перца и кориандра в дистиллированной воде; эфирные масла - мятное, кориандровое, анисовое, пихтовое, камфарное - в качестве ароматизирующего компонента, а также глицерин и водный раствор аммиака. Ароматизирующий компонент использован с тонизирующими добавками в количестве не более 0,1% от веса основы. Средство допускает различные комбинации ингредиентов и их содержания. Предложен также способ получения средства. 2 с.п. ф-лы.

КОМПОЗИЦИЯ ИНГРЕДИЕНТОВ ДЛЯ БАЛЬЗАМА

Изобретение может быть использовано в ликероводочной промышленности при приготовлении бальзама. В состав композиции для бальзама "Садко" входят следующие ингредиенты при определенном соотношении: аралия манчжурская (корни), березовые почки, боярышник кроваво-красный (плоды), брусника (листья), вишня (листья), гвоздика (нераспустившиеся почки цветов), душица обыкновенная (верхушки цветущих стеблей), зверобой пронзенный (цветы и листья), кориандр посевной (плоды), корица (кора), липа (цветы), мелисса лимонная (трава), можжевельник обыкновенный (шишко-ягода), мускатный орех, родиола розовая (корни), ромашка лекарственная обыкновенная (цветочные корзинки), смородина черная (листья), тмин обыкновенный (плоды), тысячелистник обыкновенный (верхушки цветущих стеблей), черника (листья), элеутерококк (корни), брусника свежая, клюква свежая, смородина черная свежая, рябина черноплодная свежая, шиповник сушеный, чернослив, яблоки свежие, миндальное эфирное масло, мед натуральный, сахар-песок, лимонная ...

ЛЕКАРСТВЕННЫЙ СБОР ДЛЯ СНЯТИЯ СИНДРОМА ПОХМЕЛЬЯ И ТЯГИ К АЛКОГОЛЮ

Изобретение относится к медицине, а именно к созданию лекарственных средств, и может быть использовано для лечения и профилактики алкоголизма, а также ОРВИ, простудных заболеваний, а также как противолихорадочное, общеукрепляющее, антистрессовое средство. Сбор на основе растительного сырья и содержит компоненты: имбирь, кардамон, мяту, мелиссу, мускат, ферулу, гвоздику, лимонную кислоту, корицу при следующем соотношении, мас.ч.: имбирь 0,2 - 0,7; кардамон 0,1 - 0,6; мята 0,3 - 0,8; мелисса 0,05 - 0,1; мускат 0,6 - 0,9; ферула 0,04 - 0,09; гвоздика 1,5 - 1,8; лимонная кислота 0,1 - 0,5; корица 0,2 - 0,6. Сбор ускоряет метаболизм алкоголя в организме, при длительном приеме снимает усталость, тяжесть, депрессивное состояние, устраняет боли в сердце.

СПОСОБ ПОЛУЧЕНИЯ ВОДНОГО РАСТВОРА, СОДЕРЖАЩЕГО АКТИВНЫЕ ВЕЩЕСТВА АНТИВИРУСНОГО ДЕЙСТВИЯ

Использование: в медицине для восстановительной химиотерапии при инфекционных заболеваниях вирусного характера. Сущность изобретения: способ получения водного раствора антивирусного действия экстракцией лигноцеллюлозного сырья. Осуществляют водные экстракции сырья, обогащенного полисахаридами, при pH 4-14, и сырья, обедненного полисахаридами, при pH 8-14. Экстракты отделяют от твердых частиц, смешивают, доводят pH смеси до 8-14. Образующиеся в смеси продукты реакции разделяют по молекулярным массам при степени разделения 18-40 КД, а целевой раствор, содержащий низкомолекулярные фракции продуктов реакции, обрабатывают H+ катионообменником до установления стабильной величины pH в диапозоне 3-7, отделяют от твердых частиц и стерилизуют. 17 з.п. ф-лы, 7 табл., 9 ил.

БАЛЬЗАМИЧЕСКОЕ БИОЛОГИЧЕСКИ АКТИВНОЕ СРЕДСТВО - ФИТАОН-4 И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Изобретение относится к медицине, а именно к лечебно-профилактическому разделу медицины, физиотерапии, терапии. Бальзамическое биологически активное средство содержит спиртовые экстракты растений, растительные масла в качестве ароматизирующего компонента, консервант, растворитель, перец черный душистый и тонизирующие добавки. Предложен также способ получения средства. Средство обладает широким спектром действия. 2 с. и 3 з.п.ф-лы.

ПРЕПАРАТИВНЫЕ ФОРМЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ МУЖСКОЙ И ЖЕНСКОЙ ИМПОТЕНЦИИ

... 1. Фармацевтическая композиция, включающая экстракты Tribulus terrestris, Epimedium koreanum и Cinnamon cassia в весовом соотношении 1,5-3,5:1-2:0,1-0,4 соответственно; и необязательно аргинин или физиологически эквивалентный эфир, его соль или предшественник и подходящий носитель или наполнитель. 2. Композиция по п. 1, в которой весовое соотношение экстрактов Tribulus terrestris, Epimedium koreanum и Cinnamon cassia составляет 2,5:1,5:0,2. 3. Композиция по п. 1 или 2, содержащая экстракты Tribulus terrestris, Epimedium koreanum, Cinnamon cassia и L-аргинин или гидрохлорид L-аргинина соответственно в весовых соотношениях 1,5-3,5:1-2:0,1-0,4:0,5-1,5. 4. Композиция по п. 3, в которой весовое соотношение экстрактов Tribulus terrestris, Epimedium koreanum и Cinnamon cassia и L-аргинина или гидрохлорида L-аргинина составляет 2,5:1,5:0,2:1. 5. Применение экстрактов Tribulus terrestris, Epimedium koreanum и Cinnamon cassia в весовом соотношении 1,5-3, 5:1-2:0,1-0,4, соответственно, и необязательно ...

ЛЕКАРСТВЕННЫЙ СБОР ДЛЯ ДЕТОКСИКАЦИИ ОРГАНИЗМА (ВАРИАНТЫ) И СПОСОБ ДЕТОКСИКАЦИИ ОРГАНИЗМА

Изобретение относится к медицине, а именно к фитотерапии и может быть использовано для детоксикации организма. Целью изобретения является сокращение сроков лечения и удлинение ремиссии. Поставленная цель достигается тем, что в лекарственный сбор, содержащий цветы календулы, хвощ полевой, семена укропа, траву зверобоя, лист подорожника, дополнительно включены: плод алойного дерева, плод арековой пальмы, плоды можжевельника, лист лавра, корень шлемника байкальского, корень марены красильной, цвет бузины, рыльца цветков шафрана, трава фиалки трехцветной в сборе N 1, и лист лавра, корень марены красильной, цвет бузины, корица китайская, корень солодки, корень гранатника дикого, лист барбариса - в сборе N 2. При этом сбор N 1 принимается в течение 7 дней по 50 г 4 раза в день за 20 мин до еды. Вечером последнего дня приема лекарственного сбора N 1 проводится очистительная клизма. На восьмой день на фоне полного голодания принимается отвар лекарственного сбора N 2 по 50 г каждые 2 ч (6 раз).

СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ КОСТНО-МЫШЕЧНОЙ СИСТЕМЫ НА ОСНОВЕ КОМПОЗИЦИИ "ИЗУМРУДНАЯ"

Изобретение относится к созданию лекарственных средств, которые могут быть использованы для комплексного лечения заболеваний костно-мышечной системы, в том числе суставов и позвоночника в санаторно-курортных условиях. Композиция "Изумрудная" содержит, в заданных количествах, следующие активные ингредиенты: аир (корень), осину (кора), чабрец (трава), шалфей (соцветия), мяту блошиную (трава), девясил (корни), лавр благородный (листья), азалию (цветки), бузину черную (цветки), агримонию (трава), лопух (корни), полынь (трава), сосну (хвоя), донник лекарственный (трава), багульник, а также целевую добавку: масло подсолнечное, масло беленное, масло камфорное, анестезина порошок, раствор аммиака, раствор димексида, порошок глины голубой. Из указанного состава композиции задают отдельные составы и применяют их для каждого отдельного этапа лечения заболеваний костно-мышечной системы. Все этапы лечения входят в единый лечебный процесс, при котором на первом этапе тело больного прогревают в лечебной ...

Оздоровительно-профилактический напиток "Чакура", обладающий противовирусной, противоопухолевой, против болезни Альцгеймера активностью

БИОЛОГИЧЕСКИ АКТИВНАЯ КОМПОЗИЦИЯ "ФИТАОН-2,2" И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Использование: лечебно-профилактические разделы медицины - хирургия, урология, дерматология, стоматология, отолорингология, гинекология, проктология, физиотерапия. Сущность изобретения: бальзамическая биологически активная композиция содержит водные экстракты растений - травы сушеницы топяной, тысячелистника, чистотела, чабреца, душицы и зверобоя, листья мяты, почки сосны, цветки ноготков, ромашки, плоды и/или листья конского каштана и корень солодки, эфирные масла из ряда: мятное, кориандровое, анисовое пихтовое и камфорное - в качестве ароматизирующего компонента, аммиак водный - в качестве консерванта, глицерин, олеиновая кислота - в качестве косметического средства, вода дистиллированная - в качестве экстрагента. Ароматизирующий компонент использован с тонизирующими добавками в количестве не более 0,2% по весу основы. Композиция допускает различные комбинации ингредиентов и их содержание. Предложен также способ получения средства.

РЕСУРСОСБЕРЕГАЮЩИЙ СПОСОБ ПОЛУЧЕНИЯ СУХОГО ЭКСТРАКТА ИЗ КОРЫ КОРИЧНИКА ЦЕЙЛОНСКОГО

Способ получения сухого экстракта коричника цейлонского, включающий экстракцию, фильтрование, упаривание, отличающийся тем, что экстракция проводится в два этапа 30%-ным водным раствором этанола при температуре 70°С каждая стадия, с выдержкой 1 ч, экстракт очищается спиртовым методом при температуре 4°С, после этого полученный продукт фильтруют от пектинового осадка и упаривают фильтрат до сухого остатка при абсолютном давлении 0,2-0,3 атм. технических.

БИОЛОГИЧЕСКИ АКТИВНАЯ ДОБАВКА "ИММУННЫЕ ПЛЮС"

Препарат, обладающий иммунокорректирующим действием, характеризующийся тем, что содержит сухой концентрат настоя травы эхинацеи, сухой концентрат экстракта корня солодки, сухой концентрат экстракта родиолы розовой, цветочную пыльцу, корицу, корень имбиря, кислоту лимонную, сульфат цинка, витамин Е крахмал, стеарат кальция и сахар при следующем соотношении компонентов в г, на таблетку массой 0,55 г: Сухой концентрат настоя травы эхинацеи 0,00003-0,000075 Сухой концентрат экстракта корня солодки 0,0050-0,0500 Сухой концентрат экстракта родиолы розовой 0,0006-0,0024 Цветочная пыльца 0,0050-0,0400 Корица 0,0025-0,0100 Корень имбиря 0,0025-0,0100 Кислота лимонная 0, 0025-0,0100 Сульфат цинка 0,0025-0,0100 Витамин Е 0,0010-0,0050 Крахмал 0,0250-0,100 Стеарат кальция 0,0025-0,0100 Сахар Остальное ...

ПРИМЕНЕНИЕ КОСТОЧКИ АВОКАДО ДЛЯ ПОЛУЧЕНИЯ МАСЛА АВОКАДО, ОБОГАЩЕННОГО АЛИФАТИЧЕСКИМИ МНОГОАТОМНЫМИ СПИРТАМИ И/ИЛИ ИХ АЦЕТИЛИРОВАННЫМИ ПРОИЗВОДНЫМИ

... 1. Применение семян авокадо для получения путем механического прессования масла авокадо, обогащенного алифатическими многоатомными спиртами и/или их ацетилированными производными, при этом указанные семена составляют от 10 до 50 мас.% от общей массы используемого авокадо, указанные алифатические многоатомные спирты являются насыщенными, мононенасыщенными или полиненасыщенными трехатомными спиртами С-Cалифатического неразветвленного линейного 1,2,4-тригидроксильного типа.2. Применение по п. 1, где семена авокадо составляют от 15 до 40 мас.%, в особенности от 20 до 40 мас.%, от общей массы используемого авокадо.3. Применение по п. 1 или п. 2, где авокадо измельчены или нарезаны долькамии, затем высушены при высокой температуре, как правило от 60 до 150°С, предпочтительно до получения остаточной влажности, меньшей или равной 5%, перед получением масла путем механического прессования.4. Применение по п. 3, где после измельчения и сушки авокадо перед получением масла путем механического прессования ...

Der "Kräuter-Reissack zum Schutze der Gesundheit", seine Herstellung und Verwendung

Topisch applizierbares Wirkstoffgemisch

TONIKUM FUER DIE HUMANMEDIZIN UND TIERMEDIZIN UND VERFAHREN ZU SEINER HERSTELLUNG

VERWENDUNG VON EINEM PRODUKT AUS PFLANZLICHEM ÖL ZUR ERHÖHUNG DER HAUTLIPIDEN PRODUKTION

A pharmaceutical composition having anti-decrepit action and a process for preparation thereof

Ozonated oil formulations

Manufacture of health foods by fermentation of rocks

Health food compositions comprising i) The products of fermentation of sedimentary and/or metamorphic rocks using microorganisms; ii) starch and iii) at least one of the following a Yin invigorating agent e.g. Rhizoma anemarrhenae , a heat alleviating agent e.g. sea tangle, a perspiring, antipoisoning and thirst quenching agent e.g. Ramulus cinnamomi , an impurity purifying agent e.g. Rhizoma zedoariae , an energy invigorating agent e.g. Radix astragali , a blood building-up agent e.g., Radix angelicae giganiois , a mitigigative e.g. Radix glycyrrhizae , a lung, kidney and liver invigorating agent e.g., Radix ophiopogonis , an anti-palsy agent, e.g. Radix ligustici tenuissimae , a stomachic e.g., Fructus hordei germinatus and micronutrients. The compositions are used to improve appetite, reduce fatigue and treat nephritis, hepatitis, and bronchitis.

Process for preparing anti-AIDS ayurvedic medicine

COMPOSITION FOR MITIGATING SIDE-EFFECTS OF ANTI-CANCER AGENT

BETEL NUT AND NICOTINE CHEWING GUM

A gum based chewing product, particularly a chewing or bubble gum, containing a synthetic or natural betel nut source, and nicotine. Each gum piece may contain between 1 and 12.6 mg of nicotine. The product may contain taste enhancers such as catechu and lime. A process for the preparation of the gum is also outlined.

Use of a combination of essential oils for the treatment of acne

A composition of essential oils for use in the treatment of acne. The composition comprises (i) Jojoba base oil (Simmondsia chinesis), (ii) Avocado base oil (Persea americana), (iii) Sesame seed base oil (Sesamum indicum), (iv) Pumpkin seed oil (Cucurbita pepo), (v) Juniper oil (Juniperus communis), (vi) Cajuput oil (Melaleuca leucodendron), (vii) Lavender oil (Lavandula angustifolia) and (viii) Grapefruit seed oil (Citrus paradisi). Each of the essential oils i) to viii) is preferably 100% organic. Preferably, the components (i) to (viii) are present in the following amounts by volume of the composition: (i) 60%, (ii) 10%, (iii) 10%, (iv) 10%, (v) 3%, (vi) 3%, (vii) 3% & (viii) 1%. In another aspect, a method of preparation of the acne treatment composition as shown above in Figure 3.

Antimicrobial composition

Compositions for the preservation of foodstuffs, for the sterilization and hygiene ofair in confined spaces and for cosmetic and pharmaceutical purposes

A composition for the preservation of foodstuffs, for the sterilization of air in confined spaces and for cosmetic and pharmaceutical purposes comprising an essential oil having bacteriostatic and/or bactericidal properties or a bacteriostatically and/or bactericidally active compound extracted from such an oil, acetic or citric acid and ethanol or ispropyl alcohol. The composition may comprise oil of cloves, cinnamon oil, peppermint oil, oil of thyme, oil of rosemary, mustard oil, thymol, cinnamic aldehyde, polyoxyethylene oleate or stearate, polyoxyethylene sorbitan mono-palmitate, mono- or tri-oleate, or mono- or tri-stearate, and mucilages of animal, vegetable or synthetic origin (e.g. tragacanth or agar-agar). The composition may be in the form of an aqueous concentrate. The composition may be applied to the food by steeping or spraying. Sheep's guts, pigs' intestines, fish, shellfish, sausages, cheese and pastry goods may be treated. The composition may be sprayed or vapourized in ...

Gum based chewing product and process for preparing the same

Viricidal substances and preparations and use thereof

The invention relates to a process and a preparation for deactivating viruses inside living human and animal organisms by application of a terpene obtainable from aromatic plants by steam distillation. The terpenes cited are: black pepper oil, cinnamon flower oil, cardamon oil, linallyl acetate, cinnamic aldehyde, safrol, carvon and cis/trans citral.

Cream SAGINA.

PROCEDURE FOR THE PRODUCTION OF A ADMINICULUMS

PROCEDURE FOR THE PRODUCTION OF A DRUG PREPARATION FOR THE IMPROVEMENT OF CANCER SYMPTOMS

COMPLEMENTARY COMPOSITIONS FOR THE DECREASE OF THE BLOOD SUGAR MIRRORS AND FOR THE TREATMENT OF DIABETES

ETHERI OILS COMBINATION AND THERAPEUTIC USES

INSECT DEFENSE MEANS

CLEANING DEVICE FOR CHILDREN WITH A BIOLOGICAL EXCERPT

PROCEDURE FOR THE PRODUCTION OF A ADMINICULUMS

PROCEDURE FOR THE PRODUCTION OF A DRUG PREPARATION FOR THE IMPROVEMENT OF CANCER SYMPTOMS

PRODUCTION PROCEDURE OF A UNVERSEIFBAREN AVOCADOFRAKTION WITH A HIGHER ONE FURANLIPIDENGEHALT

MOLECULE COMPOUND SYSTEM TO RETORT ESKALATIVEN THE THERAPY VIRALER INFECTIONS.

USE FROM COMPOSITIONS TO VERHUTUNG OR ALLEVIATION OF SYNDROMES WITH MULTIPLE FACTORS OF RISK

COMPOSITIONS TO THE TREATMENT OF THE MALE ONES AND FEMALE ONES IMPOTENZ

PROCEDURE FOR THE PRODUCTION OF THE ACTIVE SUBSTANCES FROM VEGETABLE DRUGS

VERFAHREN ZUM AUFBEREITEN VON LEBENSMITTELN

COMPOSITION FOR THE TREATMENT OF EVIL-SMELLING BREATH

Procedure for the production of a pharmakologisch effective substance from Ravensara aromatica

CRACKING PROCEDURE

Traditional Chinese medicine composition for treating metabolic syndrome and preparations thereof

Disclosed are a traditional Chinese medicine composition and a traditional Chinese medicine extract composition for treating metabolic syndrome. The traditional Chinese medicine composition consists of the following raw materials in the following weight ratio: 5-80% of Coptis Chinensis, 5-70% of Fructus Aurantii Immaturus, 0-60% of Pinellia Ternata, 0-40% of Fructus Trichosanthis, 0-12% of ChineseCinnamon, and 10-60% of red yeast rice. The traditional Chinese medicine extract composition consists of the following raw materials in the following weight ratio: 2-30% of Coptis Chinensis extract, and 70-98% of a mixed extract from five traditional Chinese medicines including Fructus Aurantii Immaturus, Pinellia Ternata, Red Yeast Rice, Fructus Trichosanthis and Chinese Cinnamon. The traditional Chinese medicine composition or the traditional Chinese medicine extract composition contains the following active ingredients (mg/g): 6-122mg of total alkaloids, including 4-89mg of berberine; 30-315mg ...

Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care

Processes for making caralluma extracts and uses

Abstract This invention provides Caralluma extract products that are standardised, representative of the caralluma plant material from which they are derived, are reproducible and which form suitable starting materials (intermediates) for the medicinal, nutraceutical and food products of caralluma and which are, furthermore, suitable for direct administration to subjects. The invention also provides a process for making a composition for medicinal, nutraceutical and food applications, that chiefly comprises one or more pregnane glycosides, from plant matter wherein the nature of the solvent/solvent mixture for extraction and the conditions of extraction and of concentration of the extract are selected such as to prevent/minimise the decomposition of said glycosides and the simultaneous extraction of non-glycoside matter such as pectins, tannins and the resinous matter contained in said plant matter. WO 2004/108148 PCT/IN2004/000150 PRETREATMENT 110 CRUSHING AND/OR GRINDING 120 EXTRACTION ...

Nutritional composition for increasing creatine uptake in skeletal muscle

Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts

The present invention is directed to a method for decreasing inflammation and stress in a mammal comprising; administration to a mammal a composition comprising a glucose antimetabolite; and wherein said composition comprises amounts of the glucose anti-metabolite sufficient to lower a level of a C-reactive protein in the blood of the mammal subsequent to administration of the glucose anti-metabolite.

Antimicrobial compositions

Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical

Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder (, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia bipolar disorder, ) or as at risk for a neuropsychiatric disorder a benzoic acid, benzoic acid salt, and/or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, in combination with a neuropharmacological agent (, an antipsychotic, an antidepressant, medications for attention deficit and hyperactivity disorder, cognitive impairment, or dementia, etc.) where the benzoic acid, benzoic acid salt, or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, is in an amount sufficient to increase the efficacy of the neuropharmacological ...

FORMULATIONS USEFUL IN THE TREATMENT OF MALE AND FEMALE IMPOTENCE

COMPOSITION FOR HEART DISEASE, METHOD TO PREPARE SAME AND USES THEREOF

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MENOPAUSAL SYNDROME AND PREPARATION METHOD THEREOF

Abstract Disclosed is a pharmaceutical composition for the treatment of Menopausal Syndrome, wherein the pharmaceutical composition is consisted of the following herbs in weight parts: 5 1-3 parts Ramulus Cinnamomi, 0.5-2 parts Rhizoma Zingiberis, 2-4 parts Fructus Schisandrae Chinensis, 2-4 parts Flos Inulae, 3.5-5 parts Herba Lophatheri, 2-4 parts Cortex Moutan Radicis, 0.5-2 parts Fructus Jujubae, 2-4 parts Semen Ziziphi Spinosae, 2-4 parts Fructus Corni, 2-4 parts Radix Rehmanniae Recens, 2-4 parts Radix Codonopsis, and 0.5-2 parts Fructus Gardeniae. All herbs of the composition have synergistic effects to tonify liver and 10 supplement qi, nourish blood and tranquilize mind, clear deficient heat, and relieve restlessness. This invention also discloses a method for preparing the pharmaceutical composition for the treatment of Menopausal Syndrome, which is easy to implement, simple, safe and reliable, and suitable for industrial scale production.

Medical formulation for treating hypercholesterolemia

The present invention relates to a medical formulation comprising: cinnamomum zeylanicum; Pinus pinaster; extract of a plant belonging to the Saccharum genus; Monascus purpureus; Taraxacum officinale; Camellia sinensis; vitamin B3; alpha tocopherol; coenzyme Q ...

Use of avocado skin for obtaining an avocado unsaponifiable material enriched with saturated aliphatic hydrocarbons and with sterols

The present invention relates to the use of avocado skin for obtaining an avocado unsaponifiable material enriched with saturated aliphatic hydrocarbons and with sterols, wherein said avocado skin represents 5% to 50% by weight relative to the total weight of avocados used. The invention also relates to a process for obtaining an avocado unsaponifiable material enriched with saturated aliphatic hydrocarbons and with sterols from at least avocado skin, wherein said avocado skin represents 5% to 50% by weight relative to the total weight of avocados used. The invention also relates to an avocado unsaponifiable material enriched with saturated aliphatic hydrocarbons and with sterols, which can be obtained by means of this process. Finally, the invention relates to an avocado unsaponifiable material enriched with saturated aliphatic hydrocarbons and with sterols, for use as a medicament, advantageously in the prevention and/or treatment of connective tissue disorders such as arthrosis, pathological ...

Use of whole soft avocados for preparing avocado oil rich in unsaponifiables

The present invention relates to the use of whole soft avocados for preparing avocado oil rich in unsaponifiables, said unsaponifiables containing aliphatic acetogenins and/or derivatives thereof. Advantageously, the oil has an acid value of less than or equal to 3 mg KOH/g. The invention further relates to a method for preparing avocado oil rich in unsaponifiables from whole soft avocados, said unsaponifiables containing aliphatic acetogenins and/or derivatives thereof. The invention further relates to avocado oil which is rich in unsaponifiables and which can be prepared by said method. The invention further relates to the use of the avocado oil for preparing an avocado oil concentrate enriched with unsaponifiables, or avocado unsaponifiables that are rich in aliphatic furans. Finally, the invention relates to avocado unsaponifiables which are rich in aliphatic furans or to an avocado oil concentrate which is enriched with unsaponifiables, and which can be prepared from said avocado oil ...

Antitumor and antiviral medications and method for producing the same

Herbal compositions and uses for the treatment of allergic reactions

ANTIMICROBIAL COMPOSITION COMPRISING SOY OIL, RICE BRAN OIL AND JOJOBA OIL

An embodiment of the present invention, including a treatment for cuticles or other skin tissue comprising a mixture of soy oil, rice bran oil, jojoba oil, and an effective amount an antifungal/antimicrobial agent is disclosed. In addition, in a preferred embodiment of the present invention, a treatment for cuticles or other skin tissue comprising a mixture of soy oil, rice bran oil, jojoba oil, avocado oil, primrose oil, juniper oil, grapefruit oil, chamomile oil, lavender oil with an effective amount of an antifungal/antimicrobial agent is described.

ANTIPHLOGISTIC

NOVEL COMPOSITIONS CONTAINING ISOLATED TETRAMERIC TYPE A PROANTHOCYANADIN AND METHODS OF USE AND MANUFACTURE

The present invention relates to compositions containing an isolated novel tetrameric type A proanthocyanidin isomer having a formula Of C60H48O24. The isomer is most preferably isolated from cinnamon (Cinnamomum spp.) and may be used in pharmaceutical compositions as antiinflammatories, bactericides, antimicrobial formulations, or supplements for general or specific uses.

CURATIVE AND PREVENTIVE AGENT FOR ULCERS OF DIGESTIVE ORGANS

A curative and preventive agent for ulcers of digestive organs comprising as the main constituent an active component having anti-ulcer activity derived from a hot-water, an alcohol or a water-alcohol mixed solution extract of cassia buds.

THERAPEUTIC AND PROPHYLACTIC AGENTS FOR PEPTIC ULCER

A therapeutic and prophylactic agent for peptic ulcers which contains as an active ingredient a compound of the general formula (I): (I) wherein R1 represents hydrogen or =O; R2 represents hydrogen or -OR5; R3 represents hydrogen or -OR6; R4 represents OR7 in the case of the absence of double bond, R5 R6 and R7 each represents hydrogen or an organic residue; X represents group (A): ?C?CH?COR8 (A) or group (B): (B) wherein R8 represents alkyl, and R9 and R10 each represents hydrogen or an organic residue; with the proviso that when X represents group (A), then R1 and R3 both represent hydrogen, R2 represents -OR5,R4 represents OR7 and the bond between the carbon atom to which X is attached and the carbon atom to which R4 is attached is a single bond, and when X represents group (B), then R1 represents =O, R2 represents hydrogen, R3 represents -OR6 and the bond between the carbon atom to which X is attached and the carbon atom to which R4 is attached is a double bond, or a pharmaceutically ...

TONIC COMPOSITION FOR MAN AND OTHER ANIMALS AND A METHOD FOR THE MANUFACTURE THEREOF

HERBAL COMPOSITIONS AND USES FOR THE TREATMENT OF ALLERGIC REACTIONS

The present invention relates generally to a composition for the treatment or prophylaxis of allergic and inflammatory reactions such as but not limited to Type I hypersensitivity reactions in mammals. More particularly, the present invention is directed to compositions comprising herbs or extracts of herbs or botanical or horticultural equivalents of the herbs or chemical or functional equivalents of the herbal extracts useful in the treatment or prophylaxis of allergic and inflammatory reactions such as but not limited to respiratory disorders. The present invention further contemplates a method of treating allergic and inflammatory reactions in mammals and in particular Type I hypersensitivity disorders and even more particularly respiratory disorders by the administration of a herbal composition or its chemical or functional equivalent.

COMPOSITIONS AND METHODS FOR TREATING THE EYE

The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.

USE OF C7 SUGARS IN PREVENTION AND TREATMENT OF MYCOSES

L'invent ion a pour objet l'utilisation d'au moins un sucre en C7 pour la fabrication d'une composition destinée à la prévention et/ou au traitement de mycoses choisies dans le groupe constitué par les candidoses et les pityr osporoses. Les sucres en C7 sont de préférence un extrait hydrosoluble de su cres d'avocat.

METHODS AND COMPOSITIONS FOR INCREASING ENERGY EXPENDITURE USING CINNAMALDEHYDE

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde but otherwise identical. The composition comprising cinnamaldehyde can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehyde is administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement to a food product.

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEPRESSION AND PREPARATION METHOD THEREOF

Disclosed is a pharmaceutical composition for the treatment of depression, wherein the pharmaceutical composition is comprised of the following herbs in weight parts: 2-10 parts Ramulus Cinnamomi, 2-10 parts Rhizoma Zingiberis, 2-10 parts Fructus Schisandrae Chinensis, 2-8 parts Semen Ziziphi Spinosae, 2-8 parts Radix Codonopsis, 1-3 parts Rhizoma Dioscoreae, 0.5-2.5 parts Flos Inulae, 1-3 parts Caulis Bambusae in Taenia, 1-3 parts Fructus Trichosanthis, 1.5-4 parts Caulis Polygoni Multiflori, 1.5-4 parts Radix Ophiopogonis, 2-8 parts Radix Rehmanniae, 1.5-4 parts Cortex Moutan Radicis, 0.5-2.5 parts Fructus Gardeniae, 0.5-2.5 parts Herba Lophatheri, and 0.2-1.5 parts Folium Sennae. Also disclosed is a method for preparing the pharmaceutical composition as described above for treatment of depression.

SYSTEM, METHOD AND FORMULATION FOR TREATING USED ANIMAL BEDDING

A method, system and formulation for treating animal bedding and animals is provided. For the method, it comprises: mixing used bedding with unused bedding to produce mixed bedding; deodorizing the mixed bedding; drying the mixed bedding to have a moisture content of between approximately 7 and 14 %; removing lighter fibers from the mixed bedding; adding an oil treatment to the mixed bedding to have a moisture content of between approximately 7 and 14 % in the mixed bedding; and bagging the mixed bedding while the mixed bedding is still moist from the oil treatment.

COCHLEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME

The present invention provides, in part, cochleate compositions and methods for making and using same.

USE OF AVOCADO PIT FOR OBTAINING AN AVOCADO OIL ENRICHED WITH ALKYL POLYOLS AND/OR ACETYLATED DERIVATIVES THEREOF

La présente invention concerne l'utilisation de noyau d'avocat pour obtenir une huile d'avocat enrichie en alkyls polyols et/ou en leurs dérivés acétylés, ledit noyau d'avocat représentant 10 à 50% en masse par rapport à la masse totale d'avocats utilisés. L'invention concerne également un procédé d'obtention d'une huile d'avocat enrichie en alkyls polyols ou en leurs dérivés acétylés à partir d'au moins des noyaux d'avocats, lesdits noyaux d'avocat représentant 10 à 50% en masse par rapport à la masse totale d'avocats utilisés. L'invention concerne également une huile d'avocat enrichie en alkyls polyols et/ou en leurs dérivés acétylés, susceptible d'être obtenue par ce procédé. L'invention concerne également l'utilisation de l'huile d'avocat pour préparer un concentrât d'huile d'avocat enrichi en alkyls polyols et/ou en leurs dérivés acétylés, ou pour préparer un insaponifiable d'avocat enrichi en alkyls polyols. Enfin, l'invention concerne un insaponifiable d'avocat enrichi en alkyls ...

USE OF AVOCADO SKIN FOR OBTAINING AN AVOCADO UNSAPONIFIABLE MATERIAL ENRICHED WITH SATURATED ALIPHATIC HYDROCARBONS AND WITH STEROLS

La présente invention concerne l'utilisation de peau d'avocat pour obtenir un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques saturés et en stérols, ladite peau d'avocat représentant 5 à 50% en masse par rapport à la masse totale d'avocats utilisés. L'invention concerne également un procédé d'obtention d'un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques saturés et en stérols à partir d'au moins de la peau d'avocat, ladite peau d'avocat représentant 5 à 50% en masse par rapport à la masse totale d'avocats utilisés. L'invention concerne également un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques saturés et en stérols, susceptible d'être obtenu par ce procédé. Enfin, l'invention concerne un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques saturés et en stérols, pour son utilisation comme médicament, avantageusement dans la prévention et/ou le traitement des troubles du tissu conjonctif tels que l'arthrose, des pathologies articulaires ...

PROCEDURE FOR PREPARING FOOD.

PHARMACEUTICAL PREPARATION FOR INACTIVATING OF VIRUSES.

MEANS FOR THE REINFORCEMENT OF THE ANTI-TUMOR EFFECTIVENESS OF MITOMYCIN C AND DOXORUBICIN HYDROCHLORIDE.

ANTI-ACNE COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE OTHER ACTIVE INGREDIENT.

DRUG PREPARATION FOR THE IMPROVEMENT OF CANCER SYMPTOMS.

Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc.

Herbal medicaments are prepd. by (a) dissolving 3-7 pts.wt. of antimicrobial essential oils in 90% EtOH; (b) adding a mixt. of 20-40 pts.wt. of a tincture of the leaves and roots of Echinacea angustifolia and E.pallida (1:1) and 20-40 pts. wt. of a tincture of the leaves and roots of E.purpurea; (c) diluting to 100 pts.wt. with 90% EtOH; (d) allowing the mixt. to stand; and (e) filtering off the ppte. to obtain the medicament as a clear soln. USE - Medicaments may be used to treat infections, colds, influenza, bronchitis, inflammations and infections of the oral cavity, nose and throat, infections of the urogenital tract, and immunodeficiency due to repeated infections.

Mixed herbs for producing tea drinks, comprises coriander, cinnamon, ginger powder, black tea, rose hips, cardamom, cloves, star anise and pepper

The mixed herbs for producing tea drinks, comprises coriander (9.3-25 wt.%) , cinnamon (0.46-1.5%), ginger powder (0.09-3 wt.%), black tea, rose hips (9.3-31.25%), cardamom (0.09-3%), cloves (0.46-0.93%), star anise (0.93-2.5%) and pepper (0.93-1.56%). An independent claim is included for an aqueous solution.

Cosmetic preparation against hair loss as well as procedure for their production.

Spice mixture for the production of a tea beverage.

Es wird ein neues ayurvedisches Teegetränk vorgeschlagen, das auf Basis einer Gewürzmischung, die als wesentliche Bestandteile Koriander, Zimt und Ingwerpulver umfasst. Das Teegetränk wird als Kaltgetränk, als sogenannter Eistee, konsumiert. Die Auswahl der Zutaten ist so getroffen, dass diese vorzugsweise die Hauptenergiezentren (sieben Chakren) des menschlichen Körpers positiv beeinflussen. Neben diesem energetisierenden Effekt wird durch die gezielte Zusammenstellung der einzelnen Zutaten eine gesundheitsfördernde Wirkung auf den menschlichen Organismus erzielt.

Probiotisches Nahrungsergänzungsmittel mit sekundären Pflanzenstoffen, hergestellt aus Kurkuma, Zimt, Pfeffer, Bienen Honig, Birnensaft Konzentrat, Speiseöl, Inulin und Hefe.

Probiotisches Nahrungsergänzungsmittel mit Sekundären Pflanzenstoffen hergestellt aus Kurkuma, Zimt, Pfeffer, Muskat, Gewürnelken,Bienen Honig, Birnensaft Konzentrat, mehrfach gesättigtem Speiseöl, Inulin, Zeolith, Spirulina und nicht aktiver Trocken-Hefe in der Formulierung einer Paste, verpackt in einer Tube, einem Schlauchbeutel oder einem Licht geschützten, geeigneten Portionen-Dispenser. Die fein abgestimmte Rezeptur der Paste basiert auf der Kombination von antioxidativen pflanzlichen Sekundärstoffen, die entgiftende und gesundheitsrelevante Eigenschaften aufweisen. Die gesundheitsrelevanten Eigenschaften der innovativen Paste lassen sich Dank der formulierten Ingredienzen zum Teil auf seine antioxidative, antiinflammatorische (entzündungshemmende), krebshemmende, schmerzlindernde, knochenerhaltende und neuroprotektive Wirkungen zurückführen. Dazu kommen noch immunstimulierende und weitere positive Eigenschaften, die sich zum Teil auch auf die Unschädlichmachung und Ausleitung von ...

ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ БОРОДАВОК

Изобретение относится к фармацевтическим композициям для лечения, и в особенности местного лечения, бородавок и их применению для лечения бородавок. В частности, изобретение относится к фармацевтическим композициям для лечения бородавок, содержащим а) от 0,1 до 10 мас.% диметикона; b) от 5 до 25 мас.% одного или более растительных масел; с) один или более фармацевтически приемлемых эксципиентов и/или носителей; d) от 2 до 6 мас.% мочевины и е) воду до 100 мас.%.

КОМПОЗИЦИЯ ИНГРЕДИЕНТОВ ДЛЯ БАЛЬЗАМА "ПОЛОНИНА"

Изобретение относится к ликероводочной промышленности, в частности к композициям ингредиентов для бальзама. Композиция содержит цвет липы, зверобой, дубровку-лапчатку (корень), мяту, кориандр посевной, мелиссу лимонную, корицу, ванилин, мед натуральный, сахар, колер, лимонную кислоту и водно-спиртовую жидкость.

ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ БОРОДАВОК

Настоящее изобретение относится к фармацевтическим композициям для лечения, и в особенности местного лечения, бородавок и их применению для лечения бородавок. В частности, настоящее изобретение относится к фармацевтическим композициям для лечения бородавок, содержащим: а) от 0,1 до 10 мас.% диметикона; b) от 5 до 25 мас.% одного или более растительных масел; с) один или более фармацевтически приемлемых эксципиентов и/или носителей; d) от 2 до 6 мас.% мочевины и е) воду до 100 мас.%.

СБОР ЛЕКАРСТВЕННЫХ РАСТЕНИЙ, ОБЛАДАЮЩИЙ ГИПОЛИПИДИМИЧЕСКИМ ДЕЙСТВИЕМ

Изобретение относится к медицине, а именно к созданию гиполипидемических средств нормализирующих жировой обмен, замедляющих повышение уровня холестерина и может быть использовано для лечения ожирения. Сбор лекарственных растений имеет следующие весовые соотношения ингредиентов, масс, ч: Трава зверобоя продырявленного 15,0-20,0 Трава датиска коноплявидного 10,0-15,0 Трава верхушки клевера лугового 10,0-15,0 Листья лавра благородного 10,0-15,0 Листья и почки березы 10,0-15,0 Листья зеленого чая № 95 5,0-7,0 Корня солодки голой 10,0-15,0 Корня топинамбура 10,0-15,0 Корня цикория 15,0-20,0 Кожура мандарина 5,0-7,0 ...

DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO PROMOTE ENHANCED SIRTUIN, CELL AND TELOMERE INTEGRITY

A dietary supplement composition is provided for enhancing the expression of a sirtuin gene or protein. An inventive supplement composition includes at least one cinnamon extract containing at least 0.5% doubly linked Type-A polymers by dry weight. The cinnamon extract is derived from the or plant. In some embodiments, the cinnamon extract is present at approximately 20%-50% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is optionally provided in the composition. The dietary supplement composition is administered orally to promote expression or enhanced expression of a sirtuin gene or protein. 140-. (canceled)41. A process of increasing expression of a gene encoding a sirtuin in a subject comprising:administering to a subject a composition comprising at least 0.5 percent Type-A polymers by weight, andincreasing expression of a gene encoding a sirtuin in said subject by said step of administering.42. The process of claim 41 , wherein said composition further comprises one or more vitamins claim 41 , antioxidants claim 41 , sirtuin enhancers claim 41 , or combinations thereof.43. The process of wherein said Type-A polymers comprise single and doubly linked Type-A polymers.44. The process of wherein the composition is administered orally.45. The process of wherein said vitamin is vitamin A claim 42 , vitamin B claim 42 , vitamin C claim 42 , vitamin D claim 42 , vitamin E claim 42 , or vitamin K.46. The process of wherein said antioxidant is alpha lipoic acid claim 42 , acai claim 42 , astazanthin claim 42 , wolfberry claim 42 , glutathione claim 42 , or super oxide dismutase.47. The process of wherein the sirtuin enhancer is resveratrol or polygonum.48. The process of wherein said composition is administered daily for a period of twelve weeks or more.49. The process of further comprising quantifying the expression of a sirtuin gene in said subject subsequent to said administering.50. The process of further comprising quantifying the ...

PHYTONUTRIENT COMPOSITIONS AND METHODS TO PROTECT AGAINST RADICAL MEDIATED CELLULAR AND DNA DAMAGE

Phytonutrient based compositions and methods of using the same for preventing, reducing, or treating genetic damage induced by environmental toxins are disclosed. 1Acacia nilotica. A phytonutrient composition for preventing , reducing , or treating genetic damage induced by environmental agents , wherein said composition comprises therapeutically effective amounts of two or more compounds selected from the group consisting of extract , artichoke extract , blueberry extract , catechins , chlorogenic acid , cinnamon , ellagic acid , grape seed extract , hesperidin , Momodica extract , prune extract , rosemary extract , and watercress extract and said composition is in a dosage form suitable for oral administration.2. The composition according to claim 1 , wherein said composition provides per dosage form:{'i': 'Acacia nilotica', 'a. from 0.5 mg to 10 mg of extract;'}b. from 0.5 mg to 10 mg of artichoke extract;c. from 1 mg to 25 mg of blueberry extract;d. from 2.5 mg to 25 mg of catechins;e. from 25 mg to 75 mg of chlorogenic acid;f. from 0.5 mg to 10 mg of cinnamon;g. from 10 mg to 100 mg of ellagic acid;h. from 2.5 mg to 50 mg of grape seed extract;i. from 15 mg to 120 mg of hesperidin;j. from 0.5 mg to 10 mg of Momodica extract;k. from 0.5 mg to 10 mg of prune extract;l. from 0.5 mg to 10 mg of rosemary extract; andm. from 0.5 mg to 10 mg of watercress extract.3Acacia nilotica. A method for preventing claim 1 , reducing claim 1 , or treating genetic damage induced by environmental agents claim 1 , wherein said method comprises administering a composition comprising therapeutically effective amounts of two or more compounds selected from the group consisting of extract claim 1 , artichoke extract claim 1 , blueberry extract claim 1 , catechins claim 1 , chlorogenic acid claim 1 , cinnamon claim 1 , ellagic acid claim 1 , grape seed extract claim 1 , hesperidin claim 1 , Momodica extract claim 1 , prune extract claim 1 , rosemary extract claim 1 , and watercress ...

HERBAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF URINARY INCONTINENCE AND OVERACTIVE BLADDER

Provided in one embodiment is an herbal compositions for the prevention or treatment of urogenital system disorders including urinary incontinence, overactive bladder, enuresis, benign prostatic hyperplasia, nocturia, cystitis, urinary calculi, or a urinary tract infection. Specifically one embodiment provides compositions that contain and and methods of use thereof. 1. An herb-containing composition , comprising:{'i': 'Crateva nurvala', '(i) a extract preparation;'}{'i': 'Equisetum arvense', '(ii) an extract preparation; and'}{'i': 'Lindera aggregata', '(iii) a extract preparation;'}wherein the herb-containing composition is formulated as an oral dosage unit.2Crateva nurvala. The herb-containing composition of claim 1 , wherein the preparation is present at a concentration from about 1 g to about 18 g dry weight equivalents per oral dosage unit.3Equisetum arvense. The herb-containing composition of claim 1 , wherein the extract preparation is present at a concentration from about 750 mg to about 12 g dry weight equivalents per oral dosage unit.4Lindera aggregata. The herb-containing composition of claim 1 , wherein the extract preparation is present at a concentration from about 750 mg to about 12 g dry weight equivalents per oral dosage unit.5Crateva nurvala. The herb-containing composition of claim 1 , wherein the preparation is present at a concentration from about 3 g to about 12 g dry weight equivalents per oral dosage unit.6Equisetum arvense. The herb-containing composition of claim 1 , wherein the extract preparation is present at a concentration from about 1.5 g to about 6 g dry weight equivalents per oral dosage unit.7Lindera aggregata. The herb-containing composition of claim 1 , wherein the extract preparation is present at a concentration from about 1.5 g to about 6 g dry weight equivalents per oral dosage unit.8Crateva nurvala. The herb-containing composition of claim 1 , wherein the preparation is present at a concentration from about 4 g to about 8 g ...

EXTRACT OF AERIAL PARTS OF MACA RICH IN POLYPHENOLS AND COMPOSITION COMPRISING SAME

The invention relates to an extract of aerial parts of Maca rich in polyphenols, and also to a composition comprising such an extract and, where appropriate, a suitable excipient. The invention also relates to a process for extracting an extract of aerial parts of Maca rich in polyphenols, and also to the extract that can be obtained by means of said process. The invention also relates to such a composition or such an extract for use thereof in preventing or treating disorders or pathological conditions of the skin, the mucous membranes or the superficial body growths and/or for use thereof in preventing and/or treating vascular disorders. Finally, the invention relates to a cosmetic care process for the skin, the superficial body growths or the mucous membranes, with a view to improving the condition thereof or the appearance thereof, which comprises the administration of such a composition or of such an extract. 1. Extract of aerial parts of Maca containing at least 1% , advantageously at least 3% , more advantageously at least 5% by weight of polyphenols , expressed in gallic acid equivalents , with respect to the weight of the dry extract , said polyphenols being advantageously flavonoids , typically having a flavonoid content greater than 0.2% , advantageously greater than 0.5% , more advantageously greater than 1% and even more advantageously greater than 2% , expressed in rutin equivalents , with respect to the total weight of the dry extract.2. Extract according to claim 1 , characterised in that the flavonoids contain quercetin claim 1 , kaempferol claim 1 , derivatives thereof or mixtures thereof claim 1 , advantageously at a concentration of at least 30% claim 1 , typically at least 50% claim 1 , by weight claim 1 , expressed in gallic acid equivalents claim 1 , with respect to the total weight of the flavonoids.3. Extract according to or claim 1 , characterised in that aerial parts are Maca leaves.4. Extract according to any of the above claims claim 1 , ...

METHODS AND MATERIALS FOR REDUCING MULTIPLE RISK FACTORS ASSOCIATED WITH THE METABOLIC SYNDROME

A composition containing extract reduces and/or eliminates one or more risk factors associated with Metabolic syndrome. The composition also includes optionally one of more components selected from the group consisting of vitamins, cholesterol lowering agents, lipid lowering agents, and glucose lowering agent. Also described is a method of reducing and/or eliminating risk factors associated with Metabolic syndrome in a subject through the administration of the extract. The extract supplement is administered orally, intravenously, or subcutaneously. In one embodiment, a daily dose of 10-1,000 mg of the extract supplement is administered to the subject for a period of 6 weeks to 6 months. 15-. (canceled)6. A process for altering two or more risk factors associated with metabolic syndrome in a subject , comprising the step of:{'i': 'Nelumbo nucifera', 'administering to said subject a therapeutically effective amount of a extract and'}altering two or more risk factor associated with metabolic syndrome in said subject.7Nelumbo nucifera. The process of wherein said therapeutically effective amount is from 10 milligrams to 1 claim 6 ,000 milligrams of said extract.8. The process of wherein said extract is administered as a formulation prepared as a liquid preparation claim 6 , solid preparation claim 6 , capsule preparation claim 6 , or a powder preparation.9. The process of or claim 6 , wherein at least one of said the risk factors claim 6 , as defined by NCEP-ATP-III claim 6 , is abnormal systolic blood pressure claim 6 , abnormal fasting blood glucose claim 6 , abnormal body mass index claim 6 , abnormal high-density lipoprotein claim 6 , abnormal low-density lipoprotein claim 6 , or abnormal blood triglyceride.10. The process of claim 6 , wherein the therapeutically effective amount of said extract is administered orally claim 6 , intravenously claim 6 , by intramuscular injection claim 6 , by intraperitoneal injection claim 6 , or transdermally.11. (canceled)12nelumbo ...

HERBAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RELATED DISORDERS

Provided in one embodiment is an herbal composition for the prevention or treatment of disorders of the prostate, for example, benign prostatic hyperplasia (BPH), prostatitis, and prostatic intraepithelial neoplasia, and for overactive bladder (OAB), urinary incontinence (UI), nocturia, poor urinary stream, and straining to urinate associated with these prostate disorders. Specifically one embodiment provides compositions that contain , and , and methods of use thereof. 1. An herb-containing composition , comprising:{'i': 'Crateva nurvala', '(i) a extract preparation;'}{'i': 'Equisetum arvense', '(ii) an extract preparation;'}{'i': 'Lindera aggregata', '(iii) a extract preparation; and'}{'i': 'Serenoa repens', '(iv) a extract preparation, wherein the herb-containing composition is formulated as an oral dosage unit.'}2Crateva nurvalaEquisetum arvenseLindera aggregataSerenoa repens. The herb-containing composition of claim 1 , wherein the preparation is present at a concentration from about 1 g to about 18 g dry weight equivalents per oral dosage unit claim 1 , the extract preparation is present at a concentration from about 750 mg to about 12 g dry weight equivalents per oral dosage unit claim 1 , the extract preparation is present at a concentration from about 750 mg to about 12 g dry weight equivalents per oral dosage unit claim 1 , and the preparation is present at a concentration from about 1 g to about 18 g dry weight equivalents per oral dosage unit.3Crateva nurvalaEquisetum arvenseLindera aggregataSerenoa repens. The herb-containing composition of claim 1 , wherein the preparation is present at a concentration from about 3 g to about 12 g dry weight equivalents per oral dosage unit claim 1 , the extract preparation is present at a concentration from about 1.5 g to about 6 g dry weight equivalents per oral dosage unit claim 1 , the extract preparation is present at a concentration from about 1.5 g to about 6 g dry weight equivalents per oral dosage unit claim 1 ...

COMPOSITION COMPRISING CINNAMON EXTRACT

The invention concerns a composition for lowering the glycemic index comprising, or consisting of an alcoholic extract of cinnamon in an amount of at least 10% by weight compared to the total weight of the composition, and optionally a carrier, a food composition comprising a composition for lowering the glycemic index in an amount ranging from 0.1% to 5% by weight compared to the total weight of the food composition, the use of a composition for lowering the glycemic index or of a food composition as a glycemic index lowering agent. 1cinnamomum zeylanicum. Extract of , susceptible of being obtained by the process comprising the following steps:{'i': 'cinnamomum zeylanicum', 'a) contacting dried milled bark with an extraction solvent at a temperature of around 50° C.,'}b) filtering out the solids and collecting alcoholic extract c) washing said solids by stirring with an extraction solventd) filtering out the solids and collecting alcoholic extracte) combining said alcoholic extractsf) removing non-soluble residues by decantation or filtrationg) evaporating the solvents from the combination at a temperature inferior or equal to 50° C.h) recovering a dry extract2. Extract according to claim 1 , characterised in that said extract comprises at least 25% by weight of polyphenols.3. Extract according to claim 1 , characterised in that said extract comprises at least 40% by weight of polyphenols.4. Composition comprising an extract according to any of to .5. Composition according to claim 4 , comprising at least 10% by weight of said extract.6. Food composition comprising 0.05% to 5% by weight of an extract according to any of to .7. Food composition comprising 0.2% to 2% by weight of an extract according to any of to .8. Food composition according to any of or characterised in that it comprises starch.9. Food composition according to claim 8 , characterised in that the ratio extract/starch is of 1/10000 or more.10. Food composition according to claim 8 , characterised in ...

PHYTONUTRIENT COMPOSITIONS AND METHODS OF USE

Phytonutrient based compositions and methods of using the same for preventing, reducing, or treating genetic damage induced by environmental toxins are disclosed. Additionally, said compositions and methods are used to reduce oxidized low density lipoproteins (OxLDL), myeloperoxidase (MPO), and plasminogen activator inhibitor-1 (PAI-1). 1Acacia niloticaMomodica. Use of a composition for simultaneously reducing serum OxLDL , MPO , and PAI-1 levels in a subject in need thereof , wherein said use comprises administering a composition comprising therapeutically effective amounts of two or more compounds or extracts selected from the group consisting of extract , artichoke extract , blueberry extract , catechins , chlorogenic acid , cinnamon , ellagic acid , grape seed extract , hesperidin , extract , prune extract , rosemary extract , and watercress extract and said composition is in a dosage form suitable for oral administration wherein said dosage form provides:{'i': 'Acacia nilotica', 'a. from 0.5 mg to 10 mg of extract;'}b. from 0.5 mg to 10 mg of artichoke extract;c. from 1 mg to 25 mg of blueberry extract;d. from 2.5 mg to 25 mg of catechins;e. from 25 mg to 75 mg of chlorogenic acid;f. from 0.5 mg to 10 mg of cinnamon;g. from 10 mg to 100 mg of ellagic acid;h. from 2.5 mg to 50 mg of grape seed extract;i. from 15 mg to 120 mg of hesperidin;{'i': 'Momodica', 'j. from 0.5 mg to 10 mg of extract;'}k. from 0.5 mg to 10 mg of prune extract;l. from 0.5 mg to 10 mg of rosemary extract; andm. from 0.5 mg to 10 mg of watercress extract.2Acacia niloticaMomodica. The use according to claim 1 , wherein the composition provides three or more compounds or extracts selected from the group consisting of extract claim 1 , artichoke extract claim 1 , blueberry extract claim 1 , catechins claim 1 , chlorogenic acid claim 1 , cinnamon claim 1 , ellagic acid claim 1 , grape seed extract claim 1 , hesperidin claim 1 , extract claim 1 , prune extract claim 1 , rosemary extract claim 1 ...

Nutritional Supplement Comprising Nut and Seed Oil Composition

The present invention provides a novel composition of nut and seed oils, specifically; walnut oil, almond oil, avocado oil, pistachio oil and flaxseed oil for use in maintaining and improving health in a convenient and cost-effective manner; for obtaining essential fatty acids that are required for normal body functioning; for reducing cholesterol, and for reducing retinal degeneration in an individual with retinitis pigmentosa. 1. A nut and seed oil composition for maintaining or improving health , said composition comprises two or more of the following:a. a walnut oil in an amount ranging between about 10% and about 50% by weight;b. an almond oil in an amount ranging between about 10% and about 50% by weight;c. an avocado oil in an amount ranging between about 10% and about 50% by weight;d. a pistachio oil in an amount ranging between about 10% and about 50% by weight; ande. a flaxseed oil in an amount ranging between about 10% and about 50%.2. The nut and seed oil composition of claim 1 , further including a carrier or binder.3. The nut and seed oil composition of claim 1 , further comprising a fatty acid selected from the group consisting of palmitic acid claim 1 , palmitoleic acid claim 1 , heptadecanoic acid claim 1 , stearic acid claim 1 , arachidic acid claim 1 , eicosenoic acid claim 1 , linoleic acid claim 1 , linolenic acid claim 1 , oleic acid and any combination thereof.4. The nut and seed oil composition of claim 4 , wherein the carrier comprises a softgel capsule claim 4 , a capsule claim 4 , a caplet claim 4 , a pill claim 4 , liquid formulation or any combination thereof.5. The nut and seed oil composition of claim 1 , wherein the ratio of walnut oil claim 1 , almond oil claim 1 , avocado oil claim 1 , pistachio oil and flaxseed oil in the composition is in the range of 1:1:1:1:2 claim 1 , respectively.6. A nut and seed oil composition claim 1 , said composition comprises two or more of the following:a. a walnut oil in an amount ranging between ...

SUBSTANTIALLY COUMARIN-FREE EXTRACT OF CINNAMON AND ITS PRODUCTION METHOD

A pharmaceutical composition comprising a substantially coumarin-free extract derived from cinnamon. Its production method including some steps: grinding the raw material, extracting raw material from previous step by maceration using a first solvent to obtain crude extract of , fractionating the extracted raw material from previous step through liquid-liquid extraction using a second solvent, wherein the second solvent is immiscible with the first solvent to obtain substantially coumarin-free extract, and optionally drying the substantially coumarin-free extract. 1Cinnamomum burmanii. A process for the preparation of substantially coumarin-free extract derived from which comprises the steps of:{'i': 'Cinnamomum burmanii,', '(a) grinding raw material of'}{'i': 'Cinnamomum burmanii,', '(b) extracting the raw material from step (a) by maceration using a first solvent to obtain crude extract of'}(c) fractionating the extracted raw material from step (b) through liquid-liquid extraction using a second solvent, wherein the second solvent is immiscible with the first solvent to obtain substantially coumarin-free extract, and optionally(d) drying the substantially coumarin-free extract.2. The process according to claim 1 , wherein the first solvent used in step (b) comprises water claim 1 , alcohols claim 1 , acetone or combination thereof.3. The process according to claim 1 , wherein the ratio of the crude extract of step (b) and the second solvent used in step (c) is around 1:1 to 1:2.4. The process according to claim 1 , wherein the content of coumarin in substantially coumarin-free extract has a value of equal or below 0.39 mg coumarin/kg extract.6Cinnamomum burmanii. A pharmaceutical composition or dietary supplement comprising the substantially coumarin-free extract of according to claim 5 , as a single component or in a combination with suitable pharmaceutical excipient(s) for the manufacturing in solid claim 5 , semi-solid claim 5 , or liquid dosage form claim 5 , ...

ANESTHETIC AND THERAPEUTIC COMPOSITION FOR USE IN AQUACULTURE

An anesthetic and therapeutic composition for use in aquaculture includes an essential oil preferably thyme oil that is mixed with ethanol in an amount of one part essential oil preferably thyme oil to five parts ethanol. The essential oil ethanol mixture is then dispersed in water preferably seawater to provide 10 to 60 ppm of essential oil. The oxygen in the composition is between about 5.00 and 6.5 mg/L and in a preferred embodiment is enhanced by an agar stabilizer. The invention also contemplates treating fish such as sheam and sobaity and shrimp and seahorse to reduce stress and maintain a temperature of about 20°-27° C. 1. An anesthetic and therapeutic composition for use in aquaculture , said composition comprising an essential oil selected from the group consisting of thyme oil , cinnamon oil , oregano oil , sage oil , garlic oil , eucalyptus oil , clove oil and mixtures thereof;a mass of ethanol and wherein said essential oil is mixed with ethanol in amounts of one part essential oil to five parts ethanol and wherein said essential oil and alcohol is added to a tank of water to provide 10 to 60 ppm of essential oil.2. An anesthetic and therapeutic composition for use in aquaculture according to in which said tank of water contains sea water.3thymus vulgariscinnamon zeylaricumoriganum vulgariszygun aromaticum. An anesthetic and therapeutic composition for use in aquaculture according to in which said essential oil is selected from the group consisting of thyme oil () claim 2 , cinnamon oil () claim 2 , oregano oil () claim 2 , clove oil (} and mixtures thereof.4. An anesthetic and therapeutic composition for use in aquaculture according to in which said composition comprises an essential oil selected from the group consisting of thyme oil claim 3 , cinnamon oil claim 3 , oregano oil and mixtures thereof.5. An anesthetic and therapeutic composition for use in aquaculture according to in which the dissolved oxygen of the anesthetic and therapeutic composition ...

Method, Apparatus And Kit For The Treatment Of Neurodegenerative Diseases And Impairments

A method, apparatus and kit have been discovered which regenerate with the use of odorants the connections of the neurons of the brain and central nervous system in the treatment of such person afflicted neuro-disorders caused by disease or trauma. 1. A method for the treatment of neurodegenerative diseases or trauma , the method comprising:intranasal administering a blend of odorants dispersed in a media, the odorant blend including at least two of the odorants citrus (orange), lemon, rosemary, cinnamon, banana oil, cumin, vanillin, ethylvanillin, garlic, paprika, curry, nutmeg, thyme, tarragon, celery, ginger, lavender, marjoram, basil leaves, cardamom, cloves, chocolate and anise, the administering including pumping the blend as a part of a flow of gas which includes oxygen and odorant blend, the flow created by a pump which creates a positive pressure to create a flow of oxygen and odorant blend through the nose, the concentration of the blend, the ratio of odorants, the rate of flow of the blend and oxygen, a time of treatment, and the ratios of odorants in the blend effective for effecting an improvement of a neurofunction of a person afflicted with the neurodegenerative disease or trauma.2. The method of wherein the blend includes at least three of the odorants.3. The method of wherein the blend includes citrus claim 1 , lemon claim 1 , rosemary and cinnamon.4. The method of wherein the odorants are dispersed into pharmaceutically acceptable oil which solvates the odorants and the odorants are each in a concentration in the range of from about 0.5 to about 6.0 weight percent.5. The method of wherein flow of gas through the nose is from about 0.5 to about 2 liters per minute.6. The method of wherein the odorants are dispersed into pharmaceutically acceptable oil which solvates the odorants and the odorants are each in a concentration in the range of from about 0.5 to about 6.0 weight percent.7. A method for the treatment of neurodegenerative diseases selected ...

Pharmaceutical Compositions for the Treatment of Warts

The present invention relates to pharmaceutical compositions for the treatment, and especially topical treatment, of warts and the use thereof for the treatment of warts. Specifically, the present invention relates to pharmaceutical compositions for the treatment of warts, comprising: a) 0.1 to 10 weight % dimethicone; b) 5 to 25 weight % of one or more vegetable oils; c) one or more pharmaceutically acceptable excipients and/or carriers; d) 2 to 6 weight % urea; and e) water up to 100 weight %. 1. A method of treating warts , comprising: a) 0.1 to 10 weight % dimethicone;', 'b) 5 to 25 weight % of one or more vegetable oils;', 'c) one or more pharmaceutically acceptable excipients and/or carriers;', 'd) 2 to 6 weight % urea; and', 'e) water up to 100 weight %., 'applying a topical medicament to at least one wart, the medicament comprising2. The method according to claim 1 , wherein said one or more vegetable oils of said medicament are chosen from the group consisting of almond oil claim 1 , tea tree oil claim 1 , lavender oil claim 1 , geranium oil claim 1 , lemon oil claim 1 , thuja oil claim 1 , and cinnamon oil.3. The method according to claim 1 , the medicament further comprising:f) 0.5 to 2 weight % red pepper powder.4. The method according to claim 1 , wherein said one or more pharmaceutically acceptable excipients and/or carriers of said medicament are chosen from the group consisting of ammonium acryloyldimethyl taurate/VP copolymer claim 1 , sodium benzoate claim 1 , potassium sorbate and citric acid.5. The method according to claim 1 , wherein the medicament comprises:a) 0.5 to 3 weight % dimethicone; 1) 1 to 3 weight % almond oil;', '2) 1 to 3 weight % tea tree oil;', '3) 1 to 2 weight % lavender oil;', '4) 1 to 2 weight % geranium oil;', '5) 0.5 to 2 weight % lemon oil;', '6) 0.5 to 2 weight % thuja oil; and', '7) 0.5 to 2 weight % cinnamon oil;, 'b) vegetable oils comprising 1) 0.5 to 3 weight % ammonium acryloyldimethyl taurate/ VP copolymer;', '2) 0 ...

CINNAMOMUM BURMANII EXTRACT, EXTRACTION PROCESS AND ITS USE AS PROTON PUMP DOWN-REGULATOR, ENZYME INHIBITOR, AND MUCOPROTECTOR

Extract and/or fraction from (DLBS2411) related to its extraction method and its biological activities show activities as antiulcer by conferring mucoprotection and down-regulating H/K ATPase. Treatment with DLBS2411 decreases the H/K ATPase mRNA level in HEK 293 and gastric parietal cells. In addition, DLBS2411 inhibits activity of H/K ATPase gastric enzyme wherein pH influences this inhibition mechanism. DLBS2411 also has characteristic as antioxidant which is shown by the increase of reducing power as the given dosage increases. 1Cinnamomum burmanii. An extract comprising , and/or its fraction or its group of compound derived therefrom , in pharmaceutical preparation , as a single active ingredient or in combination , in an amount or dose that is effective as antiulcer.2. Extract and/or fraction according to claim 1 , whereby said extract and/or fraction has the activity as down-regulator of H/K ATPase proton pump.3. Extract and/or fraction according to claim 1 , whereby said extract and/or fraction has the activity as inhibitor of H/K ATPase enzyme.4. Extract and/or fraction according to claim 1 , whereby said extract and/or fraction has the activity as mucoprotector.5. Extract and/or fraction according to claim 1 , whereby such extract is obtained by the process comprising the steps of:(a) extraction using hot water at temperature of 50-100° C.,(b) liquid liquid extraction using organic solvent to obtain water fraction.6. Extract and/or fraction according to claim 5 , whereby the process further comprises the step of repetition of step (b) to optimize the collection of water fraction.7. Extract and/or fraction according to claim 5 , whereby the organic solvent(s) at step (b) is selected from the group consisting of chloroform claim 5 , dichloromethane claim 5 , hexane claim 5 , ethyl acetate and butanol.8. A pharmaceutical composition comprising said extract and/or fraction according to claim 1 , as a single active ingredient or in combination claim 1 , and ...

COMPOSITIONS AND METHOD FOR TREATING AND PREVENTING MALNUTRITION

Provided herein are compositions and methods for treating, preventing, and reversing malnutrition. In particular, provided herein are compositions and methods for facilitating cognitive repair and preventing obesity (e.g. in children). 193.-. (canceled)94. A composition for the treatment and prevention of malnutrition , comprising:a) at least 20 mg of a plurality of flavonoids, wherein at least a portion of the flavonoids cross the blood-brain barrier, wherein at least one of said flavonoids is catechin or epicatechin; b) at least 0.1 g of omega-3 fatty acids, wherein said omega-3 fatty acids comprise EPA and DHA;c) at least 1 mg caffeine; d) a plurality of micronutrients selected from the group consisting of iron, phosphorous, zinc, thiamine, riboflavin, niacin, vitamin B6, folate, vitamin, B12, pantothenic acid, biotin, choline, chromium, copper, manganese, seleniusm, molybdenum, iodine, vitamin A, calcium, potassium, magnesium, vitamin E, vitamin C, a carotenoid, vitamin D, and vitamin K; and e) a sufficient amount of energy comprising 11-35% of calories from protein, 10-50% of calories from carbohydrates, and 30-60% of calories from fat.95. The composition of claim 94 , wherein said composition comprises 20-2000 mg of flavonoids.96. The composition of claim 94 , wherein said composition comprises at least 200 mg of flavonoids.97. The composition of claim 94 , wherein said composition comprises 200-500 mg of catechin and/or epicatechin.98. The composition of claim 94 , wherein said catechin and/or epicatechin are in or obtained from cocoa and/or green tea.99. The composition claim 94 , wherein said flavonoids are derived from a plant or plant component selected from the group consisting of cocoa claim 94 , green tea claim 94 , black tea claim 94 , tea extracts claim 94 , quercetin claim 94 , green vegetables claim 94 , spinach claim 94 , moringa claim 94 , matcha claim 94 , kaempferol claim 94 , kale claim 94 , tomato claim 94 , acai berry claim 94 , blueberry ...

ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION

An orally administrable composition for treating or reducing damage to connective tissue or for treating or reducing inflammatory symptoms associated with damage to connective tissue includes a synergistic combination of: (i) avocado/soybean unsaponifiables; and (ii) lipoic acid, or a salt or derivative thereof. Methods for treating or reducing damage to connective tissue, for treating or reducing inflammatory symptoms associated with damage to connective tissue, or for reducing levels of one or more inflammatory mediators in connective tissue include administering the orally administrable composition to an avian or mammalian subject. 1. An orally administrable composition for treating or reducing damage to connective tissue , or for treating or reducing inflammatory symptoms associated with damage to connective tissue , comprising a synergistic combination of:(i) avocado/soybean unsaponifiables; and(ii) lipoic acid, or a salt or derivative thereof.2. The composition of claim 1 , comprising the avocado/soybean unsaponifiables and the lipoic acid.3. The composition of claim 1 , wherein the lipoic acid claim 1 , or salts or derivatives thereof claim 1 , comprise a compound selected from the group consisting of: esters and amides of lipoic acid claim 1 , conjugates of lipoic acid claim 1 , and analogues of lipoic acid.4. The composition of claim 1 , wherein the lipoic acid claim 1 , or salts or derivatives thereof claim 1 , comprise a compound selected from the group consisting of: 5-[1 claim 1 ,2]-dithiolan-3-yl-pentanoic acid 3-(5-[1 claim 1 ,2]-dithiolan-3-yl-pentanoyloxy)-propyl ester; 5-[1 claim 1 ,2]-dithiolan-3-yl-pentanoic acid 3-(5-[1 claim 1 ,2]-dithiolan-3-yl-pentanoylamino)-propyl-amide; coumarin-lipoic acid conjugates; 5-[1 claim 1 ,2]dithiolan-3-yl-pentanoic acid [1-(4-fluoro-benzyl)-1H-indole-5-yl] -amide; N-lactobionyl-N-(5-[1 claim 1 ,2]-dithiolan-3-yl-penoyl)-L-lysinyl-1H claim 1 ,1H claim 1 , 2H-perfluorooctylamide; 1 claim 1 ,2-diselenolane-3- ...

METHODS OF TREATING OR PREVENTING OVERWEIGHT AND OBSESITY IN MAMMALS BY ADMINISTERING A COMPOSITION COMPRISING MANNOHEPTULOSE

The present invention is based on the discovery that mannoheptulose (mHep) reduces or inhibits the differentiation process of fat stem cells into adipocytes so as to decrease the body's fat storage capacity. Compositions comprising a mHep, process of making the compositions, and methods of using the compositions for treating or preventing overweight and obesity in a mammal, such as, for example, a growing pet (e.g., puppy, kitten), or a spayed/neutered pet, are encompassed by the present invention. 1. A method of treating or preventing overweight and obesity in a mammal , wherein the method comprises administering to the mammal a composition comprising an effective amount of a mannoheptulose (mHep).2. The method of claim 1 , wherein the method is for preventing overweight and obesity in a mammal having:i. a body condition characterized as thin, underweight or ideal as determined based on a body condition chart as disclosed herein; orii. a body condition score (BCS) of 1 to 3 based on a scale from 1 to 5.3. The method of claim 1 , wherein the mammal is:a) a growing pet selected from the group consisting of a reproductively-intact growing pet, an overweight or obese growing pet, and a spayed or neutered growing pet;b) an adult pet selected from the group consisting of a reproductively-intact adult pet, an overweight or obese adult pet, and a spayed or neutered adult pet; orc) a senior pet selected from the group consisting of a reproductively-intact senior pet, an overweight or obese senior pet, or a spayed or neutered senior pet.4. The method of claim 3 , wherein:a) the adult pet is selected from the group consisting of a reproductively-intact adult dog, a reproductively-intact adult cat, a spayed or neutered adult dog, a spayed or neutered adult cat; orb) the senior pet is selected from the group consisting of a reproductively-intact senior dog, a reproductively-intact senior cat, a spayed or neutered senior dog, and a spayed or neutered senior cat;wherein the adult ...

ANESTHETIC AND THERAPEUTIC COMPOSITION FOR USE IN AQUACULTURE

An anesthetic and therapeutic composition for use in aquaculture includes an essential oil preferably thyme oil that is mixed with ethanol in an amount of one part essential oil preferably thyme oil to five parts ethanol. The essential oil ethanol mixture is then dispersed in water preferably seawater to provide 10 to 60 ppm of essential oil. The oxygen in the composition is between about 5.00 and 6.5 mg/L and in a preferred embodiment is enhanced by an agar stabilizer. The invention also contemplates treating fish such as sheam and sobaity and shrimp and seahorse to reduce stress and maintain a temperature of about 20°-27° C. 17-. (canceled)8. An anesthetic and therapeutic composition for use in aquaculture consisting of:an essential oil selected from the group consisting of thyme oil, cinnamon oil, oregano oil and mixtures thereof;ethanol and sea water;wherein said essential oil and ethanol are provided in the ratio of one part essential oil to five parts ethanol and wherein the amount of sea water provides a composition having between 10 ppm to 60 ppm essential oil plus a dissolved oxygen content between 5.00 and 6.5 mg/l.910-. (canceled)12. A method for treating fish with an anesthetic and therapeutic composition according to wherein said contents of said first and second tanks are each maintained with a dissolved oxygen content of between about 5.0 to about 6.5 mg/l.13. (canceled)14SparidentexAcanthopalatus. A method for treating sobaity (pasta) fish claim 11 , sheam () fish and shrimp with an anesthetic and therapeutic composition for reducing stress during routine procedures and as a therapeutic for bacterial and parasitic infections claim 11 , said method consisting of:providing a first tank and a mass of sea water disposed in such first tank and maintaining sea water in said first tank at a temperature of between about 20° C. and 27° C. and providing a mass of essential oils selected from the group consisting of thyme oil, cinnamon oil, oregano oil and ...

USE OF AVOCADO SKIN FOR OBTAINING AN AVOCADO UNSAPONIFIABLE MATERIAL ENRICHED WITH SATURATED ALIPHATIC HYDROCARBONS AND WITH STEROLS

The present invention relates to the use of avocado peels in order to obtain avocado unsaponifiable enriched in saturated aliphatic hydrocarbons and in sterols, said avocado peels accounting for 5 to 50% by weight relative to the total weight of avocado used. The invention also relates to a method for obtaining avocado unsaponifiable enriched in saturated aliphatic hydrocarbons and in sterols from at least avocado peels, said avocado peels accounting for 5 to 50% by weight relative to the total weight of avocado used. The invention also relates to an avocado unsaponifiable enriched in saturated aliphatic hydrocarbons and in sterols, obtainable by this method. Lastly, the invention relates to an avocado unsaponifiable enriched in saturated aliphatic hydrocarbons and in sterols, for use as a drug, advantageously in the in the prevention and/or treatment of conjunctive tissue disorders such as arthrosis, articular pathologies such as rheumatism, or periodontal diseases such as gingivitis or periodontitis. 1. A process for obtaining avocado unsaponifiable enriched in saturated aliphatic hydrocarbons and in sterols from avocado peels , said avocado peels accounting for 5 to 50% by weight relative to the total weight of avocado used , and said unsaponifiable comprising at least 0.2% saturated aliphatic hydrocarbons by weight and at least 1% sterols by weight , relative to the total weight of the unsaponifiable.2. The process according to claim 1 , wherein the avocado peels account for 10 to 40% by weight relative to the total weight of avocado used.3. The process according to claim 1 , wherein the unsaponifiable comprises at least 0.2% saturated aliphatic hydrocarbons by weight claim 1 , relative to the total weight of the unsaponifiable.4. The process according to claim 1 , wherein the saturated aliphatic hydrocarbons are one or more unbranched linear hydrocarbons.5. The process according to claim 1 , wherein the unsaponifiable comprises at least 1% sterols by weight ...

ANTI-ACHING SUPPLEMENT

A composition of phyto-medicaments comprising essentially of , turmeric and for the treatment necessary to alleviate ailments associated therewith. 2. The composition of claim 1 , wherein the formulation is available as a paste or emulsion.3. The composition of claim 1 , further comprising between about 4 and 12 ounces of ginger.4. The composition of claim 1 , further comprising about 1 teaspoonful of Ceylon Cinnamon.5. The composition of claim 1 , wherein adjuvants selected from the group consisting ginger claim 1 , Ceylon Cinnamon claim 1 , honey or a combination thereof.6. The composition of claim 1 , wherein water is added to texture. People who suffer from chronic pains, nagging health issues such as stress and depression, addictions, inflammation and matters of immune health can attest to the challenges and desperation in getting or obtaining treatment for their ailments without the rigor of suffering with adverse effects of the medicaments that they have to take. It is also an issue of concern that almost all the medicament taken or consumed by these patients present yet again foreign material or abstracts into them. One can presently imagine taking opioids for pain and suffering from diarrhea as an outcome, or becoming addicted to the opioids, just as examples.In other instances, nutraceuticals and other pharmaceuticals may present medicaments that come with issues of potency and sourcing. Potency, in that nutraceuticals may come from sources that may affect the efficacy of the medicament and quality of the raw materials used. Biologics offer some solutions to sufferers and there is recognition that biologics may provide challenges because of the process and the additives that make them usable for their intended purpose or purposes.Drugs, and other non-homeopathic formulations or similarly fabricated medicines used to treat issues of anti-inflammation, agues or weight management, among others are typically tied to some adverse effects of such treatment. It ...

NOVEL COMPOSITIONS INCLUDING CANNABIS AND AVOCADO/SOYBEAN UNSAPONIFIABLES AND METHODS OF USE

The present application relates to compositions comprising avocado/soybean unsaponifiables (“ASU”) and , and related methods of use. In one embodiment, the is a oil extract that is combined with ASU to reduce inflammatory responses and inflammation in humans and animals. 1. A composition comprising a synergistic combination of avocado/soybean unsaponifiables and cannabinoids.2. The composition of claim 1 , wherein the cannabinoids comprise cannabidiol.3cannabis.. The composition of claim 2 , wherein the source of the cannabinoids is4cannabis. The composition of claim 3 , wherein the source of the cannabidiol is a extract.5cannabis. The composition of claim 3 , wherein the source of the cannabidiol is a oil extract.6. The composition of claim 2 , wherein the cannabidiol is synthetic.7. The composition of claim 1 , further comprising terpenes.8. The composition of claim 1 , further comprising flavonoids.9. The composition of claim 1 , formulated for oral administration to an avian subject.10. The composition of claim 1 , formulated for oral administration to a mammalian subject.11. The composition of claim 9 , wherein the mammalian subject is selected from the group consisting of a human claim 9 , dog claim 9 , cat claim 9 , horse claim 9 , camel claim 9 , or cow.12. A method of reducing levels of one or more inflammatory mediators comprising administering to a subject in need thereof a synergistic combination of avocado/soybean unsaponifiables and cannabinoids.13. The method of claim 12 , wherein the cannabinoids comprise cannabidiol.14cannabis.. The method of claim 13 , wherein the source of the cannabidiol is15cannabis. The method of claim 13 , wherein the source of the cannabidiol is a extract.16cannabis. The method of claim 13 , wherein the source of the cannabidiol is a oil extract.17. The method of claim 13 , wherein the cannabidiol is synthetic.18. The method of claim 12 , wherein the synergistic combination further comprises terpenes.19. The method of claim ...

COMPOSITIONS AND METHODS FOR TREATING THE EYE

The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye. 2AcronychiaLicaria.. The composition according to claim 1 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract claim 1 , or source of extracts claim 1 , from plants of the genus and/or3Acronychia.. The composition according to claim 2 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract claim 2 , or source of extracts claim 2 , from plants of the genus4AcronychiaAcronychia aberrans, Acronychia acidula, Acronychia acronychioides, Acronychia acuminate, Acronychia baeuerlenii, Acronychia chooreechillum, Acronychia crassipetala, Acronychia eungellensis, Acronychia imperforate, Acronychia laevis, Acronychia laurifolia, Acronychia littoralis, Acronychia oblongifolia, Acronychia octandra, Acronychia parviflora, Acronychia pauciflora, Acronychia pedunculata, Acronychia pubescens, AcronychiaAcronychia suberosa, Acronychia vestita, Acronychia wilcoxiana,. The composition according to claim 3 , wherein the botanical extract claim 3 , or source of extracts claim 3 , from plants of the genus is selected from the group consisting of species (Batavia Downs) claim 3 , and combinations of two or more thereof.5AcronychiaAcronychia acidula.. The composition according to claim 4 , wherein the botanical extract claim 4 , or source of extracts claim 4 , from plants of the genus is8. The composition according to claim 7 , wherein the compound of formula (II) are in the form of an acid or alkylester selected from 3-(4-farnesyloxyphenyl)-propionic acid claim 7 , 3-(4-farnesyloxy-3-hydroxyphenyl)-propionic acid claim 7 , 3-(4-farnesyloxy-3-methoxyphenyl)-propionic acid claim 7 , alkylesters thereof and combinations of two or more thereof.9. The composition according to claim 8 , wherein the ...

COMPOSITIONS AND METHODS FOR TREATING THE EYE

The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye. 2AcronychiaLicaria.. The method according to claim 1 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract claim 1 , or source of extracts claim 1 , from plants of the genus and/or3Acronychia.. The method according to claim 2 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract claim 2 , or source of extracts claim 2 , from plants of the genus4AcronychiaAcronychia aberrans, Acronychia acidula, Acronychia acronychioides, Acronychia acuminate, Acronychia baeuerlenii, Acronychia chooreechillum, Acronychia crassipetala, Acronychia eungellensis, Acronychia imperforate, Acronychia laevis, Acronychia laurifolia, Acronychia littoralis, Acronychia oblongifolia, Acronychia octandra, Acronychia parviflora, Acronychia pauciflora, Acronychia pedunculata, Acronychia pubescens, AcronychiaAcronychia suberosa, Acronychia vestita, Acronychia wilcoxiana. The method according to claim 3 , wherein the botanical extract claim 3 , or source of extracts claim 3 , from plants of the genus is selected from the group consisting of species (Batavia Downs) claim 3 , claim 3 , and combinations of two or more thereof.5AcronychiaAcronychia acidula.. The method according to claim 4 , wherein the botanical extract claim 4 , or source of extracts claim 4 , from plants of the genus is8. The method according to claim 7 , wherein the compound of formula (II) are in the form of an acid or alkylester selected from 3-(4-farnesyloxyphenyl)-propionic acid claim 7 , 3-(4-farnesyloxy-3-hydroxyphenyl)-propionic acid claim 7 , 3-(4-farnesyloxy-3-methoxyphenyl)-propionic acid claim 7 , alkylesters thereof and combinations of two or more thereof.9. The method according to claim 8 , wherein the compound of Formula II ...

COMPOSITION CONTAINING AT LEAST ONE C7 SUGAR FOR ALOPECIA TREATMENT, COSMETIC TREATMENT OF HAIR AND NAILS, AND CARE OF HAIR, EYELASHES OR NAILS

The present invention relates to a composition including at least one C7 sugar, or derivative from esterification of said sugar, and a pharmaceutically acceptable carrier for treating alopecia. The present invention also relates to a method for cosmetically treating hair and nails, said method being intended to stimulate the growth thereof and/or slow the loss thereof. According to said method, a cosmetic composition including at least one C7 sugar, or derivative from esterification of said sugar, is administered. The present invention finally relates to a method for cosmetic care of hair and/or eyelashes and/or nails. 115-. (canceled)16. A method to stimulate the growth of hair and nails and/or to slow the loss of the hair and nails by reducing inflammation , comprising administering to a person in need thereof a composition comprising a mannoheptulose , a perseitol or a mixture thereof and an acceptable excipient.17. The method of claim 16 , wherein the composition is topically applied to the hair and/or eyelashes and/or nails and then left in contact with the hair and/or eyelashes and/or nails.18. The method of claim 16 , wherein the composition is topically applied to the hair and/or eyelashes and/or nails and then left in contact with the hair and/or eyelashes and/or nails and rinsed.19. The method of claim 16 , wherein the composition is administered orally.20. The method of claim 19 , wherein the composition is administered in the form of soft or hard capsules claim 19 , tablets claim 19 , cereal bars or beverages.21. The method of claim 16 , wherein the person has alopecia.22. The method of claim 16 , wherein said composition contains 0.001 to 30% by weight D-mannoheptulose claim 16 , in relation to the total weight of said composition claim 16 , and/or 0.001 to 30% by weight perseitol claim 16 , in relation to the total weight of said composition.23. The method of claim 22 , wherein the source of D-mannoheptulose and/or perseitol is an avocado sugar water- ...

COMPOSITIONS FOR PERIODONTAL ADJUNTIVE THERAPY

The scaling, root planning, and curettage procedure, even without additional treatment, benefits the patient by providing a reduction in pocket depth. The present disclosure provides high pH periodontal adjuvant compositions that, in conjunction with scaling and root planning, can reduce or eliminate a population of bacteria from a site of periodontal treatment. The compositions are applied as a paste and removed by lavage, thereby reducing or removing an active periodontal infection and allowing the periodontium to return to a state of health. 1. A periodontal adjunct composition consisting of potassium hydroxide , a metal salt , a phenolic compound , an Hreceptor antagonist , and an essential oil , wherein the potassium hydroxide is between about 54% and about 95% by weight; the metal salt is between about 0.5% and about 5% by weight; the phenolic compound is between about 0.5% and about 5% by weight; the essential oil is between about 0.5% and about 5% by weight; and the Hreceptor antagonist is between about 0.1% and about 1% by weight , wherein % by weight is % by weight of the final composition weight.2. The periodontal adjunct composition of claim 1 , wherein the composition is admixed with an excipient.3. (canceled)4. The periodontal adjunct composition of claim 1 , wherein the Hreceptor antagonist is selected from the group consisting of: cimetidine claim 1 , nizatidine claim 1 , famotidine claim 1 , and ranitidine.5. (canceled)6. The periodontal adjunct composition of claim 1 , wherein the phenolic compound is selected from the group consisting of thymol claim 1 , carvacrol claim 1 , cresol claim 1 , estradiol claim 1 , eugenol claim 1 , gallic acid claim 1 , guaiacol claim 1 , methyl salicylate claim 1 , raspberry ketone claim 1 , salicylic acid claim 1 , sesamol claim 1 , tumeric claim 1 , phenol claim 1 , bisphenol A claim 1 , BHT claim 1 , 4-nonylphenol claim 1 , orthophenyl phenol claim 1 , phenolphthalein claim 1 , and xylenol.7. The periodontal ...

WATER EXTRACTS OF CINNAMON AND RADIX ASTRAGALI

This invention relates to methods and compositions for providing improved insulin-sensitivity and/or enhanced insulin-like action, which leads to improved glucose uptake and utilization. This invention also relates to methods and compositions for lowering LDL, lowering triglycerides, increasing HDL, and lowering high blood pressure in a subject. The methods comprise administering to a subject an effective amount of a water extract of cinnamon and an effective amount of a water extract of Radix Astragali. 1. A method for increasing glucose uptake in a subject , comprising administering to a subject in need thereof an effective amount of a water extract of Cinnamon bark and an effective amount of a water extract of Radix Astragali , wherein said water extracts are administered in an amount sufficient to increase insulin sensitivity and to increase glucose uptake in the subject , and the method does not further contain a step of administering to the subject another active ingredient that that increases insulin sensitivity.2. The method according to claim 1 , wherein the water extract of Cinnamon bark and the water extract of Radix Astragali are provided in a composition containing the two water extracts.3. The method according to claim 1 , wherein the weight ratio of Cinnamon to Radix Astragali is about 5:1 to 1:5.4. The method according to claim 1 , wherein the weight ratio of Cinnamon to Radix Astragali is about 3:1 to 1:3.5. The method according to claim 1 , wherein the weight ratio of Cinnamon to Radix Astragali is about 2:1 to 1:2.6. A method for decreasing blood glucose level in a hyperglycemic subject claim 1 , comprising administering to a hyperglycemic subject an effective amount of a water extract of Cinnamon bark and an effective amount of a water extract of Radix Astragali claim 1 , wherein said water extracts are administered in an amount sufficient to increase insulin sensitivity and to increase glucose uptake in the subject claim 1 , and the method does ...

TREATMENT OF DERMATOLOGICAL CONDITIONS

The present disclosure relates to an oxygen-permeable topically-applied composition (OPTC) and methods of its use for the treatment of skin conditions and injuries. 1. A method of treating a patient that has undergone laser ablation of the skin , comprising topically administering to an ablated skin of the patient a therapeutically effective amount of a water-free , oxygen-permeable formulation such that re-epithelialization and reduction of edema and erythema of the ablated skin occurs , the formulation comprising: white petrolatum; avocado oil; and hydrogenated polyisobutene.2. The method of claim 1 , wherein the formulation comprises 79.3% white petrolatum claim 1 , 0.9% avocado oil claim 1 , and 19.8% hydrogenated polyisobutene.3. A method of treating a patient with a rash associated with incontinence dermatitis or diaper rash claim 1 , the method comprising topically administering to the rash a therapeutically effective amount of a water-free claim 1 , oxygen-permeable formulation claim 1 , such that a reduction of rash claim 1 , edema claim 1 , and erythema of the ablated skin occurs claim 1 , the formulation comprising: white petrolatum; avocado oil; and hydrogenated polyisobutene.4. The method of claim 3 , wherein the formulation comprises 79.3% white petrolatum claim 3 , 0.9% avocado oil claim 3 , and 19.8% hydrogenated polyisobutene. This application claims the benefit under 35 U.S.C. § 119(e) of both U.S. Provisional Application No. 62/880,800, filed Jul. 31, 2019 and U.S. Provisional Application No. 63/024,156, filed May 13, 2020, each of which are also incorporated herein by reference in their entireties.The present invention is in the field of medicine. More particularly, the invention relates to treatment of injured skin after laser ablation and/or scarring.Skin injuries and actinic lesions can result in scarring, edema, and/or erythema, the recovery from which can take months and even years, during which a subject suffering from such an injury can ...

COMPOSITION FOR PREVENTING OR TREATING DRY EYE SYNDROME, CONTAINING AUCUBA JAPONICA EXTRACT

Provided is a composition for preventing, alleviating or treating dry eye syndrome, containing an extract as an active ingredient. The composition containing an extract can be effectively used in the prevention, alleviation or treatment of dry eye syndrome. 1Aucuba japonica. A method for preventing or treating dry eye syndrome , comprising administering an extract to a subject.2Aucuba japonica. The method for preventing or treating dry eye syndrome according to claim 1 , wherein the extract is an ethanol extract or a hot water extract.3. The method for preventing or treating dry eye syndrome according to claim 2 , wherein the ethanol extract is a 20-40% ethanol (w/w) extract.4. The method for preventing or treating dry eye syndrome according to claim 2 , wherein the hot water extract is extracted at a temperature of 90-120° C.5Aucuba japonica. The method for preventing or treating dry eye syndrome composition according to claim 1 , wherein the extract is administered orally.6Aucuba japonicaAucuba japonica.. The method for preventing or treating dry eye syndrome according to claim 1 , wherein the extract is an extract of the leaf or stem of7Aucuba japonica. A functional health food composition for preventing or alleviating dry eye syndrome claim 1 , comprising an extract as an active ingredient.8Aucuba japonica. The functional health food composition according to claim 7 , wherein the extract is an ethanol extract or a hot water extract.9Aucuba japonicaAucuba japonica.. The functional health food composition according to claim 7 , wherein the extract is an extract of the leaf or stem of The present disclosure relates to a composition for preventing, alleviating or treating dry eye syndrome.Dry eye syndrome (dry eye) is a common disease occurring in around 20% of Korean adults. Its incidence is increasing consistently due to global climate change and environmental pollution. Dry eye syndrome causes not only simple tear deficiency but also eye discomfort caused by ...

Edible Product Comprising Reconstituted Plant Material

The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product. 1. An edible product , the product comprising a layer of a fibrous plant product and a plant extract applied to the layer of the fibrous plant product.2. The product of claim 1 , wherein the fibrous plant product comprises substances from one or more specific parts of one or more plants.3. The product of claim 1 , wherein the plant extract comprises substances from one or more specific parts of one or more plants.4. The product of claim 1 , wherein the fibrous plant product comprises substances from one or more specific parts of one or more plants or the plant extract comprises substances from one or more specific parts of one or more plants or a combination thereof claim 1 , and wherein the plants are selected from one or more of the group consisting of herbs claim 1 , medicinal plants claim 1 , tea claim 1 , vegetables claim 1 , or spices.5AbelmoschusAbiesAbroma augusta, AcaciaAcalypha indica, Acanthus mollis, AcerAchilleaAchyranthes bidentata, Acmella oleracea, Acorus calamus, ActaeaActinidiaAdansonia digitata, AdiantumAdoxa moschatellina, Aegopodium podagraria, AesculusAframomumAgathosmaAgaveAgrimoniaAjugaAlaria esculenta, AlbiziaAlcea rosea, Alchemilla vulgaris, Aletris farinosa, AlismaAlliaria petiolata, AlliumAlnusAloeAloysia citriodora, AlpiniaAlthaea officinalis, AmaranthusAmmi visnaga, Amomum villosum, Amorphophallus konjac, Amyris balsamifera, Anacardium occidentale, Ananas comosus, Andrographis paniculata, Anemarrhena asphodeloides, AngelicaAngostura trifoliata, Aniba rosaeodora, AnnonaAnogeissus ...

COMPOSITION FOR PREVENTING OR TREATING GASTRITIS OR PEPTIC ULCER

The present invention relates to a pharmaceutical or food composition comprising pretreated extract exhibiting an excellently enhanced pharmacological effect than extract prepared by a conventional common extraction method of and extract prepared with single herb medicine, or a method for preventing, improving or treating gastritis or peptic ulcer using the composition. In addition, the present invention relates to a preparation method of pretreated extract which is characterized by pretreating with a non-polar solvent and extracting it with a polar solvent. 1Cinnamomum cassia,. A method for preventing , improving or treating gastritis or peptic ulcer , comprising a step of administering a composition comprising extract of{'i': ['Cinnamomum cassia', 'Cinnamomum cassia', 'Cinnamomum cassia'], '#text': 'wherein the extract of is prepared by a method comprising a) a step of immersing into ethyl acetate to reduce cinnamic aldehyde and 2-methoxycinnamic aldehyde in the extract; b) a step of removing the ethyl acetate in the step a); and c) a step of extracting obtained in the step b) with water.'}2. The method according to claim 1 , wherein the composition is a pharmaceutical composition or food composition.3. The method according to claim 2 , wherein the composition is health functional food claim 2 , health supplementary food or functional food.4. The method according to claim 1 , wherein the peptic ulcer is stomach ulcer or duodenal ulcer.5Cinnamomum cassia. The method according to claim 1 , wherein the composition is administered once or several times as divided claim 1 , wherein the composition is characterized by comprising the extract so that the daily dose of the water extract is 9.7 to 2 claim 1 ,919 mg.6Cinnamomum cassiaCinnamomum cassiaCinnamomum cassia. A preparation method of extract comprising a) a step of immersing into ethyl acetate to reduce cinnamic aldehyde and 2-methoxycinnamic aldehyde in the extract; b) a step of removing the ethyl acetate in the ...

Antifungal, antibacterial topical composition for the prevention and treatment of various skin conditions including diaper rash

A topical, over the counter, all natural, organic, antifungal, antibacterial cream having superior moisturizing and water repellency performance that absorbs into the epidermis without spreading thereby eliminating and preventing the growth of the rash-causing fungus that causes diaper rash, and other skin irritation rashes.

ION CHANNEL ACTIVATORS AND METHODS OF USE

The present invention relates to compositions of ion channel activators and methods of preparation, formulation, and the medical use of these compositions. In one aspect, the present invention features a composition formulated for oral administration, said composition comprising an effective amount of an ion channel activator (e.g., a TRPV1 channel activator, a TRPA1 channel activator, an ASIC channel activator, or combination thereof). 1. A composition formulated for oral administration , said composition comprising an effective amount of an ion channel activator and a pharmaceutically acceptable excipient , wherein said composition is a liquid or solid , and wherein said composition is formulated for delayed release of said ion channel activator.2. The composition of claim 1 , wherein said composition comprises a plurality of ion channel activators and a pharmaceutically acceptable excipient.3. The composition of and claim 1 , wherein said composition comprises two ion channel activators and a pharmaceutically acceptable excipient.4. The composition of any one of - claim 1 , wherein said composition comprises an ion channel activator and a plurality of pharmaceutically acceptable excipients.5. The composition of any one of - claim 1 , wherein said pharmaceutically acceptable excipient comprises an agent for delayed release of an ion channel activator such that claim 1 , when orally administered to a subject claim 1 , the ion channel activator is not substantially released in the stomach of said subject.6. The composition of claim 5 , wherein the agent for delayed release is selected from the group consisting of: hydroxypropyl cellulose claim 5 , hydroxypropyl methyl cellulose claim 5 , methyl cellulose claim 5 , carboxymethyl cellulose claim 5 , and mixtures thereof.7. The composition of any one of - claim 5 , wherein said pharmaceutically acceptable excipient comprises a coating.8. The composition of claim 7 , wherein said coating is selected from the group ...

PHARMACEUTICAL COMPOSITION

A composition comprising a therapeutically effective amount of at least one alkaloid combined with one or more non-alkaloid components, wherein the composition is configured to be administered to a subject. 1. A composition comprising a therapeutically effective amount of at least one alkaloid combined with one or more non-alkaloid components , wherein the composition is configured to be administered to a subject.2. The composition of claim 1 , wherein the at least one alkaloid is selected from the group consisting essentially of berberine claim 1 , allocryptopine claim 1 , alpha-homochelidonine claim 1 , beta-homochelidonine claim 1 , chelidonine claim 1 , chelerythrine claim 1 , coptisine claim 1 , magnoflorine claim 1 , protopine claim 1 , sparteine claim 1 , chelamine claim 1 , and sanguinaria.3. The composition of wherein the composition further comprises at least one component selected from the group consisting essentially of allocryptopine claim 1 , chelamine claim 1 , chelidonine claim 1 , chelerythrine claim 1 , coptisine claim 1 , magnoflorine claim 1 , protopine claim 1 , sparteine claim 1 , alpha-homochelidonine claim 1 , beta-homochelidonine claim 1 , chelidonic acid claim 1 , malic acid claim 1 , and citric acid.4. The composition of claim 1 , wherein at least one of the one or more non-alkaloid components is a polyphenol.5. The composition of claim 1 , wherein the at least one alkaloid is berberine6. The composition of wherein the therapeutically effective amount of berberine is at least 50 mg.7. The composition of claim 1 , wherein the composition is a solid and wherein the composition is orally administered via a capsule.8. The composition of claim 1 , wherein the subject is a mammal.9. The composition of claim 1 , wherein the therapeutically effective amount is determined by a desired biological response of the subject.10. The composition of claim 9 , wherein the composition comprises at least 50 mg of berberine claim 9 , 50 mg of beetroot claim 9 ...

ANTI-MICROBIAL AMALGAMATE OF NON-TOXIC NATIVE COMPOSITION

An anti-microbial formulation of native ingredients for human and non-human vertebrate animal feeds, feed supplements/additives, or for direct doses to replace in whole or supplement traditional anti-microbial with side-effects such as allergies, microbial-resistance, and drug-interactions with non-toxic, side-effect free native anti-microbial for all vertebrates. The invention comprises of non-toxic, side-effect free native substances amalgamations having anti-microbial properties for food additives, food supplements, or direct doses. Furthermore, these native formulas can be use with or without other prescription or nonprescription anti-microbial medications. We describe the method of manufacture and also the process of use for this amalgamates. 1. An anti-microbial composition comprising coconut/MCT oil , Elantria DHA 400 algae , cranberry seed , black cumin , oregano , carob , and Agaricus mushroom; wherein the composition is side-effect-free in any vertebrate; and wherein the composition is non-toxic to any vertebrates.2. The composition of claim 1 , further comprises at least one or more selected from chia claim 1 , krill claim 1 , micro-algae claim 1 , cinnamon claim 1 , lemon claim 1 , coriander claim 1 , ginger claim 1 , peppermint claim 1 , fenugreek claim 1 , moringa claim 1 , insect protein claim 1 , cardamom claim 1 , or any combination thereof.3. The composition of any of claim 1 , wherein krill comprises from 5% to 40% by weight/volume claim 1 , wherein micro-algae comprises from 5% to 40% weight/volume claim 1 , wherein cranberry seed comprises from 0.1% to 10% by weight/volume claim 1 , wherein chia comprises from 5% to 30% by weight/volume claim 1 , wherein black cumin comprises from 0.05% to 5% by weight/volume claim 1 , wherein carob comprises from 0.1% to 5% by weight/volume claim 1 , and wherein cardamom comprises from 0.01% to 5% by weight/volume or any combination thereof.4. The composition of claim 1 , wherein oregano oil 11-24% claim 1 , ...

Methods of Diagnosing and Treating Dry Eye Syndrome and Compositions for Treating a Human Eye

In preferred the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil. 1. A method of diagnosing and treating dry eye syndrome comprising:testing the tears of a patient to determine whether the patient has dry eye syndrome and, if so, to determine the characteristics of the dry eye syndrome present in the eye or eyes of the patient;inquiring of the patient as to what degree of sensitivity the patient has that would affect the choice of medication to be used in treating the dry eye syndrome in the eye or eyes of the patient; andproviding, based on the testing and inquiring, a treatment composition for use in the patient's eye to treat the patient's dry eye syndrome, the treatment composition being selected from a series of different compositions comprising water and a natural oil component selected from the group consisting of jojoba oil, avocado oil, tea tree oil, coconut oil, argan, oleuroleupein, cottonseed oil, sunflower oil, maize oil, linseed oil, rapeseed oil, tea tree oil, argan oil, castor oil, soybean oil, caraway oil, rosemary oil, peppermint oil, sunflower oil, eucalyptus oil, bergamot oil, fennel oil, sesame oil, menthol oil, ginseng oil, jujube oil, okra oil; ...

NUTRACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF TYPE 2 DIABETES

A dietary supplement in capsule or tablet form includes a source of zinc in an amount equivalent to 6 mg to 40 mg of zinc chloride; optionally a source of chromium in an amount equivalent to 100 micrograms to 1000 micrograms of chromium picolinate; optionally from 4 micrograms to 100 micrograms of Vitamin B12; optionally an extract or powdered form of American Ginseng in an amount that provides from 20 mg to 200 mg of ginsenoside(s), or 20 mg to 200 mg of isolated or synthesized ginsenoside(s); optionally an oil, extract or powdered form of cinnamon bark in an amount that provides 1000 mg to 5000 mg of methylhydroxychalcone polymer; optionally 2 mg to 50 mg lutein; and optionally green tea extract in an amount that provides from 200 mg to 4000 mg of epigallocatechin gallate or 200 mg to 4000 mg of isolated or synthesized epigallocatechin gallate. 1. A dietary supplement in capsule or tablet dosage form , comprising:an orally administrable source of magnesium in an amount that is the equivalent of from 10 mg to 400 mg of magnesium chloride;an orally administrable source of zinc in an amount that is the equivalent of from 3 mg to 20 mg of zinc chloride;optionally an orally administrable source of chromium in an amount that is the equivalent of up to 500 micrograms of chromium picolinate;optionally Vitamin B12 in an amount up to 100 micrograms;optionally an extract or powdered form of American Ginseng in an amount that provides up to 100 mg of ginsenosides;optionally an oil, extract or powdered form of cinnamon bark in an amount that provides up to 2500 mg of methylhydroxychalcone polymer;optionally lutein in an amount up to 25 mg; andoptionally green tea extract in an amount that provides up to 2000 mg of epigallocatechin gallate.2. The dietary supplement of claim 1 , in which the orally administrable source of chromium is present in an amount that is the equivalent of at least 50 micrograms of chromium picolinate.3. The dietary supplement of claim 2 , in which ...

PLANT EXTRACTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

Ehanolic plant extracts of aerial parts of at least a first plant, a second plant and optionally a third plants are described with related compositions, methods and systems, in which the first plant belongs to plant genus and is in flowering stage, the second plant belongs to plant genus and the third plant belongs to the genus 1JasminumCinnamomum.. An ethanolic plant extract obtainable by contacting aerial parts of at least a first plant and a second plant with ethanol with a volume/volume ratio first plant:ethanol from about 1:1.25 to about 1:1.75 and a volume/volume ratio second plant:ethanol from about 1:10 to about 1:18 wherein the first plant belongs to plant genus and is in flowering stage , and the second plant belongs to plant genus2. The ethanolic plant extract of claim 1 , wherein the volume/volume ratio first plant:ethanol ratio is about 1:1.5 and the volume/volume ratio second plant:ethanol ratio is about 1:143Jasminum officinale. The ethanolic plant extract of claim 1 , wherein the first plant is4Cinnamomum verum. The ethanolic plant extract of claim 1 , wherein the second plant is5. The ethanolic plant extract of wherein the extract comprises alkaloids claim 1 , phenolic acids and derivatives claim 1 , polyphenols claim 1 , terpenes and steroids claim 1 , methylated phenols claim 1 , and benzopyrans claim 1 , carbohydrates free fatty acids and triglycerides.6Coffea. The ethanolic plant extract of claim 1 , wherein the aerial parts of at least a first and a second plants further comprise aerial parts of a third plant claim 1 , the third plant belongs to the genus and the aerial parts are green beans of the third plant claim 1 , and wherein the contacting further comprises contacting the aerial parts of the third plants with ethanol with a volume/volume ratio third plant:ethanol from about 1:25 to about 1:35.7. The ethanolic plant extract of claim 6 , wherein the volume/volume ratio third plant:ethanol ratio is about 1:308. The ethanolic plant extract ...

COMPOSITION FOR PREVENTING OR TREATING GASTRITIS OR PEPTIC ULCER

The present invention relates to a pharmaceutical or food composition comprising pretreated extract exhibiting an excellently enhanced pharmacological effect than extract prepared by a conventional common extraction method of and extract prepared with single herb medicine, or a method for preventing, improving or treating gastritis or peptic ulcer using the composition. In addition, the present invention relates to a preparation method of pretreated extract which is characterized by pretreating with a non-polar solvent and extracting it with a polar solvent. 1Cinnamomum cassia.. A pharmaceutical composition for preventing or treating gastritis or peptic ulcer comprising non-polar solvent pretreatment and polar solvent extract of2. The pharmaceutical composition according to claim 1 , wherein the peptic ulcer is stomach ulcer or duodenal ulcer.3. The pharmaceutical composition according to claim 1 , wherein the non-polar solvent is ethyl acetate.4. The pharmaceutical composition according to claim 1 , wherein the polar solvent is water.5Cinnamomum cassia. The pharmaceutical composition according to claim 1 , which is administered once or several times as divided claim 1 , wherein the pharmaceutical composition is characterized by comprising the extract so that the daily dose of the pretreated extract is 9.7 to 2 claim 1 ,919 mg.6Cinnamomum cassia. The pharmaceutical composition according to claim 1 , wherein the yield of the pretreated extract is 15 to 20→1 (meaning that 1 Kg of the final extraction dry ex is obtained when adding 15 to 20 Kg of crude herb medicine).7Cinnamomum cassia.. A food composition for preventing or improving gastritis or peptic ulcer comprising non-polar solvent pretreatment and polar solvent extract of8. The food composition according to claim 7 , wherein the peptic ulcer is stomach ulcer or duodenal ulcer.9. The food composition according to claim 7 , wherein the non-polar solvent is ethyl acetate.10. The food composition according to claim ...

Composite with the Function of Regulating Blood Glucose

A composite with the function of regulating blood glucose is formed into a tablet by clustering and mixing bitter gourd extract, olive extract, cinnamon extract, zinc gluconate, and chromium yeast. Animal experiment results clearly show that diabetic patients have significant improvements by taking a blood glucose regulating tablet with the compound recipe of the composite. 1. A composite with the function of regulating blood glucose , comprising:a tablet, containing a bitter gourd extract, an olive extract, a cinnamon extract, a zinc gluconate, and a chromium yeast as active ingredients, an excipient containing sugar alcohol or disaccharide, and a lubricant containing one or more items selected from the group consisting of curing oil, stearate and sucrose fatty acid ester.2. The composite with the function of regulating blood glucose according to claim 1 , wherein the tablet is formed into a solid table by weighing the bitter gourd extract claim 1 , the olive extract claim 1 , the cinnamon extract claim 1 , the zinc gluconate claim 1 , and the chromium yeast which are in a powder form according to a proportion precisely and sieving claim 1 , mixing claim 1 , and tabletting the powders.3. The composite with the function of regulating blood glucose according to claim 1 , wherein the excipient containing sugar alcohol or disaccharide is selected from one or more items of the group consisting of lactose claim 1 , erythritol (sugar alcohol) and mannitol.4. The composite with the function of regulating blood glucose according to claim 1 , wherein the tablet contains 45% of the bitter gourd extract claim 1 , 12% of the olive extract claim 1 , 10% of the cinnamon extract claim 1 , 0.3% of the zinc gluconate claim 1 , 0.18% of the chromium yeast claim 1 , 0.003% of the lubricant claim 1 , and 32.517% of the excipient. The present invention relates to a composite with the function of regulating blood glucose, more particularly to the composite that provides a significant ...

Compositions and Methods for Treating the Eye

The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye. 2AcronychiaLicaria.. The composition according to claim 1 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract claim 1 , or source of extracts claim 1 , from plants of the genus and/or3Acronychia.. The composition according to claim 2 , wherein the compound and/or extract having retinol-like properties and/or benefits is a botanical extract claim 2 , or source of extracts claim 2 , from plants of the genus4AcronychiaAcronychia aberrans, Acronychia acidula, Acronychia acronychioides, Acronychia acuminate, Acronychia baeuerlenii, Acronychia chooreechillum, Acronychia crassipetala, Acronychia eungellensis, AcronychiaAcronychia laevis, Acronychia laurifolia, Acronychia littoralis, Acronychia oblongifolia, Acronychia octandra, Acronychia parviflora, Acronychia pauciflora, Acronychia pedunculata, Acronychia pubescens, AcronychiaAcronychia suberosa, Acronychia vestita, Acronychia wilcoxiana. The composition according to claim 3 , wherein the botanical extract claim 3 , or source of extracts claim 3 , from plants of the genus is selected from the group consisting of imperforate claim 3 , species (Batavia Downs) claim 3 , claim 3 , and combinations of two or more thereof.5AcronychiaAcronychia acidula.. The composition according to claim 4 , wherein the botanical extract claim 4 , or source of extracts claim 4 , from plants of the genus is8. The composition according to claim 7 , wherein the compound of formula (II) are in the form of an acid or alkylester selected from 3-(4-farnesyloxyphenyl)-propionic acid claim 7 , 3-(4-farnesyloxy-3-hydroxyphenyl)-propionic acid claim 7 , 3-(4-farnesyloxy-3-methoxyphenyl)-propionic acid claim 7 , alkylesters thereof and combinations of two or more thereof.9. The composition according to claim ...

CLARIGEST COMPOSITION

A nutritional supplement composition is provided including an extract derived from common white kidney beans (), Capsicum extract of the fruit of the strain and Cinnamon extract of the bark of the strain. The nutritional supplement is in the form of a compound known as CLARIGEST™. 1. A nutritional composition consisting of:{'i': 'Phaseolus vulgaris;', 'an extract derived from'}{'i': 'Capsicum frutescens', 'an capsicum extract of the fruit of the strain;'}and{'i': 'Cinnamonium cassia', 'an cinnamon extract of the bark of the strain.'}2. The composition of claim 1 , wherein:{'i': 'Phaseolus vulgaris', 'the extract derived from is in the amount of 100 mg,'}{'i': 'Capsicum frutescens', 'the capsicum extract of the fruit of the strain is in the amount of 25 mg,'}and{'i': 'Cinnamonium cassia', 'the cinnamon extract of the bark of the strain is in the amount of 30 mg.'} In the past, we commonly used all parts of natural foods when we consumed a meal. Human eating patterns naturally accessed nutrients available from what was eaten and very little nutrients were wasted as a result. For example, when eating fish, the muscular parts of the fish were consumed along with other parts such as connective tissue. When eating plants, the edible portion of the plant was consumed in its entirety. Our bodies would then filter out what was not consumable, such as the outer shell of a kernel of corn for example. As this occurred, our bodies would extract what nutrients could be found in the food to sustain and grow the human form. This allowed use of local foods to provide nutrients which were available, but was somewhat limited in that foods not available locally could not be used in most cases. Over time, we learned to travel and to ship food from where it was produced to where it could be consumed. Additionally, we learned to prepare foods, removing portions of the food which were either inedible, or undesirable. Removing the inedible parts typically provided some benefit, while parts ...

Optilumine composition

In an embodiment, a nutritional supplement composition is provided. The nutritional supplement composition is provided including a combination of 100 mg of avocado oil, 15 mg of zeaxanthin of a five percent concentration and 20 mg marigold extract from the tagetes erecta strain. The nutritional supplement is in the form of a compound known as OPTILUMINE™.

Natural Pet Treat and Method of Production

The invention disclosed herein is directed to a pet treat composition and the method of producing such a composition. The pet treat comprises a mixture of whole wheat flour, blueberries, cinnamon, vanilla yogurt, and almond milk. The composition includes organic and natural ingredients and contains a high level of antioxidants, which provides anti-inflammatory properties that help prevent joint and hip pain. Additionally, the composition contains probiotics that enhance digestive function. When consumed, the probiotics have shown to help the chemical balance and reduce tearing as well as the bacteria that causes tear stains. The present method generally involves mixing all of the ingredients together to form a dough and baking the dough. The composition is suitable for daily consumption and as supplement to a pet's existing diet regimen. 1) A pet treat composition adapted to reduce inflammation , consisting essentially of:whole wheat flour in an amount of approximately 42.2% by weight;frozen blueberries in an amount of approximately 15.0% by weight;cinnamon in an amount of approximately 0.1% by weight;yogurt in an amount of approximately 21.6% by weight;almond milk in an amount of approximately 21.1% by weight;wherein said whole wheat flour, said frozen blueberries, said cinnamon, said yogurt, and said almond milk are mixed together to form a dough;wherein said dough is baked.2) The pet treat composition of claim 1 , wherein said yogurt is vanilla flavored.3) A method of preparing a pet treat claim 1 , comprising the steps of:blending frozen blueberries, cinnamon, yogurt; and almond milk at a room temperature to create a smooth mixture;combining said smooth mixture to whole wheat flour;mixing said smooth mixture and said whole wheat flour to create a dough;rolling said dough into a thin sheet;cutting out said dough into desired shapes;baking said dough.4) The method of preparing a pet treat of claim 3 , wherein said room temperature is 62 degrees to 73 degrees ...

DIETARY SUPPLEMENT COMPOSITIONS

This document provides dietary supplement compositions as well as methods for using dietary supplement compositions to control glucose levels. For example, a dietary supplement composition including chromium (e.g., Chromium Oligofructose Complex), a sweet potato extract, and one or more of a mulberry extract, a green tea extract, a cinnamon extract, or a ginseng extract (e.g., Korean Red Ginseng extract) are provided. 1. A dietary supplement composition , comprising:a sweet potato extract;a chromium; andone or more ingredients selected from the group consisting of a mulberry extract, a green tea extract, a cinnamon extract, and a ginseng extract.2. The dietary supplement composition of claim 1 , wherein the dietary supplement composition comprises a mulberry extract claim 1 , a green tea extract claim 1 , a cinnamon extract claim 1 , and a ginseng extract.3. The dietary supplement composition of claim 1 , wherein the dietary supplement composition is in the form of a dry powder.4. The dietary supplement composition of claim 3 , wherein the dry powder dietary supplement composition is suitable for blending with a liquid to form a beverage comprising a solution claim 3 , aqueous slurry claim 3 , or combination thereof.5. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.1 weight percent and 2.0 weight percent of one or more sweet potato extracts.6. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.01 weight percent and 0.1 weight percent of a chromium containing compound.7. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.5 weight percent and 10 weight percent one or more mulberry extracts.8. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.1 weight percent and 5 weight percent one or more ginseng extracts.9. The dietary ...

PAIN RELIEF COMPOSITIONS AND METHODS

An analgesic composition useful for soothing body aches, pains and sores. The analgesic composition can include methyl salicylate, turpentine oil, camphor oil, sassafras oil, beta carotene, emu oil, oleoresin capsicum, chlorophyllin, and mustard oil. Methods for soothing body aches. The methods include administering an analgesic composition topically at a location of a body ache. 1. A topical analgesic composition comprising 2%-6% methyl salicylate , 2%-6% camphor oil , 2%-6% turpentine oil , 2%-6% sassafras oil , 0.1%-5% oleoresin capsicum , 0.05%-1% chlorophyllin , and 0.1%-5% emu oil , wherein all percentages are by weight , based on the total weight of the composition.2. The topical analgesic composition according to claim 1 , further comprising 0.01%-0.1% mustard oil claim 1 , and 2%-6% beta carotene.3. The topical composition of claim 1 , further comprising a pharmaceutically acceptable carrier.4. The topical analgesic composition according to claim 3 , wherein the carrier comprises white petrolatum and/or medium wax.5. The topical analgesic composition according to claim 4 , wherein the carrier comprises 2%-6% medium wax claim 4 , and 60%-80% white petrolatum.6. The topical analgesic composition of claim 3 , wherein the pharmaceutically acceptable carrier comprises polysorbate claim 3 , glycerin claim 3 , oloxamer 188 claim 3 , alcohol claim 3 , and/or water.7. The topical analgesic composition according to comprising 4.75% methyl salicylate claim 1 , 4.75% camphor oil claim 1 , 4.75% turpentine oil claim 1 , 4.75% sassafras oil claim 1 , 0.59% oleoresin capsicum claim 1 , 0.3% chlorophyllin claim 1 , and 1% emu oil.8. The topical analgesic composition according to further comprising 0.03% mustard oil claim 7 , and 4.75% beta carotene.9. The topical analgesic composition according to claim 8 , further comprising 4.79% medium wax claim 8 , and 69.54% white petrolatum.10. A topical analgesic composition according to claim 1 , consisting of 4.75% methyl ...

COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASE, CONTAINING OIL OF LITSEA JAPONICA AS ACTIVE INGREDIENT, AND METHOD FOR PREPARING SAME

The present invention relates to a composition for an inflammatory disease, using Litsea japonica, and more specifically to a composition for preventing and treating an inflammatory disease, containing the oil derived from the fruits or the seeds of Litsea japonica, and a method for preparing the same. The present invention uses the fruits (excluding the seeds) or the seeds of Litsea japonica and obtains the oil, which is used as an active ingredient of a composition for preventing and treating an inflammatory disease, by using n-hexane, wherein the oil is obtained by: separating the fruits (excluding the seeds) of Litsea japonica from the seeds; injecting n-hexane, which is a solvent, into the fruits (excluding the seeds) or the seeds, 9-11 times greater than the weight of each: stirring the same for 24 hours at room temperature and extracting the same; and removing a hexane layer. 1. A composition for preventing and treating an inflammatory disease , comprising: an oil extracted from Litsea japonica as an active ingredient.2. The composition of claim 1 , wherein the oil from Litsea japonica can be obtained from any of fruits excluding seeds claim 1 , seeds and fruits containing seeds of Litsea japonica.3. The composition of claim 2 , wherein the oil from Litsea japonica is either a fruit oil from fruits excluding seeds of Litsea japonica or a seed oil from seeds of Litsea japonica claim 2 , and the fruit oil and the seed oil can be used in a singular form or can be used mixed together.4. The composition of claim 1 , wherein the oil from Litsea japonica can be obtained by an extraction method which uses n-hexane as a solvent claim 1 , a supercritical extraction method claim 1 , a distillation method claim 1 , or a compression method.5. A method for preparing oil from Litsea japonica for preventing and treating an inflammatory disease claim 1 , comprising:inputting the fruits of Litsea japonica 9-11 times weight into n-hexane which is a solvent;agitating the ...

CAMEL HUMP OIL - BASED HERBAL COMPOSITIONS AND METHOD OF MAKING THE SAME

The embodiments herein provide camel hump oil based herbal compositions and methods for preparing these compositions for treatment of a plurality of diseases such as dermatological conditions, musculoskeletal conditions and hair conditions. The embodiments herein also provide a method of extraction of camel hump oil from a camel hump and a method of de-odorizing the extracted camel hump. The camel hump-oil based herbal composition comprises camel hump oil, a herbal oil extract, a curing agent and a plurality of additives. The camel hump oil based composition is topically applied. 1. A camel hump oil-based herbal compositions comprises:a camel hump oil;a herbal oil extract, wherein the herbal oil is an extract of a herb in a botanical oil, and wherein the herb is a pain relieving, anti-inflammatory or antioxidant herb, and wherein the herb is bay leaves and thyme;a curing agent, wherein the curing agent is selected from a group consisting of a vitamin C, a botanical oil and an analgesic agent; anda plurality of additives, and wherein the plurality of additives includes a petroleum jelly, a vitamin E, a fragrance and a preservative.2. The herbal composition according to claim 1 , wherein the herbal composition is used in a dermatological condition claim 1 , in a musculoskeletal condition and in hair treatment.3. The herbal composition according to claim 1 , wherein the herbal composition for treatment of dermatological conditions comprises:a camel hump oil, wherein the camel hump oil is present with an amount of 70 weight percent to 80 weight percent;a herbal oil extract of bay leaves and thyme, wherein the herbal oil extract of bay leaves and thyme is present in an amount of 10 weight percent to 15 weight percent;a vitamin C, wherein the vitamin C is present with an amount of 5 weight percent to 10 weight percent;a petroleum gel, wherein the petroleum gel is present with an amount of 10 weight percentage to 15 weight percentage;a glycerin, wherein the glycerin is ...

SENSITIZATION COMPOSITION AND METHOD OF USE

The present invention relates to a topical composition and method of use, specifically an oil-in-water emulsion, comprised of sweet almond oil, lavender oil, rose oil, cinnamon bark oil, and coriander seed oil in a physiologically acceptable topical carrier. The composition is applied to a circumcised penis to enhance sensitivity, preferably twice daily for a time period of at least about two weeks. Thereafter a maintenance dose can be applied once a day to maintain a desired level of sensitivity. 1. A topical composition which comprises an admixture of sweet almond oil , lavender oil , cinnamon bark oil , coriander seed oil and rose oil in a physiologically acceptable oil-in-water emulsion.2. The topical composition in accordance with wherein the oil-in-water emulsion is a topical cream.3. The topical composition in accordance with wherein said oils are present in said admixture in a respective weight proportion of about 200:33:25:17:1.4. A topical composition comprising claim 1 , based on the weight of the composition:about 2 to about 10 weight percent sweet almond oil, about 0.01 to about 2 weight percent lavender oil, about 0.005 to about 1 weight percent of rose oil, about 0.01 to about 2 weight percent cinnamon bark oil, about 0.01 to about 1 weight percent of coriander seed oil, about 0.7 to about 7 weight percent sorbitol, zero to about 7 weight percent isopropyl alcohol, about 5 to about 25 weight percent of propylene glycol, about 0.01 to about 2 weight percent butylated hydroxytoluene, about 0.05 to about 3 weight percent triethanolamine, about 0.01 to about 3 weight percent benzyl alcohol, about 0.01 to about 5 weight percent benzyl benzoate, about 1 to about 5 weight percent of polyethylene glycol (40)-hydrogenated castor oil, about 0.25 to about 4 weight percent acrylate/C10-30 alkyl acrylate crosspolymer, about 0.01 to about 0.2 weight percent disodium ethylene diamine tetraacetic acid, and the remainder water.5. The topical composition of and ...

Neutraceutical formulation for treatment of diabetes

Disclosed are compositions of matter useful for the treatment of diabetes. In one embodiment a nutraceutical composition is administered to a patient in need, said composition comprising of one or more ingredients selected from a group consisting of: magnesium, chromium picolinate, alpha lipoic acid, Garcina indica , holy basil, Morodica charantica , cinnamon, Salacia reticulate, Salacia oblonga, Gymnema sylvestre , nopal cactus, fenu greek, vanadium, 1-carnitine, and vitamin D3.

Edible Product Comprising Reconstituted Plant Material

The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product. 136.-. (canceled)37. A fibrous material comprising:a reconstituted cocoa shell material comprising (1) extracted cocoa shell fibers combined with (2) cellulosic fibers.38. A fibrous material as defined in claim 37 , wherein the reconstituted cocoa shell material contains water solubles in an amount of less than about 50% by weight.39. A fibrous material as defined in claim 37 , wherein the reconstituted cocoa shell material contains water solubles in an amount of less than about 30% by weight.40. A fibrous material as defined in claim 37 , wherein the reconstituted cocoa shell material contains water solubles in an amount of about 5% by weight to about 20% by weight.41. A fibrous material as defined in claim 37 , wherein the cellulosic fibers comprise wood pulp fibers.42. A fibrous material as defined in claim 37 , wherein the cellulosic fibers comprise flax fibers claim 37 , hemp fibers claim 37 , abaca fibers claim 37 , softwood fibers claim 37 , hardwood fibers claim 37 , bamboo fibers claim 37 , coconut fibers claim 37 , ramie fibers claim 37 , jute fibers or mixtures thereof.43. A fibrous material as defined in claim 37 , wherein the cellulosic fibers are present in the reconstituted cocoa shell material in a weight ratio to the cocoa shell fibers of from about 20/80 to about 80/20.44. A fibrous material as defined in claim 37 , wherein the cellulosic fibers are present in the reconstituted cocoa shell material in a weight ratio to the cocoa shell fibers of from about 20/80 to about 40/60.45. A fibrous ...

Aqueous Solution Formulated to Raise Body Temperature

An aqueous solution that is useful for helping to increase body temperature in people with chronic low body temperature, as well as people who suffer from cold hands and feet, includes a combination of ginseng, cinnamon, ginger, and jasmine tea. The body temperature raising solution may be in the form of a beverage and include a sweetener, such as honey, to improve the taste thereof. The body temperature raising solution is formulated by steeping leaves of the jasmine tea in a host liquid, suspending predetermined amounts of the ginseng, cinnamon, ginger, and honey into the host liquid, and storing the combination in an airtight container. 1. An aqueous solution formulated to raise body temperature , comprising about 0.5 to 1% by volume ginseng; about 0.5 to 1% by volume cinnamon; about 0.75 to 1.25% by volume ginger; and about 0.25 to 0.5% by volume jasmine tea.2. The aqueous solution of claim 1 , comprising 0.5 to 1% by volume ginseng; 0.5 to 1% by volume cinnamon; 0.75 to 1.25% by volume ginger; and 0.25 to 0.5% by volume jasmine tea.3. The aqueous solution of claim 2 , further comprising 7.54 to 11.27 mg/l dissolved oxygen.4. The aqueous solution of claim 3 , further comprising a sweetener.5. The aqueous solution of claim 4 , wherein the sweetener is selected from the group consisting of: honey claim 4 , sucralose claim 4 , dextrose claim 4 , fructose claim 4 , lactose claim 4 , maltodextrin claim 4 , saccharin claim 4 , maltodextrin claim 4 , pure cane sugar claim 4 , and stevia.6. The aqueous solution of claim 5 , wherein the sweetener is honey.7. The aqueous solution of claim 1 , further comprising about 9 to about 12% by volume honey and about 7.54 to about 11.27 mg/l dissolved oxygen.8. The aqueous solution of claim 7 , comprising about 0.6% by volume ginseng;about 0.6% by volume cinnamon; about 0.9% by volume ginger; about 0.3% by volume jasmine tea; about 10% by volume honey; and about 7.54 mg/l dissolved oxygen.9. The aqueous solution of claim 8 , ...

NOVEL COMBINATION PRODUCT

A combination product comprising a nasal spray dispenser containing a formulation for nasal administration, and a balm holder element containing a skin-care balm, attached to a bottom of the nasal spray dispenser. 1. A combination product comprising a nasal spray dispenser containing a formulation for nasal administration , and a balm holder element containing a skin-care balm , attached to a bottom of the nasal spray dispenser.2. A combination product according to claim 1 , wherein the balm holder element is detachably attached to the bottom of the nasal spray dispenser.3. A combination product according to claim 1 , wherein the nasal spray dispenser comprises a dispensing head mounted on a top of a container.4. A combination product according to claim 3 , wherein the dispensing head is a metered dose spray pump.5. A combination product according to claim 1 , wherein the balm holder element comprises a base element on which the balm is mounted claim 1 , a balm cover with a cylindrical portion surrounding the balm claim 1 , and a cover portion.6. A combination product according to claim 5 , wherein the cylindrical portion of the balm cover is aligned with a cylindrical wall of the nasal spray dispenser.7. A combination product according to claim 5 , wherein the cover portion of the balm cover is attached to the bottom of the nasal spray dispenser.8. A combination product according to claim 7 , wherein the cover portion of the balm cover is glued to the bottom of the nasal spray dispenser.9. A combination product according to claim 7 , wherein the cover portion is dome-shaped and matches a recess in the bottom of the nasal spray dispenser.10. A combination product according to claim 7 , wherein the cover portion of the balm cover is clipped or snap-fitted to the bottom of the nasal spray dispenser.11. A combination product according to claim 5 , wherein the base element of the balm holder element is attached to the bottom of the nasal spray dispenser.12. A ...

SYNERGISTIC HERBAL COMPOSITIONS FOR TESTOSTERONE BOOSTING

Synergistic herbal compositions for Testosterone boosting comprising at least two ingredients selected from the extracts, fractions or pure phytochemicals derived from and for improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. The present invention also describes a synergistic composition comprising at least one testosterone booster ingredient selected from the extracts, fractions or pure phytochemical derived from and and at least one aromatase inhibitor ingredient selected from the extracts, fractions or pure phytochemicals derived from and for improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. The invention further provides methods of improving testosterone levels and alleviating symptoms associated with low levels of testosterone hormone in humans. 1Punica granatum, Cinnamomum zeylanicum, Nigella sativa, Brassica nigra, Mangifera indica. A synergistic herbal composition comprising at least two testosterone booster ingredients selected from the group consisting of extracts and fractions of , and mixtures thereof.2. A synergistic herbal composition comprising:{'i': Punica granatum, Cinnamomum zeylanicum, Nigella sativa, Brassica nigra', 'Mangifera indica, 'a testosterone booster ingredient comprising at least one extract or fraction of a testosterone booster herb selected from the group consisting of and ; and'}{'i': Allium cepa, Tamarindus indica', 'Cinnamomum tamala, 'an aromatase inhibitor ingredient comprising at least one extract or fraction of an aromatase inhibitor herb selected from the group consisting of and'}wherein the testosterone booster ingredient and the aromatase inhibitor ingredient are used in a ratio of from 1:3 to 3:1 by weight.3. The synergistic herbal composition as claimed in claim 1 , wherein the testosterone booster ingredients are present in an amount effective to treat at least one symptom associated with ...

PROCESSES FOR PREPARING A CARBOHYDRATE EXTRACT COMPRISING MANNOHEPTULOSE AND COMPOSITIONS COMPRISING SAME

Disclosed herein is a process for preparing a carbohydrate extract comprising mannoheptulose from avocados, as well as compositions, including food compositions, comprising such extracts. The process includes separating the aqueous emulsion into different fractions by centrifugation, and isolating the water-soluble fraction (water extract) comprising avocado carbohydrates, including mannoheptulose. In various aspects, the process optionally includes steps of heating, ultrafiltration, nanofiltration, concentrating, and or drying the extract. Also described herein are methods for using the carbohydrate extract comprising mannoheptulose and compositions comprising the carbohydrate extract comprising mannoheptulose. 1. A process for preparing a carbohydrate extract comprising mannoheptulose and/or perseitol , the process comprising separating an aqueous phase from other phases of an avocado emulsion by centrifugation to provide a carbohydrate extract comprising at least about 2% mannoheptulose and/or perseitol.2. The process according to claim 1 , wherein carbohydrates in the avocado emulsion are solubilized in the aqueous phase of the emulsion by heating.3. The process according to claim 1 , wherein the avocado emulsion is further combined with an enzyme and/or an acid.4. The process according to claim 1 , further comprising the step of concentrating the carbohydrate extract comprising mannoheptulose utilizing at least one concentration method selected from the group consisting of heating claim 1 , vacuum drying claim 1 , evaporating claim 1 , refractance window drying claim 1 , freeze drying claim 1 , and spray drying.5. The process according to claim 1 , wherein centrifugation is carried out by a horizontal or vertical bowl centrifuge.6. The process according to claim 5 , wherein centrifugation is carried out by a two-phase separator or a three-phase separator.7. The process according to claim 1 , wherein the centrifugation is carried out with a relative centrifugal ...

Composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa

The invention relates to a composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa comprising cranberry concentrate, urea, L-arginine, a buffer ensuring a pH value of the composition of 3.0 to 4.0, water and, optionally, additional active and/or auxiliary substances. The present invention also relates to a two-compartment blister pack containing the composition and to a kit comprising the two-compartment blister pack and an applicator fitting to the outlet channel of the blister pack easy to apply the composition to the desired areas. 1. A composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa comprising cranberry concentrate , urea , L-arginine , a buffer ensuring a pH value of the composition of 3.0 to 4.0 , water and , optionally , additional active and/or auxiliary substances.2hamamelis. The composition for use according to comprising one or more plant extracts selected from the group consisting of rosemary leaf extract claim 1 , cinnamon extract claim 1 , extract claim 1 , ginger extract and sage extract and/or aloe vera gel.3. The composition for use according to comprising fucose and/or fucosyllactose.4. The composition for use according to claim 1 , wherein claim 1 , independently from each other claim 1 , the cranberry concentrate is contained from 2 to 8 wt % claim 1 , urea is contained from 0.5 to 3 wt % and L-arginin is contained from 1 to 3 wt % claim 1 , the percentages being related to the total weight of the composition.5. The composition for use according to claim 1 , wherein each of fucose and/or fucosyllactose is contained in the composition from 0.5 to 4.0 wt % claim 1 , the percentages being related to the total weight of the composition.6. The composition for use according to comprising a matrix-forming agent claim 1 , preferably from 0.8 to 2 wt % claim 1 , the percentages being related to the total weight of the composition.7. The ...

COMPOSITION FOR PREVENTING AND TREATING GASTROINTESTINAL DISEASES, CONTAINING ESSENTIAL OILS EXTRACTED FROM LITSEA JAPONICA FRUIT

The present invention relates to a composition for preventing and treating gastrointestinal diseases by using , and specifically, to a composition for preventing and treating gastrointestinal diseases, containing essential oils extracted from fruit as an active ingredient. According to the present invention, the essential oils extracted from fruits (pure fruit, seed fruit, and seeds) and used as the active ingredient of the composition for preventing and treating gastrointestinal diseases have been confirmed to have excellent effects in an efficacy evaluation for relieving gastrointestinal diseases caused by , which is a gastrointestinal disease factor, physical factors induced by stress, and chemical factors induced by indomethacin. Therefore, the essential oils extracted from fruit (pure fruit, seed fruit, and seeds) are useful for preventing and treating gastrointestinal diseases caused by various factors. 1Litsea japonica.. A composition for preventing and treating gastrointestinal diseases , comprising: essential oils extracted from ea fruit of2Litsea japonica.. The composition of claim 1 , wherein the essential oils are extracted from any of the pure fruit claim 1 , seed fruit and seeds of3Litsea japonicaLitsea japonica. The composition of claim 1 , wherein the essential oils are formed of a pure fruit essential oil extracted from the pure fruit of claim 1 , and a seeds essential oil extracted from the seeds of claim 1 , and the pure fruit essential oils and the seeds essential oils can be used in singular forms or can be used in a combination thereof.4. The composition of claim 1 , wherein the essential oils are extracted using any of an alcohol extraction method claim 1 , a hexane extraction method claim 1 , a super critical extraction method claim 1 , a distillation method claim 1 , a compression method claim 1 , and an ultra-high pressure extraction method.5. The composition of claim 2 , wherein the essential oils are extracted using any of an alcohol ...

CINNAMOMUM BURMANII EXTRACT, EXTRACTION PROCESS AND ITS USE AS PROTON PUMP DOWN-REGULATOR, ENZYME INHIBITOR, AND MUCOPROTECTOR

Extract and/or fraction from (DLBS2411) related to its extraction method and its biological activities show activities as antiulcer by conferring mucoprotection and down-regulating H/KT ATPase. Treatment with DLBS2411 decreases the H/K ATPase mRNA level in HEK 293 and gastric parietal cells. In addition, DLBS2411 inhibits activity of H/K ATPase gastric enzyme wherein pH influences this inhibition mechanism. DLBS2411 also has characteristic as antioxidant which is shown by the increase of reducing power as the given dosage increases. 1Cinnamomum burmanii. An extract comprising , and/or its fraction or its group of compound derived therefrom , in pharmaceutical preparation , as a single active ingredient or in combination , in an amount or dose that is effective as antiulcer.2. Extract and/or fraction according to claim 1 , whereby said extract and/or fraction has the activity as down-regulator of H/K ATPase proton pump.3. Extract and/or fraction according to claim 1 , whereby said extract and/or fraction has the activity as inhibitor of H/K ATPase enzyme.4. Extract and/or fraction according to claim 1 , whereby said extract and/or fraction has the activity as mucoprotector.5. Extract and/or fraction according to claim 1 , whereby such extract is obtained by the process comprising the steps of:(a) extraction using hot water at temperature of 50-100° C.,(b) liquid liquid extraction using organic solvent to obtain water fraction.6. Extract and/or fraction according to claim 5 , whereby the process further comprises the step of repetition of step (b) to optimize the collection of water fraction.7. Extract and/or fraction according to claim 5 , whereby the organic solvent(s) at step (b) is selected from the group consisting of chloroform claim 5 , dichloromethane claim 5 , hexane claim 5 , ethyl acetate and butanol.8. A pharmaceutical composition comprising said extract and/or fraction according to claim 1 , as a single active ingredient or in combination claim 1 , and ...

OIL-BASED COMPOSITIONS FOR ENHANCING ORAL HEALTH AND GENERAL WELLNESS IN HUMANS

An oil-based composition comprises a glyceride of medium-chain fatty acids, at least one essential oil selected from the group consisting of cinnamon oil, oregano oil, avocado oil, coconut oil and apricot oil, and optionally cinnamon bark. The medium-chain fatty acid comprises about 6 to 12 carbon atoms. The oil-based composition may be used for oral hygiene applications, weight control applications, skin care applications, or treatment of infection. 1. An oil-based composition , comprising:a glyceride of medium-chain fatty acids, wherein the medium-chain fatty acid comprises about 6 to 12 carbon atoms; andat least one essential oil selected from the group consisting of cinnamon oil, oregano oil, avocado oil, coconut oil, and apricot oil.2. The oil-based composition of claim 1 , wherein the glyceride of medium-chain fatty acids comprises a monoglyceride claim 1 , a diglyceride claim 1 , a triglyceride claim 1 , or a mixture thereof.3. The oil-based composition of claim 1 , wherein the glyceride of medium-chain fatty acids is a triglyceride.4. The oil-based composition of claim 1 , wherein the medium-chain fatty acid is a saturated fatty acid.5. The oil-based composition of claim 1 , wherein the oil-based composition comprises an active ingredient consisting essentially of a triglyceride of medium-chain fatty acids; cinnamon bark; and at least one essential oil selected from the group consisting of cinnamon oil claim 1 , oregano oil claim 1 , avocado oil claim 1 , coconut oil claim 1 , and apricot oil.6. The oil-based composition of claim 1 , consisting essentially of a triglyceride of medium-chain fatty acids; cinnamon bark; and at least one essential oil selected from the group consisting of cinnamon oil claim 1 , oregano oil claim 1 , avocado oil claim 1 , coconut oil claim 1 , and apricot oil.7. The oil-based composition of claim 1 , comprising a monoglyceride of lauric acid claim 1 , and oregano oil.8. A mouthwash composition comprising the oil-based composition ...

WATER EXTRACTS OF CINNAMON AND RADIX ASTRAGALI

This invention relates to methods and compositions for providing improved insulin-sensitivity and/or enhanced insulin-like action, which leads to improved glucose uptake and utilization. This invention also relates to methods and compositions for lowering LDL, lowering triglycerides, increasing HDL, and lowering high blood pressure in a subject. The methods comprise administering to a subject an effective amount of a water extract of cinnamon and an effective amount of a water extract of 1Radix AstragaliRadix Astragali. A method of lowering low density lipoprotein (LDL)-cholesterol and/or triglycerides in the blood of a subject in need thereof , comprising administering to the subject an effective amount of a water extract of Cinnamon bark and an effective amount of a water extract of , wherein the weight ratio of Cinnamon to is about 3:1 to 1:3.2Radix Astragali. The method according to claim 1 , wherein the water extract of Cinnamon bark and the water extract of are provided in a composition containing the two water extracts.3Radix Astragali. The method according to claim 1 , wherein the weight ratio of Cinnamon to is about 1:1.4. The method according to claim 1 , wherein the water extracts are administered in a total amount of 200-2500 mg/day.5. The method according to claim 1 , wherein the method does not include a step of administering another active ingredient that increases insulin sensitivity or provides insulin-like action.6. The method according to claim 1 , wherein said method lowers LDL-cholesterol.7. The method according to claim 1 , wherein said method lowers triglycerides.8Radix AstragaliRadix Astragali. A method of increasing high density lipoprotein (HDL)-cholesterol in the blood of a subject in need thereof claim 1 , comprising administering to the subject an effective amount of a water extract of Cinnamon bark and an effective amount of a water extract of claim 1 , wherein the weight ratio of Cinnamon to is about 3:1 to 1:3.9Radix Astragali. The ...

NOVEL COCHLEATE FORMULATIONS

A process for producing a small-sized, lipid-based cochleates. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structures by phase separation. The liposome-containing two-phase polymer solution, treated with positively charged molecules such as Ca or Zn, forms a cochleate precipitate of a particle size less than one micron. The process may be used to produce cochleates containing biologically relevant molecules. 1a negatively charged first lipid;a divalent cation or higher valency cation andan additional biologically relevant molecule,. A cochleate composition comprising a population of cochleates, wherein the cochleates comprise: This application is a Continuation of U.S. application Ser. No. 13/441,030, filed Apr. 6, 2012; which is a Continuation of U.S. application Ser. No. 13/215,588, filed Aug. 23, 2011; which is a Continuation of U.S. application Ser. No. 12/987,925, filed on Jan. 10, 2011; which is a Continuation of U.S. application Ser. No. 12/148,942, filed Apr. 23, 2008; which is a Continuation of U.S. application Ser. No. 11/040,615, to filed on Jan. 18, 2005; which is a Continuation of U.S. application Ser. No. 10/421,358, filed on Apr. 23, 2003; which is a Continuation of U.S. application Ser. No. 09/613,840, filed on Jul. 11, 2000, issued as U.S. Pat. No. 6,592,894; which is a Continuation-in-Part of U.S. application Ser. No. 09/235,400, filed Jan. 22, 1999, issued as U.S. Pat. No. 6,153,217. The entireties of each of these applications are incorporated herein by this reference.The present invention relates to a novel method for preparing a novel lipid-based cochleate delivery system, the preparations derived from the lipid-based cochleate delivery system, such as drugs, carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids and the like, and the use of these preparations.The ability of biologically relevant molecules to ...

INTAKING AN ANTIVIRAL BY INHALATION OR SPRAYING FOR RESPIRATORY TRACT INFECTION

Methods of treatment to inhibit or kill microorganisms (Bacteria or Virus) from infecting a respiratory tract of a human patient and to treat the respiratory tract when already infected by the microorganism are described. The method of treatment may include the step of administering a therapeutically effective dose of a treatment medication comprising eugenol to the patient via a nasal passageway into a respiratory system of the patient. Eugenol is found in clove oil, cinnamon oil, and other essential oils. Any one or more of these eugenol-containing oils may be used. 1. A method , comprising: administering a therapeutically effective dose of a treatment medication in a nasal passageway of the human patient to or kill the viruses, the treatment medication comprising eugenol as an active ingredient such that as the human patient breathes, the eugenol is drawn via a nasal passageway into the respiratory tract of the human patient, wherein the eugenol is an active ingredient', 'wherein a source of the eugenol as the active ingredient is either cinnamon oil or clove oil or a mixture of the cinnamon oil and the clove oil,', 'and wherein the treatment medication comprises at least 20% v/v concentration., 'administering an antiviral treatment by inhalation to kill viruses infecting a respiratory tract of a human patient, comprising24.-. (canceled)5. The method of claim 1 , wherein the step of administering the treatment medication comprising the eugenol comprises administering a combination of any two or more of the clove oil claim 1 , the cinnamon oil claim 1 , and other essential oils.6. (canceled)7. The method of claim 1 , wherein the step of administering the treatment medication comprises administering menthol.8. The method of claim 1 , wherein the step of administering the therapeutically effective dose includes providing the therapeutically effective dose via inhalation after spraying the treatment medication into the nasal passageway of the human patient.9. The ...

USE OF ESSENTIAL OIL OF OREGANO OR OF ROSEWOOD, OR CONSTITUENTS THEREOF, IN THE COSMETIC TREATMENT OF KERATOSES

The present invention concerns various cosmetic uses of compositions comprising an essential oil or one of its constituents, preferably a major constituent, in the targeted treatment and prevention of benign keratoses, and more particularly keratoses induced by solar radiation on the skin of a subject. More particularly, the present invention concerns compositions based on the essential oil of oregano or of rosewood, or on linalool, thymol or carvacrol. The present invention also concerns therapeutic applications of a composition as described in the prevention or targeted treatment of actinic keratoses, essentially for prophylactic purposes. 115-. (canceled)16OriganumAniba.. A cosmetic method for the prevention or the targeted treatment of actinic keratoses in a human being , comprising applying to the skin a composition comprising an essential oil extracted from plants of the genus or17Origanum compactum.. The method according to claim 16 , wherein the essential oil is extracted from the species18Aniba rosaeodora.. The method according to claim 16 , wherein the essential oil is extracted from the species19. The method according to claim 16 , wherein the cumulative proportions of linalool claim 16 , thymol claim 16 , and carvacrol in the composition are more than 15% by weight.20. The method according to claim 16 , wherein said essential oil is applied in combination with other compounds claim 16 , in particular in association with vegetable oils.21. The method according to claim 16 , wherein said composition is topically applied.22. The method according to claim 16 , inducing a preferential cytotoxicity in hyperproliferative keratinocytes compared with non-hyperproliferative keratinocytes.23. The method according to claim 16 , wherein the essential oil constitutes an active principle of the composition.24. The method according to claim 16 , wherein said actinic keratoses comprise cells carrying mutations in the p53 protein.25. The method according to claim 16 , ...

SENSITIZATION CREAM COMPRISING L-ARGININE AND L-CITRULLINE AND THERAPEUTIC USES THEREOF

Topical compositions comprising L-arginine and L-citrulline are described. Methods and uses are also provided that include the administration of an effective amount of the topical compositions. The topical compositions are useful for increasing sensitization of the skin and/or for increasing blood flow to the skin. 1. A method for improving the sensitivity of the skin comprising applying to the skin an effective amount of a topical composition comprising sweet almond oil , cinnamon bark oil , coriander seed oil , L-arginine , and L-citrulline in an oil-in-water emulsion.2. The method of claim 1 , wherein the composition is applied to the skin.3. The method of claim 2 , wherein the skin is on the foot or hand.4. The method of claim 3 , wherein the skin is on the penis.5. The method of claim 4 , wherein the penis is circumcised or uncircumcised.6. The method of any one of to claim 4 , wherein the composition comprises: about 6 wt. % sweet almond oil claim 4 , about 0.75 wt. % cinnamon bark oil claim 4 , about 0.5 wt. % coriander seed oil claim 4 , about from about 0.33 wt. % to about 3.0 wt. % L-arginine claim 4 , and from about 0.67 wt. % to about 6.0 wt. % L-citrulline.7. The method of any one of to claim 4 , wherein the mass ratio of L-arginine to L-citrulline is about 1:2.8. The method of any one of to claim 4 , wherein the mass ratio of sweet almond oil to cinnamon bark oil to coriander seed oil to L-arginine to L-citrulline is about 72:9:6:4:8.9. The method of any one of to claim 4 , wherein the composition comprises: about 6 wt. % sweet almond oil claim 4 , about 0.75 weight percent cinnamon bark oil claim 4 , about 0.5 wt. % coriander seed oil claim 4 , from about 0.34 to about 3.0 wt. % L-arginine claim 4 , from about 0.68 to about 6.0 wt. % L-citrulline claim 4 , about 5.0 wt. % of a 70 percent by weight sorbitol solution in water claim 4 , about 4.0 wt. % of a 70 percent by weight isopropyl alcohol solution in water claim 4 , about 20.0 wt. % propylene ...

BEVERAGE COMPOSITIONS AND OTHER FORMULATIONS FOR TREATING ALLERGIES AND METHODS FOR MAKING THE SAME

A composition for preventing and/or alleviating an allergy related condition and methods of making such compositions are disclosed herein. A composition in accordance with a particular embodiment can include honey having pollen derived from a known plant species and/or from a known geographic location. The composition can also include a herbal and/or vitamin supplement, wherein the supplement has an anti-inflammatory property. The composition can be in liquid form, such as suitable for drinking, or in a powdered form suitable for reconstitution in liquid. 1. A composition for preventing or alleviating an allergy related condition in a human patient , the composition comprising:honey including pollen from a known geographic location; anda herbal or vitamin supplement, wherein the supplement has an anti-inflammatory property.2. The composition of wherein the composition is dissolved in water.3. The composition of wherein the composition further includes fruit juice.4. The composition of wherein the supplement includes a ginger root extract.5ginseng.. The composition of wherein the supplement includes6. The composition of wherein the supplement includes at least one of vitamin C and vitamin D.7. The composition of wherein the supplement includes cinnamon.8. The composition of wherein the pollen is from a known plant.9. The composition of wherein the composition is a powdered composition.10. The composition of wherein the composition is in a capsule or tablet formulation.11. A composition for preventing or alleviating allergy related conditions in a human patient claim 1 , the composition comprising:honey including pollen derived from a known plant species; anda herbal or vitamin supplement, wherein the supplement has an anti-inflammatory property.12. The composition of wherein the known plant species is a flower claim 11 , tree claim 11 , shrub or grass known to produce pollen that causes allergy-related symptoms in a human subject.13. A method of making a composition ...

COMPOSITION FOR TREATING HEMORRHOIDS

The composition for treating hemorrhoids includes dry components: oleander (), myrtle () and bay laurel (), which are then mixed into a homogenous solution with olive oil. In the preferred embodiment, the composition for treating hemorrhoids includes the following components: 30%-70% by weight of olive oil, 27%-44% by weight of oleander (), 15%-25% percentage by weight of myrtle () and 5%-15% percentage by weight of bay laurel (). For the most preferred embodiment, for 1 liter (about 1000 cubic centimeters) of olive oil, 1000 cubic centimeters (cc) of the dry components of the composition may include 70% percentage by weight of oleander (), 20% percentage by weight of myrtle (), and 10% percentage by weight of bay laurel (). 1nerium oleandermyrtus communislaurus nobilis. A composition for treating hemorrhoids comprising: 30%-70% by weight of olive oil , 27%-44% by weight of oleander () , 15%-25% percentage by weight of myrtle () and 5%-15% percentage by weight of bay laurel ().2nerium oleandermyrtus communislaurus nobilis. The composition of wherein olive oil being 50% percentage by weight of the composition claim 1 , oleander () being 35% percentage by weight of the composition claim 1 , myrtle () being 10% percentage by weight of the composition claim 1 , and bay laurel () being 5% percentage by weight of the composition.3nerium oleandermyrtus communislaurus nobilis. The composition of wherein the composition contains 1 liter of olive oil and 1000 cubic centimeters (cc) of dry components including 70% percentage by weight of oleander () claim 1 , 20% percentage by weight of myrtle () claim 1 , and 10% percentage by weight of bay laurel ().4. A method of making a composition for treating hemorrhoids claim 1 , comprising the steps of:{'i': nerium oleander', 'myrtus communis', 'laurus nobilis, 'A. Processing oleander (), myrtle () and bay laurel () to a fine dry composition wherein their active ingredients are released;'}B. Boiling a corresponding amount of olive oil ...

COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASE, CONTAINING OIL OF LITSEA JAPONICA AS ACTIVE INGREDIENT, AND METHOD FOR PREPARING SAME

The present invention relates to a composition for an inflammatory disease, using and more specifically to a composition for preventing and treating an inflammatory disease, containing the oil derived from the fruits or the seeds of and a method for preparing the same. The present invention uses the fruits (excluding the seeds) or the seeds of and obtains the oil, which is used as an active ingredient of a composition for preventing and treating an inflammatory disease, by using n-hexane, wherein the oil is obtained by: separating the fruits (excluding the seeds) of from the seeds; injecting n-hexane, which is a solvent, into the fruits (excluding the seeds) or the seeds, 9-11 times greater than the weight of each: stirring the same for 24 hours at room temperature and extracting the same; and removing a hexane layer. 1Litsea japonica. A method for preparing oil from for preventing and treating an inflammatory disease , comprising:{'i': 'Litsea japonica', 'inputting the fruits of 9˜11 times weight into n-hexane which is a solvent;'}agitating the material for 24 hours at room temperature, and the material is subjected to extraction; andobtaining oil after removing a hexane layer.2Litsea japonica. The method of claim 1 , wherein the fruits of are separated into fruits (excludeding seeds) and seeds claim 1 , and oil can be prepared with the separated fruits (excludeding seeds) and seeds. This application is a Division of application Ser. No.14/889,611, filed Nov. 6, 2015, which in turn claims the benefit of the U.S. National Phase under 35 U.S.C. § 371 of International Application No. PCT/KR2014/003883 filed on Apr. 30, 2014, and the benefit of Korean Application No. 10-2013-0050388, filed on May 6, 2013, the disclosures of which are incorporated by reference into the present application.The present invention relates to a composition for an inflammatory disease using a and in particular to a composition for preventing and treating an inflammatory disease, which ...

HERBAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF URINARY INCONTINENCE AND OVERACTIVE BLADDER

Provided in one embodiment is an herbal compositions for the prevention or treatment of urogenital system disorders including urinary incontinence, overactive bladder, enuresis, benign prostatic hyperplasia, nocturia, cystitis, urinary calculi, or a urinary tract infection. Specifically one embodiment provides compositions that contain and and methods of use thereof. 1. A method for treating or reducing the symptoms of urinary incontinence or overactive bladder , comprising administering an effective amount to a subject in need thereof of an herb-containing composition , comprising:{'i': 'Crateva nurvala', 'a extract preparation;'}{'i': 'Equisetum arvense', '(ii) an extract preparation; and'}{'i': 'Lindera aggregata', 'claim-text': 'wherein the herb-containing composition is formulated as an oral dosage unit whereby the oral dosage unit is in a form selected from a tablet, capsule or caplet.', '(iii) a extract preparation;'}213. The method of claim , wherein the treatment results in a reduction in at least one of (i) urinary incontinence and (ii) overactive bladder symptom after about two weeks.313. The method of claim , wherein the treatment results in a reduction in at least one of (i) urinary incontinence and (ii) overactive bladder symptom after about one month.413. The method of claim , wherein at least one of the extracts is prepared by a process comprising:{'i': Crateva nurvala', 'Crateva nurvala, 'extracting the preparation from stem/bark at an extract ratio of between about 25 and 35;'}{'i': Equisetum arvense', 'Equisetum arvense, '(ii) extracting the extract preparation from stem at an exact ratio of about 10; and'}{'i': Lindera aggregata', 'Lindera aggregata, '(iii) extracting the preparation from root at an extract ratio of about 10.'} This application is a divisional of U.S. patent application Ser. No. 15/261,021, filed Sep. 9, 2016, which claims the benefit of and priority to U.S. Pat. No. 9,452,191, filed Dec. 21, 2012, which claims the benefit of and ...

Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals

The present invention relates to a composition for the protection, treatment and repair of cartilage in humans and animal joints. The composition contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. The composition or kit may contain avocado:soybean unsaponifiables (ASU) and green tea.

Compositions and methods for treating the eye

The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.

Food Supplement Composition

A dietary supplement for promoting increased vitality, supporting mood, improving heart health, improving immune strength, improving antioxidant balance, protecting against free radical damage, improving bowel function, and enhancing flavonoid intake. The composition is a combination of cacao, chia seeds, green tea, cinnamon, ginger and turmeric in specific percents of the formulation. Other compositions include constituents of inulin, Ashwagandha, green tea, ginseng, Bacopa monnieri, Rhodiola and maca root. Still other compositions include a combination of Spirulina, wheat grass, alfalfa, chlorella and cinnamon powder. Other compositions include constituents of inulin, acerola, grape, beet, current, acai, raspberry, blackberry, pomegranate, lingonberry, mangosteen, and blueberry. Other compositions include maitake mushroom, purple corn, turmeric, cane juice, onion, basil, black pepper, coriander, oregano, rosemary, thyme, parsley, celery seed, bay leaf, tomato, garlic, yeast, salt, carrot, and spinach. 1. A composition comprising:about 23% to about 43% by weight cacao powder;about 17% to about 37% by weight whole chia seed;about 4% to about 24% by weight green tea powder;about 5% to about 25% by weight cinnamon powder;about 0.1% to about 15% by weight ginger powder; and,about 0.1 to about 10.0% by weight turmeric powder.2. A composition of comprising:about 33% by weight cacao powder;about 27% by weight whole chia seed;about 14% by weight green tea powder;about 15% by weight cinnamon powder;about 11% by weight ginger powder; and,about 5% by weight turmeric powder.3. A composition comprising:about 62.4% to about 82.4% by weight inulin;about 1% to about 16% by weight Ashwagandha;about 0.1% to about 17% by weight green tea extract;about 0.1% to about 0.4% by weight Panex ginseng;about 0.1% to about 18.6% by weight Bacopa monnieri;about 0.1% to about 4% by weight Rhodiola extract;about 0.1% to about 2% by weight maca root; andabout 0.1% to about 4% vanilla flavoring.4. ...

NUTRACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF TYPE 2 DIABETES

A dietary supplement in capsule or tablet form includes a source of zinc in an amount equivalent to 6 mg to 40 mg of zinc chloride; optionally a source of chromium in an amount equivalent to 100 micrograms to 1000 micrograms of chromium picolinate; optionally from 4 micrograms to 100 micrograms of Vitamin B12; optionally an extract or powdered form of American Ginseng in an amount that provides from 20 mg to 200 mg of ginsenoside(s), or 20 mg to 200 mg of isolated or synthesized ginsenoside(s); optionally an oil, extract or powdered form of cinnamon bark in an amount that provides 1000 mg to 5000 mg of methylhydroxychalcone polymer; optionally 2 mg to 50 mg lutein; and optionally green tea extract in an amount that provides from 200 mg to 4000 mg of epigallocatechin gallate or 200 mg to 4000 mg of isolated or synthesized epigallocatechin gallate. 1. A dietary supplement in capsule or tablet dosage form , comprising:an orally administrable source of magnesium in an amount that is the molar equivalent of from 10 mg to 400 mg of magnesium chloride;an orally administrable source of zinc in an amount that is the molar equivalent of from 3 mg to 20 mg of zinc chloride;an orally administrable source of chromium in an amount that is the molar equivalent of from 40 to 500 micrograms of chromium picolinate;vitamin B12 in an amount from 2 to 100 micrograms;an extract or powdered form of American Ginseng in an amount that provides from 10 to 100 mg of ginsenosides;an oil, extract or powdered form of cinnamon bark in an amount that provides 500 to 2500 mg of methylhydroxychalcone polymer;lutein in an amount from 1 to 25 mg; andgreen tea extract in an amount that provides 100 to 2000 mg of epigallocatechin gallate.2. The dietary supplement of claim 1 , further comprising vitamin B12 in an amount of from 2 to 100 micrograms.3. A dietary supplement in capsule or tablet dosage form claim 1 , consisting ofan orally administrable source of magnesium in an amount that is the molar ...

Solid Beverage for Conditioning Blood Stasis Constitution and Method for Producing the Same

The present application discloses a solid beverage for conditioning blood stasis constitution. The solid beverage comprises the following components in parts by weight: 21-55 parts of hawthorn, 9-33 parts of peach seed, 9-33 parts of gingko, 5-21 parts of , 9-33 parts of dried tangerine peel, 0.5-4 parts of cinnamon, 9-33 parts of the root of kudzu vine, 2-21 parts of , 10-29 parts of dextrin, 7-25 parts of maltodextrin, 8-26 parts of soluble starch and 0.05-0.2 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of blood stasis constitution, and the production process thereof is suitable for industrial mass production. 1platycodon grandiflorus,dahurian angelica,. A solid beverage for conditioning blood stasis constitution , characterized by comprising the following components in parts by weight: 21-55 parts of hawthorn , 9-33 parts of peach seed , 9-33 parts of gingko , 5-21 parts of 9-33 parts of dried tangerine peel , 0.5-4 parts of cinnamon , 9-33 parts of the root of kudzu vine , 2-21 parts of 10-29 parts of dextrin , 7-25 parts of maltodextrin , 8-26 parts of soluble starch and 0.05-0.2 parts of aspartame.2platycodon grandiflorus,dahurian angelica,. The solid beverage for conditioning blood stasis constitution according to claim 1 , characterized by comprising the following components in parts by weight: 30-44 parts of hawthorn claim 1 , 15-23 parts of peach seed claim 1 , 17-28 parts of gingko claim 1 , 9-17 parts of 15-28 parts of dried tangerine peel claim 1 , 1-3 parts of cinnamon claim 1 , 14-23 parts of the root of kudzu vine claim 1 , 8-17 parts of 19-24 parts of dextrin claim 1 , ...

Herbal Composition for The Treatment of Age Related Macular Diseases

The present invention discloses an herbal anti-AMD composition for treatment of age related macular diseases (AMD). More specifically, the present invention relates to an herbal composition for the prevention, management and treatment of neo-vascular or wet AMD. 110-. (canceled)11. An herbal anti-AMD composition which downregulates VEGF protein/activity and PDGF protein/activity , comprising:{'i': Cinnamomum verum, Terminalia chebula', 'Acacia catechu, '(a) at least one first herbal extract selected from the group consisting of extracts of , and in an amount of 40% to 50% by weight of the composition;'}{'i': Silybum marianum', 'Curcuma longa, '(b) at least one second herbal extract selected from the group consisting of and , in an amount of 30% to 40% by weight of the composition; and'}{'i': 'Punica granatum', '(c) an extract of in an amount of 1% to 10% by weight of the composition.'}12. The herbal anti-AMD composition according to claim 11 , comprising:{'i': Cinnamomum verum, Terminalia chebula', 'Acacia catechu, '(a) at least one first herbal extract selected from the group consisting of , and in an amount of 40% to 50% by weight of the composition;'}{'i': 'Silybum marianum', '(b) an extract of , in an amount of 30% to 40% by weight of the composition; and'}{'i': 'Punica granatum', '(c) an extract of in an amount of 1% to 10% by weight of the composition.'}13. The herbal anti-AMD composition according to claim 11 , comprising:{'i': Cinnamomum verum', 'Acacia catechu, '(a) at least one first herbal extract selected from the group consisting of extracts of , and in an amount of 40% to 50% by weight of the composition;'}{'i': Silybum marianum', 'Curcuma longa, '(b) at least one second herbal extract selected from the group consisting of and , in an amount of 30% to 40% by weight of the composition; and'}{'i': 'Punica granatum', '(c) an extract of in an amount of 1% to 10% by weight of the composition.'}14. The herbal composition according to claim 12 , wherein:{'i': ...

PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS

The invention relates to an extract of Ashwagandha that exhibit enhanced bioactivity and bioavailability comprising of enriched withanolide glycosides and saponins; with negligible amount of alkaloids, withanolide aglycones and oligosaccharides. The extract as disclosed prepared from root, stems, leaves and whole plant of Ashwagandha further shows improved immunomodulatory activity, anti-inflammatory activity, anti stress activity, antidiabetic activity and sleep quality. The disclosure also provides a method of improving bioactivity of withanolide glycosides even at lower doses, by the administration of an enteric coated formulation of extract of Ashwagandha to humans. The enteric coating protects the composition from hydrolysis in the acidic environment of the stomach to release the withanolide glycoside in neutral/alkaline pH in gastrointestinal tract (GIT) thus enhancing the absorption. Further the process of preparation of the extract of Ashwagandha enriched with withanolide glycosides and saponins are disclosed along with various formulations. 1Withania somnifera. A method of treatment comprising administering an extract of to a subject in need thereof , wherein the treatment comprises an improvement in anti stress activity.2. The method of claim 1 , wherein the improvement in anti stress activity is selected from the group consisting of enhanced anoxia stress tolerance time and enhanced swimming endurance time.3Withania somniferaWithania somnifera. A method of treatment comprising administering an enteric coated composition to a subject in need thereof claim 1 , wherein the treatment comprises an improvement in anti stress activity claim 1 , and wherein the enteric coated composition comprises an extract of and an enteric coating material claim 1 , wherein the extract of comprises at least about 3.5% withanolide glycosides by weight.4. The method of treatment of claim 3 , wherein the improvement in anti stress activity is selected from the group consisting of ...

Formulation Against General, Physical, And/Or Mental Fatigue

This patent presents a formulation that safely and effectively decreases the feeling of fatigue in treated individuals. Specifically, the natural formulation decreases the feeling of general fatigue, the feeling of physical fatigue, and the feeling of mental fatigue. 1. A method for treating an animal or human subject , the method comprising the steps of:a. Selecting an agent, wherein the agent consists of a green tea extract, quercetin, licorice extract, cinnamomum extract, and selenium;b. Administering the agent to the subject to decrease the feeling of fatigue in said subject.2. The method in claim 1 , wherein said decrease in fatigue levels is indicated by an increase in energy levels.3. The method in claim 1 , wherein said feeling of fatigue is the feeling of physical fatigue.4. The method in claim 1 , wherein said feeling of fatigue is the feeling of mental fatigue.5. The method in claim 1 , wherein said subject is suffering from a disease or condition claim 1 , or a sign or symptom associated with fatigue. This non-provisional application is a continuation-in-part of, and claims the benefit of, U.S. non-provisional application Ser. No. 13/893,564 that was filed on 14 May 2013, entitled: Natural Product Against Fatigue, the entire disclosure of which is hereby incorporated by reference (hereafter “564 application). The 564 application claims the benefit of U.S. provisional application Ser. No. 61/646,910, filed on 15 May 2012, entitled: Natural Product for Increasing Levels of Energy, the entire disclosure of which is hereby incorporated by reference.Studies have shown that one-third of the general population reports a feeling of fatigue, with 5% reporting a feeling of short-term fatigue (<6 months), and 31% reporting a feeling of long term or chronic fatigue (>6 months). In the US alone, the feeling of fatigue is responsible for 10-15 million visits to the family doctor every year.Studies associated the feeling of fatigue with an impaired physical and/or ...

POLYHYDROXYLATED FATTY ALCOHOLS

A process of obtaining avocado seed extracts comprising polyhydroxylated fatty alcohols (PFAs), the process comprising crushing raw undried avocado seeds; incubating the crushed avocado seeds; and extracting PFAs from the crushed seeds with an organic solvent. 1. A process of obtaining avocado seed extracts comprising polyhydroxylated fatty alcohols (PFAs) , the process comprising:crushing raw undried avocado seeds;incubating the crushed avocado seeds; andextracting PFAs from the crushed seeds with an organic solvent.2. The process of claim 1 , wherein the organic solvent is selected from the group consisting of methanol and alkyl acetates.3. The process of claim 2 , wherein the solvent is butyl acetate.4. The process of claim 1 , wherein the incubating is at room temperature.5. The process of claim 1 , excluding alkaline saponification of the crushed seeds.6. The process of claim 1 , wherein the incubating is for from 10 minutes to 48 hours.7. The process of claim 1 , wherein the incubating is allowed until acetylated PFAs in the crushed avocado seeds are endogenously de-acetylated to a predicted degree.8. The process of claim 1 , further comprising providing the crushed seeds at a bulk density between about 0.2 and 1.2 g/ml.9. (canceled)10. The process of claim 4 , wherein the incubating is carried out at a temperature between 15 and 45° C.11. The process of claim 1 , wherein about 1 to 6 parts of the solvent are used per about 1 part of the crushed seeds.12. The process of claim 11 , wherein about 3 parts of the solvent are used per about 2 parts of the crushed seeds.13. The process of claim 1 , the extracting comprising mixing the crushed seeds for about 1-5 hours with the solvent.14. (canceled)15. (canceled)16. (canceled)17. The process of claim 12 , further comprising subsequently dissolving the extract in hot hexane.18. The process of claim 17 , further comprising cool precipitation of PFAs out of the hexane solution.19. (canceled)20. An extract of raw and ...

TRADITIONAL CHINESE MEDICINE COMPOSITION AND PREPARATION METHOD AND APPLICATION THEREOF

A traditional Chinese medicine composition, made from cassia twig, poria, cortex moutan, alba, peach kernel in equal proportions. The traditional Chinese medicine composition comprises paeoniflorin, amygdalin, benzoylpaeoniflorin, cinnamic acid, paeonol, and cinnamaldehyde. The composition has the advantages of high production efficiency, high content of effective ingredients, high transfer rate of poria acid, reduced hygroscopicity, and improved dissolution of index ingredients. 1Ramulus cinnamomi, Poria cocosRadix paeoniae. A method for preparing a traditional Chinese medicine composition comprising , Cortex moutan , alba , and peach kernel in equal proportions , comprising following steps:{'i': Poria cocos', 'Poria cocos', 'Poria cocos, '(a) preparation of a powder intermediate: pulverizing 30-49% of the prescription amount of to obtain the powder intermediate;'}(b) preparation of a paeonol inclusion compound: extracting paeonol from Cortex moutan by direct connection steam distillation, and collecting aromatic water and medicinal dregs for use later; resting the aromatic water for 48-72 hours until crystals are completely crystallized, and filtering and drying in shade to obtain paeonol crystals; and including with β-cyclodextrin to prepare a paeonol inclusion compound;{'i': Ramulus cinnamomi', 'Ramulus cinnamomi', 'Ramulus cinnamomi, '(c) preparation of a volatile oil inclusion compound: extracting volatile oil from by direct connection steam distillation, adding ethyl acetate extraction during the extracting process, and collecting aromatic water at ethyl acetate layers and medicinal dregs for use later; placing the aromatic water layer in a separating funnel, resting the aromatic water layer, separating an upper ethyl acetate layer, extracting a lower layer with equal amount of ethyl acetate, combining the ethyl acetate layers, carrying out reduced-pressure recovery, and adding ethanol for further concentration to obtain pure volatile oil; including with β- ...

METHOD FOR PREVENTING AND TREATING THROMBOTIC DISORDERS USING A PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF LINDERA OBTUSILOBA

A method for preventing and treating thrombotic disorders in a subject in need thereof comprising, administering a pharmaceutical composition comprising an extract of as an active ingredient to the subject. A pharmaceutical composition and a health functional food for preventing and treating thrombotic disorders by improving blood circulation, comprising an extract of as an active ingredient. The extract of of the present invention and a crude purified product thereof can be obtained through extraction using various solvents such as water, ethanol, methanol, butanol, etc. Since the extract and the crude purified product have not only excellent inhibitory effect on platelet aggregation induced by various aggregation inductions in vitro, but also excellent inhibitory effect on rapid thrombus formation in vivo, they can be useful for preventing and treating diseases caused by blood circulation disorders such as thromboembolism, etc.

Growing Anti-Pathogen Microbes Found In Raw Seeds To Sufficient Numbers Inside An Organic Mixture Or Culture Medium So That The Entire Mixture Could Then Be Used As A Type Of All-Natural Infectious Diseases Immunotherapy

A product and method that uses the ideal raw, plant-based, nutrient-rich, organic mixture to act as the perfect culture medium which allows and encourages recently discovered, continuously evolving, and extremely small but very powerful anti-pathogen microbes found in raw seeds to rapidly grow and multiple and to sufficient numbers so that these microbes and the plant-based mixture that comprises them can then be used together as an effective type of all-natural Infectious Diseases Immunotherapy.

METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS

Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed. 1. A nutrient composition comprising:{'i': gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis', 'terminalis chebula;, 'an effective amount of a mixture or purified mixture thereof comprising botanical extracts selected from each of the group of botanicals consisting of , and'}an amino acid composition comprises a whey protein isolate;at least one copper containing compound;at least one metal containing compound, wherein the metal is selected from the group consisting of calcium, magnesium, zinc, selenium, manganese, chromium, and molybdenum.and an effective amount of an omega 3 fatty acid or pharmaceutically acceptable or food grade acceptable derivative thereof.2. A nutrient composition according to claim 1 , wherein the selenium claim 1 , manganese claim 1 , chromium claim 1 , or molybdenum containing compounds is a yeast compound containing selenium claim 1 , manganese claim 1 , chromium claim 1 , or molybdenum.3. A nutrient composition according to claim 1 , wherein the least one metal containing compound is a gluconate or lactate salt metal compound.4. A nutrient composition according to claim 1 , wherein the least one metal containing compound or the copper containing compound is a gluconate salt compound.5cinnamomum verumcapsicum annuum.. A nutrient composition according to claim 4 , wherein the nutrient composition further comprises or6. A nutrient composition according to claim 1 , wherein the nutrient composition is gluten or casein free.7. A nutrient composition according to claim 5 , wherein the nutrient composition further comprises ...

Novel Combination of Naturally Occurring Compounds to Assist With Suspected Mycobacterial Infections Related to Autoimmune Conditions

The novel aspect of this invention is that it is a unique formulation of naturally occurring compounds with a unique intention to assist the concerns associated with autoimmune conditions, mainly inflammatory bowel disease (collectively Crohn's, ulcerative colitis, irritable bowel syndrome), Type 1 diabetes, Multiple sclerosis, Psoriasis and the suspected infection of the pathogen sub-species (MAP). Furthermore, its intent is to address the lack of treatment options available for those with aforementioned autoimmune conditions. Specifically, to offer an alternative option that does not pose the amount of negative side effects that may be associated with contemporary treatment methods. The invention will offer a treatment method that is lower in cost as persons with autoimmune conditions conventional treatment methods costs are rising even under most insurance provider's coverage. In addition, the invention offers an available method without the barriers to care most people with autoimmune conditions may encounter. The invention will provide educational information to persons with autoimmune conditions to offer an individual choice in methods of treatment. The invention will offer persons with autoimmune conditions a variety of options as said invention can be utilized con-currently with conventional treatment methods. 1O. vulgareC. asiaticaMahonia aquifoliumberberineBoswellia serrataB. serrataMycobacterium paratuberculosis. We claim that the synergistic action of the compounds contained in the invention—the naturally occurring compounds from the botanicals Cinnamon oil at 300 mg of hydro or ethanolic extract yielding the active compounds found in Cinnamomum species—cinnamaldehyde , trans-cinnamaldehyde , ethyl cinnamate , eugenol and linalool: the naturally occurring compounds from Oregano oil at 150 mg of hydro or ethanolic extract yielding the active compounds found in —carvacrol , thymol , caryophyllene , spathulenol and beta-fenchyl; the naturally occurring ...

Tumor cell-inhibited composition

A composition utilizing natural materials is selected from a group of plant extract comprising: Taiwan cypress, stout camphor tree, Taiwan incense cedar, , Taiwan smith, and . The tumor cell-inhibited composition having the efficiency of inhibiting the growth of tumor cells is formed by mixing these extracts based on a specific ratio. 1Cinnamomum camphora, Cymbopogon nardus, Litsea cubeba, Cinnamomum zeylanicumCunninghamia lanceolatavar, Melaleuca alternifolia, Eucalyptus robustaCryptomeria japonicaAcacia confuse.. A tumor cell-inhibited composition , in which the composition comprises a plant extract from the following group of plants: Taiwan cypress , stout camphor tree , Taiwan incense cedar , , Taiwan smith , and2. The tumor cell-inhibited composition according to claim 1 , wherein the plant extract is a purification made by a distillation method.3Cinnamomum camphoraCymbopogon nardusLitsea cubebaCinnamomum zeylanicumCunninghamia lanceolatavarMelaleuca alternifoliaEucalyptus robustaCryptomeria japonicaAcacia confuse. The tumor cell-inhibited composition according to claim 2 , wherein the composition comprises: 40%-50% of the Taiwan cypress purification claim 2 , 10%-20% of the stout camphor tree purification claim 2 , 10%-20% of the Taiwan incense cedar purification claim 2 , 8%-10% of the purification claim 2 , 8%-10% of the purification claim 2 , 6%-8% of the purification claim 2 , 6%-8% of the purification claim 2 , 4%-6% of the Taiwan purification claim 2 , 2%-4% of the purification claim 2 , 2%-4% of the smith purification claim 2 , 2%-4% of the purification and 2%-4% of the purification.4. The tumor cell-inhibited composition according to claim 3 , wherein the composition may inhibit the growth of the breast cancer cells.5. The tumor cell-inhibited composition according to claim 3 , wherein the composition may inhibit the growth of the hepatic carcinoma cells.6. The tumor cell-inhibited composition according to claim 3 , wherein the composition may inhibit ...

COMPOSITIONS AND METHOD FOR TREATING AND PREVENTING MALNUTRITION

Provided herein are compositions and methods for treating, preventing, and reversing malnutrition. In particular, provided herein are compositions and methods for facilitating cognitive repair and preventing obesity (e.g. in children). 1. A composition for the treatment and prevention of malnutrition , comprising:a) at least 20 mg of a plurality of flavonoids, wherein at least a portion of the flavonoids cross the blood-brain barrier, wherein at least one of said flavonoids is catechin or epicatechin;b) at least 0.5 g of omega-3 fatty acids, wherein said omega-3 fatty acids comprise EPA and DHA; andc) at least 1 mg caffeine.2. The composition of claim 1 , wherein said composition comprises 20-2000 mg of flavonoids.3. The composition of claim 1 , wherein said composition comprises at least 200 mg of flavonoids.4. The composition of claim 1 , wherein said composition comprises 200-500 mg of catechin and/or epicatechin.5. The composition of claim 1 , wherein said catechin and/or epicatechin are in or obtained from cocoa and/or green tea.6. The composition of claim 1 , wherein said flavonoids are one or more additional flavonoids selected from the group consisting of cocoa claim 1 , green tea claim 1 , black tea claim 1 , tea extracts claim 1 , quercetin claim 1 , green vegetables claim 1 , spinach claim 1 , moringa claim 1 , matcha claim 1 , kaempferol claim 1 , kale claim 1 , tomato claim 1 , acai berry claim 1 , blueberry claim 1 , gingko balboa onion claim 1 , cherry tomato claim 1 , cinnamon claim 1 , flax seeds claim 1 , chia seeds claim 1 , legumes claim 1 , and curcumin.7. The composition of claim 6 , wherein said composition comprises at least 50 mg of said additional flavonoids.8. (canceled)9. The composition of claim 1 , wherein said composition comprises at least 150 mg DHA.1012-. (canceled)13. The composition of claim 1 , wherein said composition comprises 1-50 mg caffeine.1416-. (canceled)17. The composition of claim 1 , wherein said composition further ...

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC COMPLICATIONS AND ANGIOEDEMA, CONTAINING NATURAL MIXTURE EXTRACT AS ACTIVE INGREDIENT

The extract of a mixture of cinnamon twig and moutan root bark, cinnamon twig and peony root, or cinnamon twig and poria according to the present invention has been confirmed to inhibit the excessive generation of advanced glycation end-products, which occurs under chronic diabetic conditions, exhibit the effect of fragmentizing a cross-link between the advanced glycation end-products and matrix proteins, have an excellent effect in inhibiting the generation of the advanced glycation end-products in a human retinal pigment epithelial cell line subjected to a hyperglycemic or aging environment, and have excellent effects in delaying, preventing, and treating diabetic complications, muscular degeneration, commotio retinae, and lower extremity edema in various animal models of diabetic complications, macular degeneration, and lower extremity edema, and thus the mixture extract can effectively be used as an active ingredient for a composition for preventing and treating diabetic complications, including diabetic retinopathy, diabetic nephropathy. and diabetic neuropathy, and angioedema, including macular (retinal) edema, macular degeneration, and varicose veins. 119-. (canceled)20. A method for treating angioedema , the method comprising administering a pharmaceutically effective amount of a mixed extract which comprises a cinnamon twig extract and a moutan root bark extract to a subject having angioedema.21. The method of claim 20 , wherein the extract is extracted using water claim 20 , ethanol claim 20 , methanol claim 20 , or a mixture thereof as a solvent.22. The method of claim 20 , wherein the extract is extracted by a high-temperature decompression method claim 20 , a hot-water extraction method claim 20 , a reflux extraction method claim 20 , a hydrothermal extraction method claim 20 , a maceration extraction method claim 20 , a room-temperature extraction method claim 20 , an ultrasonification extraction method claim 20 , or a steam extraction method.23. The ...

HERBAL COMPOSITIONS FOR THE TREATMENT OF DIABETES AND/OR CONDITIONS ASSOCIATED THEREWITH

The present invention provides a method for treating type II diabetes, conditions associated therewith, or both, by administering to a subject in need thereof a therapeutically effective amount of a herbal composition comprising (i) an extract of leaves of at least one species, (ii) at least one species or an extract thereof, and (iii) at least one species or an extract thereof. 1. A method of treating type II diabetes , conditions associated therewith , or both , the method comprising administering to a subject in need thereof a therapeutically effective amount of a herbal composition comprising:{'i': Morus', 'Morus, 'an extract of leaves of at least one species, said extract comprising latex,'}{'i': 'Urtica', 'at least one species or an extract thereof, and'}{'i': 'Artemisia', 'at least one species or an extract thereof.'}2. The method of claim 1 , wherein{'i': Morus', 'Morus alba, Morus bombycis, Morus indica, Morus insignis, Morus nigra', 'Morus Australis, 'said species is selected from the group consisting of and , and any combination thereof;'}{'i': Urtica', 'Urtica dioica, Urtica urens', 'Urtica pilulifera, 'said species is selected from the group consisting of and , and any combination thereof; and'}{'i': Artemisia', 'Artemisia dracunculus, Artemisia herba alba, Artemisia pallens', 'Artemisia roxburghiana', 'Artemisia judaica, 'said species is selected from the group consisting of Wall, and , and any combination thereof.'}3MorusMorus albaMorus nigra.. The method of claim 2 , wherein said species claim 2 , is a combination of and4CinnamomumCanellaTaraxacumRosaTrigonella. The method of claim 1 , wherein said herbal composition further comprises at least one extract of a species claim 1 , a species claim 1 , a species claim 1 , a species claim 1 , or a species claim 1 , or any combination thereof.5. The method of claim 4 , wherein{'i': Cinnamomum', 'Cinnamomum cassia, Cinnamomum zeylanicum; Cinnamomum saigonicum, Cinnamomum aromaticum', 'Cinnamomum laurus;, ' ...

COMPOSITION AND METHOD FOR BLOOD SUGAR MODULATION

Compositions and methods for modulating blood sugar are provided. The composition comprises gymnema, green coffee, grape seed, hibiscus, cinnamon, holy basil, Russian tarragon, ginger, turmeric, and chromium. 1. A composition for modulating blood sugar in a subject in need thereof , the composition comprising an effective amount of a mixture of herbal extracts and a mineral , the mixture comprising gymnema , green coffee , grape seed , hibiscus , cinnamon , holy basil , Russian tarragon , ginger , turmeric , and chromium.2. The composition of claim 1 , wherein the composition comprises hydroalcoholic extracts of gymnema claim 1 , green coffee claim 1 , hibiscus claim 1 , cinnamon claim 1 , holy basil claim 1 , ginger claim 1 , and turmeric; supercritical extracts of cinnamon claim 1 , holy basil claim 1 , ginger claim 1 , and turmeric; and aqueous extracts of grape seed and Russian tarragon claim 1 , in combination with chromium.3. The composition of claim 1 , wherein the composition is administered orally.4. The composition of claim 3 , wherein the orally administered composition is in the form of one or more capsules claim 3 , one or more tablets claim 3 , or one or more pills.5. The composition of claim 1 , wherein a daily dose is from about 250 mg to about 2000 mg.6. The composition of claim 5 , wherein a daily dose is from about 500 mg to about 1500 mg.7. The composition of claim 2 , wherein the composition comprises:from about 30% to about 50% by weight of the hydroalcoholic extract of gymnema;from about 5% to about 15% by weight of the hydroalcoholic extract of green coffee;from about 5% to about 15% by weight of the aqueous extract of grape seed;from about 5% to about 15% by weight of the hydroalcoholic extract of hibiscus;from about 2% to about 5% by weight of the supercritical extract of cinnamon;from about 3% to about 10% by weight of the hydroalcoholic extract of cinnamon;from about 1% to about 3% by weight of the supercritical extract of holy basil;from ...

Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting

Compositions containing one or more compounds with inhibitory effect on a 5-HT3a and/or NK-1 receptor are effective for preventing or treating idiopathic vomiting in a mammal. 1. A dietary composition for preventing or treating idiopathic vomiting in a companion animal , comprising one or more compounds in an effective amount for inhibiting a 5-hydroxytryptamine-3a serotonin (5-HT3a) receptor and/or a neurokinin-1 (NK-1) receptor , wherein said one or more compounds are selected from the group consisting of ubiquinone-O (CAS NO. 605-94-7) , resveratrol (CAS No. 501-36-0) , 1 ,4-benzenediol , 2 ,3-dimethyl-(9CI) (CAS NO. 608-43-5) , vetiverol (CAS NO. 89-88-3) , 3 ,6-dihydroxyflavone (CAS NO. 92439-20-8) , nonivamide (CAS NO. 2444-46-4) , DL-palmitoylcarnitine chloride (CAS NO. 6865-14-1) , asiatic acid (CAS NO. 464-92-6) , farnesal (CAS NO. 19317-11-4) , nootkatone (CAS NO. 4674-50-4) , alpha-amylcinnamyl alcohol (CAS NO. 101-85-9) , delta-dodecalactone (CAS NO. 713-95-1) , gamma-dodecalactone (CAS NO. 2305-05-7) , alpha-lonone (CAS NO. 127-41-3) , biochanin A (CAS NO. 491-80-5) , delta-undecalactone (CAS NO. 104-67-6) , delta-tetradecalactone (CAS NO. 2721-22-4) , 2-(3-phenylpropyl)pyridine (CAS NO. 2110-18-1) , 1 ,14-tetradecanediol (CAS NO. 19812-64-7) , (+)-cedrol (CAS NO. 77-53-2) , 3-heptyldihydro-5-methyl-2(3H)-furanone (CAS NO. 40923-64-6) , delta-undecalactone (CAS NO. 710-04-3) , methyl dihydrojasmonate (CAS NO. 24851-98-7) , ethoxyquin (CAS NO. 91-53-2) , petroselinic acid (CAS NO. 593-39-5) , methyl isoeugenol (CAS NO. 93-16-3) , vanillyl butyl ether (CAS NO. 82654-98-6) , guiaiacwood oil (CAS NO. 8016-23-7) , luteolin (CAS NO. 491-70-3) , 18-beta-glycyrrhetic acid (CAS NO. 471-53-4) , tributyl citrate (CAS NO. 77-94-1) , palmitoleic acid (CAS NO. 373-49-9) , bisabolol (CAS NO. 515-69-5) , curcumin (CAS NO. 458-37-7) , piperine (CAS NO. 94-62-2) , flavone (CAS NO. 525-82-6) , menthoxypropanediol (CAS NO. 87061-04-9) , 4-hydroxychalcone (CAS NO. 2657-25-2 ...

METHODS OF TREATING OR PREVENTING OVERWEIGHT AND OBSESITY IN MAMMALS BY ADMINISTERING A COMPOSITION COMPRISING MANNOHEPTULOSE

The present invention is based on the discovery that mannoheptulose (mHep) reduces or inhibits the differentiation process of fat stem cells into adipocytes so as to decrease the body's fat storage capacity. Compositions comprising a mHep, process of making the compositions, and methods of using the compositions for treating or preventing overweight and obesity in a mammal, such as, for example, a growing pet (e.g., puppy, kitten), or a spayed/neutered pet, are encompassed by the present invention. 1. A method of treating or preventing overweight and obesity in a mammal , wherein the method comprises administering to the mammal a composition comprising an effective amount of a mannoheptulose (mHep).2. The method of claim 1 , wherein the method is for preventing overweight and obesity in a mammal having:i. a body condition characterized as thin, underweight or ideal as determined based on a body condition chart as disclosed herein; orii. a body condition score (BCS) of 1 to 3 based on a scale from 1 to 5.3. The method of claim 1 , wherein the mammal is:a) a growing pet selected from the group consisting of a reproductively-intact growing pet, an overweight or obese growing pet, and a spayed or neutered growing pet;b) an adult pet selected from the group consisting of a reproductively-intact adult pet, an overweight or obese adult pet, and a spayed or neutered adult pet; orc) a senior pet selected from the group consisting of a reproductively-intact senior pet, an overweight or obese senior pet, or a spayed or neutered senior pet.4. The method of claim 3 , wherein:a) the adult pet is selected from the group consisting of a reproductively-intact adult dog, a reproductively-intact adult cat, a spayed or neutered adult dog, a spayed or neutered adult cat; orb) the senior pet is selected from the group consisting of a reproductively-intact senior dog, a reproductively-intact senior cat, a spayed or neutered senior dog, and a spayed or neutered senior cat;wherein the adult ...

Specialty Pharmaceutically Active Agent Composites

The present invention is a pharmaceutical cocktail of at least two botanical leaves (or extracts therefrom) specifically harvested from trees or plants that bear edible fruit, and including no other leaves of any kind. The combination of leaves from multiple families or at the very least genera provides the greatest variety of phytochemicals. A prime nonlimiting example is a combination of leaves such as Soursop (Annonaceae Family, Annona Genus), Blackberry (Rosaceae Family, Rubus Genus), Lemon (Rutaceae Family, Citrus Genus). In an embodiment of the invention, at least twelve leaf types (from at least different species if not higher biological categories) are admixed into such an active agent admixture—again, with each leaf type coming from a plant or tree that bears edible fruit. The present compositions and extracts always contain a minimum of 25 distinct active phytochemicals, which together provide nutraceutical and pharmaceutical action as to animals and humans.

Procedure and extraction of a regenerative product for vital organs and a by-product for cutaneous use

A procedure and extraction of a regenerative product and a by-product for cutaneous use consisting of an infusion based on one litre of water boiled at between 95° and 100° centigrade and where, for said quantity of water, the following products must be added, quantified by weight: 1. Procedure and extraction of a regenerative product and by-product for cutaneous use consisting of an infusion of various natural products functioning as a natural antibiotic with regenerative qualities , and especially indicated for the regeneration of vital organs which have degenerated as a consequence of illness and other cellular degenerative processes , characterised essentially because the procedure in the invention consists of an infusion based on one litre of water boiled at between 95° and 100° centigrade and where , for said quantity of water , the following products must be added , quantified by weight:{'i': 'Rosmarinus officinalis', '12 g rosemary ()'}{'i': 'Eucaliptus camaldulensis', '6 g eucalypt ()'}{'i': 'Thymus vulgaris', '6 g thyme ()'}{'i': 'Laurus nobilis', '6 g bayleaf ()'}{'i': 'Tilia', '3 g linden flower (sp.)'}{'i': 'Mentha', '3 g fresh mint (ssp)'}{'i': 'Origanum vulgare', '3 g oregano ()'}the infusion is allowed to macerate for 3 hours, and yields a liquid which is filtered and considered to be natural antibiotic.2. Procedure and extraction of a regenerative product and by-product as set forth in and characterised because claim 1 , if the mixture obtained according to the previous claim is allowed to macerate a minimum of 16 hours claim 1 , a product for cutaneous use with the same antibiotic characteristics is obtained. A patent of invention for a procedure and extraction of a regenerative product and a byproduct for cutaneous use consisting of an infusion of various natural products functioning as a natural antibiotic, immediately effective and with no side-effects, where the residual byproduct of said infusion offers a series of regenerative qualities for ...

Cassytha filiformis and/or cuscuta sandwichiana administered orally to induce sleep

The present invention includes a composition and composition comprising: an extract of Cassytha filiformis, an extract of Cuscuta sandwichiana, or both, adapted for oral administration and in an amount sufficient to induce sleep, improve sleep, or both.

PAIN RELIEVER COMPOSITION

A topical pain reliever composition that includes a blend of peppermint essential oil, rosemary essential oil, aloe vera oil, grapeseed oil, avocado oil, camphor essential oil, lemon essential oil, tangerine essential oil, camphor distillate, lavender essential oil, and tea tree essential oil. 1. A method for providing pain relief in bodily pains , the method comprising the steps of:providing a pain reliever composition comprising peppermint essential oil, rosemary essential oil, aloe vera oil, grapeseed oil, avocado oil, camphor essential oil, lemon essential oil, tangerine essential oil, camphor distillate, lavender essential oil, and tea tree essential oil; andtopically applying the pain relief composition to an affected area.2. The method according to claim 1 , wherein the bodily pains are associated with premenstrual pains and the pain relief composition is applied to abdomen.3. The method according to claim 1 , wherein the bodily pains are associated with fibromyalgia syndrome.4. The method according to claim 1 , wherein the bodily pains are associated with arthritis and the pain relief composition is applied to joints.54873. The method according to claim 1 , wherein the peppermint essential oil is in the range of about to percent by weight claim 1 , the rosemary essential oil is in the range of about 15 to 25 percent by weight claim 1 , the aloe vera oil is in the range of about 5 to 10 percent by weight claim 1 , the grapeseed oil is in the range of about 3 to 8 percent by weight claim 1 , the avocado oil is in the range of about 3 to 8 percent by weight claim 1 , the camphor essential oil is in the range of about 2 to 8 percent by weight claim 1 , the lemon essential oil is in the range of about 1 to 8 percent by weight claim 1 , the tangerine essential is in the range of about 1 to 8 percent by weight claim 1 , the camphor distillate is in the range of about 1 to 3 percent by weight claim 1 , the lavender essential oil is in the range of about 1 to 8 ...

SYSTEM, METHOD AND FORMULATION FOR TREATING USED ANIMAL BEDDING

A method, system and formulation for treating animal bedding and animals is provided. For the method, it comprises: mixing used bedding with unused bedding to produce mixed bedding; deodorizing the mixed bedding; drying the mixed bedding to have a moisture content of between approximately 7 and 14%; removing lighter fibers from the mixed bedding; adding an oil treatment to the mixed bedding to have a moisture content of between approximately 7 and 14% in the mixed bedding; and bagging the mixed bedding while the mixed bedding is still moist from the oil treatment. 1. A method of processing animal bedding material , comprising:mixing used bedding with unused bedding to produce mixed bedding;deodorizing the mixed bedding;drying the mixed bedding to have a moisture content of between approximately 7 and 14%;removing lighter fibers from the mixed bedding;adding an oil treatment to the mixed bedding to have a moisture content of between approximately 7 and 14% in the mixed bedding; andbagging the mixed bedding while the mixed bedding is still moist from the oil treatment.2. The method of claim 1 , further comprising:deodorizing the mixed bedding with bicarbonate soda after the used bedding is mixed with the unused bedding.3. The method of claim 1 , wherein the oil treatment is added through an auger on an incline that mixes the mixed bedding with the oil treatment.4. The method of claim 3 , wherein the oil treatment comprises a formulation of essential oils comprising:between approximately 9 and 14% of black spruce essential oil.5. The method of claim 4 , wherein the formulation of essential oils further comprises:between approximately 12 and 18% of Canadian balsam essential oil;between approximately 9 and 11% of douglas fir essential oil; andbetween approximately 22 and 26% of Canadian spruce essential oil.6. The method of claim 5 , wherein the formulation of essential oils further comprises:between approximately 0.5 and 2% of cassia.7. The method of claim 6 , wherein ...

NUTRITIONAL SUPPLEMENT FOR WEIGHT MANAGEMENT

According to one embodiment, a nutritional supplement for suppressing an appetite while maintaining muscle mass of a subject during weight loss is provided. The nutritional supplement includes beta-hydroxy beta-methylbutyric acid (HMB), chromium, and 1. A nutritional supplement for suppressing an appetite while maintaining muscle mass of a subject during weight loss , comprising:beta-hydroxy beta-methylbutyric acid (HMB);chromium; and{'i': 'Caralluma fimbriata.'}2. The nutritional supplement of further comprising:magnesium oxide;alpha lipoic acid and Coenzyme Q10 (CoQ10);vitamin C, vitamin E, and cinnamon3. The nutritional supplement of claim 1 , comprising at least 1200 mg of HMB.4. The nutritional supplement of comprising at least 100 mcg of chromium.5Caralluma fimbriata.. The nutritional supplement of comprising at least 400 mg of6. The nutritional supplement of comprising at least 30 mg of magnesium oxide.7. The nutritional supplement of comprising at least 50 mg of alpha lipoic acid.8. The nutritional supplement of claim 2 , comprising at least 15 mg of CoQ10.9Caralluma fimbriata. A composition comprising an appetite suppressing and lean muscle mass augmentation and/or preservation amount of a synergistic composition comprising: claim 2 , HMB claim 2 , chromium claim 2 , magnesium oxide claim 2 , cinnamon claim 2 , vitamin C claim 2 , vitamin E claim 2 , alpha lipoic acid claim 2 , and CoQ10.10Caralluma fimbriata. A method of providing a synergistic appetite suppressing activity to a subject claim 2 , comprising administering to said subject a food item comprising HMB claim 2 , chromium claim 2 , claim 2 , magnesium oxide claim 2 , alpha lipoic acid claim 2 , CoQ10 claim 2 , cinnamon claim 2 , vitamin E claim 2 , and vitamin C.11Caralluma fimbriata. The method of claim 10 , wherein said food item comprises an admixture of at least 1200 mg of HMB claim 10 , at least 100 mcg chromium claim 10 , at least 400 mg of claim 10 , at least 300 mg of magnesium oxide ...

COMBINATION OF UNSAPONIFIABLE LIPIDS COMBINED WITH POLYPHENOLS AND/OR CATECHINS FOR THE PROTECTION, TREATMENT AND REPAIR OF CARTILAGE IN JOINTS OF HUMANS AND ANIMALS

The present invention relates to a composition and a kit for the protection, treatment and repair of cartilage in humans and animal joints. The composition or kit contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. Preferably, the composition or kit contains avocado:soybean unsaponifiables (ASU) and green tea. 1. A formulation for oral administration for the treatment and repair of connective tissue and reduction of inflammation in joints of a human or animal in need thereof comprising avocado/soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG).2. The formulation of claim 1 , wherein the ASU is in an amount of about 5 mg to about 12 g.3. The formulation of claim 1 , wherein the EGCG is in an amount of between about 3 mg to about 10 g.4. The formulation of claim 1 , wherein the EGCG is sourced from green tea or green tea extract.5. The formulation of claim 4 , wherein the formulation provides a dose of about 0.04 mg/kg to about 40 mg/kg of green tea extract to the human or animal.6. The formulation of claim 1 , wherein the formulation provides a dose of about 0.04 mg/kg to about 4 mg/kg of EGCG to the human or animal.7. The formulation of claim 1 , wherein the formulation provides a dose of about 1 mg/kg to about 5 mg/kg of ASU to the human or animal.8. The formulation of claim 1 , further comprising phosphatidylcholine.9. A formulation for oral administration for the treatment and repair of connective tissue and reduction of inflammation in joints of a human or animal in need thereof comprising unsaponifiable lipids and one or more catechins.10. The formulation of claim 9 , wherein the unsaponifiable lipids are in an amount of about 5 mg to about 12 g.11. The formulation of claim 9 , wherein the one or more catechins are in an amount of between about 3 mg to about 10 g.12. The formulation of claim 9 , wherein the one or more catechins are sourced from green tea or green tea extract.13. The ...

Transdermal formulations suitable for administration of natural products comprising plant flour and an adhesive

Pharmaceutical and nutraceutical compositions suitable for transdermal administration of plant-derived medicinal compounds are disclosed. The compositions comprise ground plant material (plant flour) and a dermally acceptable adhesive. In preferred embodiments, the plant flour is derived from Cannabis sp. and the adhesive is a polymer selected from the group consisting of acrylic polymers, silicone polymers, urethanes, isobutylenes, polyisobutylenes, vinyl acetate, and styrene polymers or copolymers.

TOPICAL HAIR AND SKIN FORMULATION

A topical hair and skin formulation which has primarily medicinal and healing properties, but may also be used to moisturize skin and dress or style hair of all types. The formulation is a blend of oils each having various individual properties. The invented oil blend keeps connective tissues strong and supple while protecting against the breakdown of the skin's cell structure and the hair's follicle and inner cuticle with essential vitamins, minerals, amino and fatty acids implementing healing and regeneration. The invented oil blend stimulates blood circulation and has anti-inflammatory, anti-oxidant, anti-bacterial, antimicrobial, antiviral, antifungal, analgesic, and hypoallergenic properties. The method of making the formulation ensures proper emulsification, a long shelf life, as well as a proper balance of the various ingredients to enhance effectiveness. 1. A topical formulation for application to skin or hair comprising:coconut oil, jojoba oil, avocado oil, tamanu oil, natural mixed 90% tocopherol, and distilled monoglyceride.2. The formulation of wherein said coconut oil is in amount from about 40% to 60% by volume claim 1 , said avocado oil is in amount from about 40% to 60% by volume claim 1 , said jojoba oil is in amount from about 2% to 20% by volume claim 1 , said tamanu oil is in amount from about 5% to 10% by volume claim 1 , said natural mixed 90% tocopherol oil is in amount from 0.01% to 5% by volume claim 1 , and said distilled monoglyceride is in amount from 0.01% to 5% by volume.3. A method of making a topical formulation for application to skin or hair comprising the steps of:heating a mixture of coconut oil, avocado oil, jojoba oil, tamanu oil, natural mixed 90% tocopherol, and granulated distilled monoglyceride; and,stirring said mixture at between 86 and 140 degrees Fahrenheit until said granulated distilled monoglyceride is liquid. This application claims the priority date of U.S. Provisional Application No. 62/697,239 filed on Jul. 12, ...

METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS

Nutrient compositions comprising botanical extracts and an omega 3 fatty acid as well as methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed. 1. A nutrient composition comprising:{'i': gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis,', 'terminalis chebula;, 'an effective amount of a mixture or purified mixture thereof comprising three or more botanical extracts selected from the group of botanicals consisting of and and'}an effective amount of an omega 3 fatty acid or pharmaceutically acceptable or food grade acceptable derivative thereof.2. A method for treating apraxia , autism , speech impairments , traumatic brain injury , seizure disorders , epilepsy , global delays , Alzheimer's Disease , or ADHD , comprising administering to a patient in need thereof:{'i': gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis,', 'terminalis chebula;, "a nutrient composition that ameliorates one or more symptoms of apraxia, autism, speech impairments, traumatic brain injury, seizure disorders, epilepsy, global delays, Alzheimer's Disease, or ADHD, said nutrient composition comprising an effective amount of a mixture or purified mixture thereof comprising three or more botanical extracts selected from the group of botanicals consisting of and and"}an effective amount of an omega 3 fatty acid or pharmaceutically acceptable or food grade acceptable derivative thereof.3gymnema sylvestre, commiphora mukul, curcuma longa, camellia sinensis, emblica officinalis,terminalis chebula.. A nutrient composition according to claim 1 , wherein the nutrient composition comprises a mixture or purified mixture thereof comprising botanical ...

Methods and materials for reducing multiple risk factors associated with the metabolic syndrome

Provided are processes of reducing and/or eliminating risk factors associated with metabolic syndrome in a subject through the administration of a nelumbo extract. The nelumbo extract supplement is administered orally, intravenously, or subcutaneously. In one aspect, a daily dose of 10-1,000 mg of the extract supplement is administered to the subject for a period of 6 weeks to 6 months.

ORAL ANTI-PARASITIC COMPOSITION

The present invention relates to a composition for use as an oral anti-parasitic, the composition comprises one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus or a source of saponin. It also relates to a method of preventing or treating parasitic infection in an animal, the method comprising orally administering to said animal a composition comprising one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus or a source of saponin. 1. A composition for use as an oral anti-parasitic , the composition comprises one or more ofi) an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol{'i': 'Cinnamomum, Eugenia, Eucalyptus', 'ii) an essential oil from genus'}iii) a source of saponin.2Cinnamomum, Eugenia, Eucalyptus.. The composition for use as claimed in claim 1 , which comprises an essential oil containing gamma-terpinene and/or carvacrol claim 1 , and/or thymol claim 1 , and/or terpinenol claim 1 , and/or eucalyptol and/or eugenol and an essential oil from genus3Satureja, Thymus, Trachyspermum, OriganumMelaleuca.. The composition for use as claimed in any one of or claim 1 , wherein the essential oil that contains gamma-terpinene claim 1 , and/or carvacrol claim 1 , and/or thymol claim 1 , and/or terpinenol claim 1 , and/or eucalyptol and/or eugenol include the genus or4Cinnamomum, Eugenia, Eucalyptus.. The composition for use as claimed in any one of to claim 1 , wherein the composition comprises one or more of the essential oils from genus5. The composition for use as claimed in any one of to claim 1 , wherein the source of saponin contains a mixture of steroid saponigenin.6. The composition for use as claimed in any one of to claim 1 , for use in a ...